You are on page 1of 599

Table of Contents

Rpt. 63005827 THE UNITED INDIA INSURANCE COMPANY LIMITED - MERGERS & ACQUISI 2 - 77
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH

Rpt. 63007113 THE ORIENTAL INSURANCE COMPANY LTD. - MERGERS & ACQUISITIONS ( 78 - 116
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH

Rpt. 62363893 GENERAL INSURANCE CORPORATION OF INDIA - MERGERS & ACQUISITION 117 - 234
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH

Rpt. 62364275 RELIANCE GROUP - MERGERS & ACQUISITIONS (M&A), PARTNERSHIPS & 235 - 278
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH

Rpt. 62369890 EDELWEISS FINANCIAL SERVICES LTD 279 - 397


22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH

Rpt. 62371048 IFCI LTD 398 - 549


22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH

Rpt. 65642391 AGRICULTURE-HIGHLIGHTS FROM NABARD’S 3-YEARLY SURVEY 550 - 565


27-Aug-2018 IIFL
- AKELLA, ABHIJIT, ET AL

Rpt. 64756985 NATIONAL INSURANCE COMPANY LTD 566 - 578


08-May-2018 TIMETRIC COMPANY PROFILE
- TIMETRIC DEPARTMENT, ET AL

Rpt. 64921245 UNITED INDIA INSURANCE CO LTD 579 - 599


04-May-2018 TIMETRIC COMPANY SWOT
- TIMETRIC DEPARTMENT, ET AL

These reports were compiled using a product of Thomson Reuters www.thomsonreuters.com

1
MarketLine Financial Deals

Vendor, acquirer, target and partner report for The United India Insurance Company Limited
and its subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint
ventures, Alliances and Investments

The United India Insurance Company Limited –


Mergers & Acquisitions (M&A), Partnerships &
Alliances and Investments

REFERENCE CODE: 5FD038C4-82CA-4015-BAEE-E3C3D5BC8917


PUBLICATION DATE: September 2018
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

2
COMPANY OVERVIEW AND KEY FACTS

COMPANY OVERVIEW AND KEY FACTS

THE UNITED INDIA INSURANCE COMPANY LIMITED

The United India Insurance Company Limited (UIIC) is a general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro insurance, credit insurance, home insurance, personal accident
insurance, and travel insurance. Its commercial policies include fire insurance policies, marine policies, motor
insurance, industry equipments insurance. It also offers accident and hospitalization policies; social policies, rural
policies, travel policies, package policies, and business policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of INR106,917.3 million in FY2015, compare to INR97,089.3 million in
FY2013, representing an annual increase of 10.1%. The net earned premium of the company was INR88,162.3
million in FY2015, compare to INR76,033 million in FY2014, representing an annual increase of 16%.

Key facts

Address 24, Whites Road

State Tamil Nadu

Country India

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Telephone 91 44 28520161

Website www.uiic.co.in

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

3
COMPANY OVERVIEW AND KEY FACTS

The United India Insurance Company Limited activity by deal The United India Insurance Company Limited M&A activity by
type - volume (trailing twelve months (TTM)) geography (TTM)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type Volume Geography Volume

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquisition 1 North America -
Capital raising 1 Europe -
Corporate venturing - Asia-Pacific 1
Divestments - Middle East and Africa -
Partnership - South and Central America -
Private equity -

The United India Insurance Company Limited activity by deal The United India Insurance Company Limited M&A average
type - volume (2014-YTD2018) deal size - value ($m)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) - - - - 1 2014 - -
Capital raising - - - 1 1 2015 - -
(CR) 2016 - -
2017 - -
2018 1 -
Note: Zero deal value indicates transactions with undisclosed deal values

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

4
COMPANY OVERVIEW AND KEY FACTS

TOP DEALS IN (2014 -YTD2018)

Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
($m)

The United India Insurance Company Limited Private


Feb 7, 2018 Completed 139.86
(India) placement

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

5
TABLE OF CONTENTS

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS ............................................ 2

TABLE OF CONTENTS .......................................................................... 5

LIST OF TABLES .................................................................................... 6

LIST OF FIGURES .................................................................................. 6

TARGETS AND PARTNERS .................................................................. 7

MERGERS & ACQUISITIONS ................................................................ 8


Mergers and Acquisitions – Overview ............................................................................................... 8

Mergers and Acquisitions – Deal reports .......................................................................................... 9

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
CORPORATE VENTURING .................................................................. 12
Corporate Venturing – Deal reports ................................................................................................. 12

PARTNERSHIP ..................................................................................... 19
Partnership – Deal reports ................................................................................................................ 19

CAPITAL RAISING ............................................................................... 21


Capital Raising – Overview ............................................................................................................... 21

Capital Raising – Deal reports .......................................................................................................... 22

Divestments – Deal reports ............................................................................................................... 51

APPENDIX............................................................................................. 66
Contact Us ......................................................................................................................................... 66

About MarketLine Financial Deals Database ................................................................................... 66

Deal Definition and Methodology ..................................................................................................... 68

About MarketLine ............................................................................................................................... 75

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

6
TABLE OF CONTENTS

LIST OF TABLES

Table 1: The United India Insurance Company Limited M&A volume and value trend (2014-YTD2018) 8

Table 2: The United India Insurance Company Limited M&A activity by geography (2014-YTD2018) 8

Table 3: The United India Insurance Company Limited capital raising volume and value trend (2014-
YTD2018) 21

Table 4: The United India Insurance Company Limited capital raising by deal type (2014-YTD2018) 21

LIST OF FIGURES

Figure 1: The United India Insurance Company Limited M&A volume and value trend (2014-YTD2018) 8

Figure 2: The United India Insurance Company Limited M&A activity by geography (2014-YTD2018) 8

Figure 3: The United India Insurance Company Limited capital raising volume and value trend (2014-

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
YTD2018) 21

Figure 4: The United India Insurance Company Limited capital raising by deal type (2014-YTD2018) 21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

7
TARGETS AND PARTNERS

TARGETS AND PARTNERS


The United India Insurance Company Limited targets and partners (2014 -YTD2018)

The United India Insurance Company Limited-


Deal Date Deal type Deal value ($m)
Target/Partner name

National Insurance Company Limited (India) Feb 1, 2018 Merger -

The Oriental Insurance Company Ltd. (India) Feb 1, 2018 Merger -

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

8
MERGERS & ACQUISITIONS

MERGERS & ACQUISITIONS


Mergers and Acquisitions – Overview

Figure 1: The United India Insurance Company Limited M&A Figure 2: The United India Insurance Company Limited M&A
volume and value trend (2014-YTD2018) activity by geography (2014-YTD2018)

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 1: The United India Insurance Company Limited M&A Table 2: The United India Insurance Company Limited M&A
volume and value trend (2014-YTD2018) activity by geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 - - North America -

2015 - - Europe -

2016 - - Asia-Pacific 1

2017 - - Middle East and Africa -

2018 1 - South and Central America -

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

9
MERGERS & ACQUISITIONS

Mergers and Acquisitions – Deal reports

Deal Report: Oriental Insurance Company and National Insurance to Merge with United
India Insurance

Deal in brief

Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance
Company Limited., a provider of general insurance for urban and rural customers, to merge with United
India Insurance Co. Ltd., a provider of non-life insurance products and services. All the companies are
based in India.

Upon completion, the merged entity will be listed in stock exchange.

Target 1 The Oriental Insurance Company Ltd.

Target 2 National Insurance Company Limited

Target 3 The United India Insurance Company Limited

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Announced

Deal category Merger

Date of announcement Feb 01, 2018

Company information: Target

Target 1: The Oriental Insurance Company Ltd.

Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and 9

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

10
MERGERS & ACQUISITIONS

Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in

Phone number 91 11 43659595

Target 2: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
10

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

11
MERGERS & ACQUISITIONS

Financial Services-->General Insurance, Property and


Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

11

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

12
CORPORATE VENTURING

CORPORATE VENTURING
Corporate Venturing – Deal reports

Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy

Deal in brief

Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.

Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
on the same terms and conditions.

Target Reliance Energy Limited

Acquirer 1 Reliance Group

Acquirer 2 The United India Insurance Company Limited

Acquirer 3 The Oriental Insurance Company Ltd.

Acquirer 4 New India Assurance Co., Ltd.

Acquirer 5 General Insurance Corporation of India

Acquirer 6 Life Insurance Corporation of India

Acquirer 7 National Insurance Company Limited

Deal status Announced

Deal value (estimated) ($m) 2,000

Deal category Private placement

Offer price ($) 45.72

Offer price (Indian Rupee) (m) 1,812

Date of announcement Dec 02, 2007

Deal rationale

The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas. 12

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

13
CORPORATE VENTURING

Deal financials

Valuation multiples (Reliance Energy Limited)

EV/Revenues 2.41

EV/Operating profit 14.15

EV/EBITDA 11.09

EV/Total assets 1.03

Bid premium (Reliance Energy Limited)

Bid premium (%) 5

Security type information

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type Common stock

Company information: Target and acquirer

Target: Reliance Energy Limited

Company type Private

Reliance Energy Limited is an integrated power utility


company enagaged in the generation, transmission,
distribution, and trading of power in India. It operates gas,
Business description
coal, wind, and hydro-based power generation projects with
aggregate capacity of approximately 13,510 megawatts. The
company is headquartered at Maharashtra, India.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Exploration
Industry Energy and Utilities-->Utilities-->Utilities Networks--
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy
Energy and Utilities-->Natural Resources-->Upstream 13

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

14
CORPORATE VENTURING

Energy-->Production

Address Reliance Energy centre, Santacruz (East)

City Mumbai

State Maharashtra

Country India

Website www.rel.co.in

Phone number 91 22 30099999

Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 65,841.10 1,516.32

Operating profit 11,226.92 258.56

EBITDA 14,330.78 330.04

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Post tax profit 8,014.50 184.57

Key ratios

Operating margin (%) 17.05

Acquirer 1: Reliance Group

Company type Private

Reliance Group is a privately-held industrial conglomerate


engaged in providing services that range from
communications and financial services, to generation,
transmission and distribution of power, infrastructure and
entertainment. The group operates through its subsidiaries,
Business description
Reliance Capital Limited, Reliance Communications Limited,
Reliance Infrastructure, Reliance Entertainment and
Reliance Power Limited. Reliance Group operates in Asia
Pacific, Africa, the Americas and Europe. It is headquartered
in Mumbai, India, and employs around 1,00,000 people.

General Business-->Industrial Conglomorates


Transport and Logistics-->Passenger Transportation-->Road
Industry
Construction and Real Estate
Financial Services
Aerospace and Defense-->Naval Ships

Address Nariman Point, Mumbai 400 021

Country India

Website www.relianceadagroup.com

Phone number 91 22 2278 5000

14

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

15
CORPORATE VENTURING

Acquirer 3: The Oriental Insurance Company Ltd.

Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in

Phone number 91 11 43659595

Acquirer 4: New India Assurance Co., Ltd.

Company type Private

New India Assurance Co., Ltd. provides nonlife insurance


services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai 15

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

16
CORPORATE VENTURING

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Acquirer 5: General Insurance Corporation of India

Company type Public

General Insurance Corporation of India (GIC) is engaged in


providing reinsurance services to the general insurers in
India. Its reinsurance portfolio includes oil and energy,
Business description aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the
UAE, Malaysia, South Africa and Russia. It is headquartered
in Mumbai, India.

Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending

Address Suraksha, 170 Jamshedji Tata Road

Country India

Website www.gicofindia.com

Phone number 91 22 2286 7000

Acquirer 6: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra
16

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

17
CORPORATE VENTURING

Country India

Website www.licindia.com

Phone number 91 22 22021625

Acquirer 7: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
17

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

18
CORPORATE VENTURING

Financial Services-->General Insurance, Property and


Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

18

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

19
CORPORATE VENTURING

PARTNERSHIP
Partnership – Deal reports

Deal Report: Tata Motors partners with United India Insurance Company

Deal in brief

Tata Motors Limited, a manufacturer of medium and heavy commercial vehicles, has entered into a
partnership agreement with United India Insurance Company Limited, a general insurance company, to
offer insurance for the Tata Nano at a rate of 2.76% of the ex-showroom price of the car. Both the
companies are based in India.

Tata Nano is a passenger car manufactured by Tata Motors.

Partner 1 The United India Insurance Company Limited

Partner 2 Tata Motors Limited

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Completed

Deal category Partnership

Deal sub-category Co-marketing

Date of completion Apr 08, 2009

Company information: Partners

Partner 1: Tata Motors Limited

Company type Public

Stock exchange BOM(Bombay Stock Exchange)

Ticker symbol 500570

Tata Motors Limited (Tata Motors or 'the company') is an


automotive manufacturing company engaged in the
development, design, manufacture and assembly, sale, and
financing of vehicles, as well as sale of auto parts and
Business description
accessories. The company primarily operates in India,
China, South Korea, South Africa, Thailand, Indonesia,
Singapore, Spain, and the UK. The company is
headquartered in Mumbai, India.

Automotive
Automotive-->Parts, Tires and Aftermarket
Industry Automotive-->Vehicle Manufacturing-->Automobiles
Automotive-->Vehicle Manufacturing-->Commercial
Vehicles-->Bus and Coach
Automotive-->Vehicle Manufacturing-->Commercial 19

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

20
CORPORATE VENTURING

Vehicles-->Light Commercial Vehicles


Automotive-->Vehicle Manufacturing-->Commercial
Vehicles-->Trucks

Address Bombay House, 24, Homi Mody Street

City Mumbai

State Maharashtra

Country India

Website http://www.tatamotors.com/

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

20

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

21
CAPITAL RAISING

CAPITAL RAISING

Capital Raising – Overview

Figure 3: The United India Insurance Company Limited Figure 4: The United India Insurance Company Limited
capital raising volume and value trend (2014-YTD2018) capital raising by deal type (2014-YTD2018)

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 3: The United India Insurance Company Limited capital Table 4: The United India Insurance Company Limited capital
raising volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)

Year Volume Value ($m) Deal Type Volume

2014 - - Public offering 1

2015 - - Private placement 1

2016 - -

2017 1 -

2018 1 139.86

21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

22
CAPITAL RAISING

Capital Raising – Deal reports

Deal Report: United India Insurance Raises USD139.86 Million in Bonds Offering

Deal in brief

United India Insurance Co. Ltd., an India-based provider of non-life insurance products and services, has
raised INR9 billion (USD139.86 million) in a subordinated debt offering.

The issued bonds bear an interest rate of 8.25%, for a 10-year period with a call option after five years.

United India Insurance had generated a net loss of INR9.14 billion (USD142.82 million) for the year ended
March 2017.

Target The United India Insurance Company Limited

Acquirer Undisclosed Investor(s)

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Completed

Deal value ($m) 139.86

Deal value (Indian Rupee)(m) 9,000

Deal category Private placement

Date of completion Feb 07, 2018

Security type information

Security type Debt

Company information: Target and acquirer

Acquirer: Undisclosed Investor(s)

Company type Private

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Industry Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
22

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

23
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and 23

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

24
CAPITAL RAISING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 24

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

25
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and 25

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

26
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment 26

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

27
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Healthcare-->Healthcare


Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare 27

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

28
CAPITAL RAISING

Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 28

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

29
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and 29

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

30
CAPITAL RAISING

Diagnostics-->Patient Monitoring Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy 30

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

31
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 31

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

32
CAPITAL RAISING

Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 32

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

33
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 33

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

34
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices 34

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

35
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 35

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

36
CAPITAL RAISING

Diagnostics-->Disposable Medical Products


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 36

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

37
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 37

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

38
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration 38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

39
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 39

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

40
CAPITAL RAISING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 40

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

41
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and 41

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

42
CAPITAL RAISING

Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics 42

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

43
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and 43

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

44
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 44

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

45
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 45

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

46
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 46

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

47
CAPITAL RAISING

Diagnostics-->CNS and Neurological Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment 47

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

48
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
48

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

49
CAPITAL RAISING

Deal Report: Government of India to divest 25% stake in United India Insurance

Deal in brief

According to Moneycontrol, The Government of India (GOI) has agreed to divest a 25% stake in United
India Insurance Company Limited, an India-based general insurance company, through listing the company
on stock exchanges. The listing will be either by fresh equity or offer for sale.

Concurrently, GOI has agreed to sell a 25% stake in each of New India Assurance Co., Ltd., The Oriental
Insurance Company Ltd., National Insurance Company Limited and General Insurance Corporation of
India.

Target The United India Insurance Company Limited

Seller/Vendor Government of India

Deal status Announced

Deal category IPO

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Filing , ipo

% to Public 25

Date of announcement Jan 18, 2017

Company information: Target and seller/vendor

Vendor: Government of India

Company type Private

Government and Non-Profit Organisations


Government and Non-Profit Organisations-->Governmental
Organizations
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Industry
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels
Environmental and Waste Management Services-->Sewage
Treatment Facilities
Construction and Real Estate-->Heavy Construction 49

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

50
CAPITAL RAISING

Construction and Real Estate-->Real Estate Transactions


Energy and Utilities-->Utilities-->Power Generation
Transport and Logistics-->Transport Infrastructure--
>Highway Operators
Transport and Logistics-->Transport Infrastructure
Transport and Logistics-->Transport Infrastructure-->Port
and Harbor Operations
Transport and Logistics-->Transport Infrastructure-->Rail
Infrastructure
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics

State Delhi

Country India

50

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

51
DIVESTMENTS

Divestments – Deal reports

Deal Report: IDBI to acquire 81% stake in Stock Holding Corporation

Deal in brief

IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.

IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.

The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.

Target Stock Holding Corporation of India Limited

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Acquirer IDBI Bank Limited

Seller/Vendor 1 Specified Undertaking of Unit Trust of India

Seller/Vendor 2 IFCI Limited

Seller/Vendor 3 The United India Insurance Company Limited

Seller/Vendor 4 New India Assurance Co., Ltd.

Seller/Vendor 5 The Oriental Insurance Company Ltd.

Seller/Vendor 6 National Insurance Company Limited

Seller/Vendor 7 Life Insurance Corporation of India

Seller/Vendor 8 General Insurance Corporation of India

Deal status Announced

Deal value (estimated) ($m) 259.94 (min)

Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 81

Date of announcement Nov 01, 2012

Company information: Target, acquirer, and seller/vendor


-2018

51

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

52
DIVESTMENTS

Target: Stock Holding Corporation of India Limited

Company type Private

Stock Holding Corporation of India Limited (SHCIL) is a


Business description provider of custodial and depository services, and other
financial services.

Financial Services-->Capital Markets and Trading


Industry
Financial Services-->Savings and Investments-->Mutual
Funds

Address SHCIL House, Plot No.P-51, TTC Industrial Area

City Mumbai

State Maharashtra

Country India

Acquirer: IDBI Bank Limited

Company type Private

IDBI Bank is a financial holding company. The company,

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->Payments
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management

Address IDBI Tower, WTC Complex, Cuffe Parade, Colaba

City Mumbai

State Maharashtra

Country India

Website www.idbi.com

Phone number 91 22 2218 9111

Vendor 1: Specified Undertaking of Unit Trust of India

Company type Private


-2018

Vendor 2: IFCI Limited

52

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

53
DIVESTMENTS

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500106

IFCI is an India-based financial institution that offers a


variety of financial products and services. The company
offers a range of financial products that includes debt
products and products related to the equity and other
Business description business segments. IFCI also provides corporate advisory
services, infrastructure advisory services, and monitors
public issues. The company also acts as a debenture trustee
for debentures issued by other companies. The company
operates in India, where it is headquartered in New Delhi.

Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Address IFCI Tower, 61 Nehru Place

City New Delhi

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
State Delhi

Country India

Website www.ifciltd.com

Phone number 91 11 4179 2800

Vendor 4: New India Assurance Co., Ltd.

Company type Private

New India Assurance Co., Ltd. provides nonlife insurance


services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai

Country India
-2018

Website www.niacl.com

53

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

54
DIVESTMENTS

Phone number 91 22 2267 461

Vendor 5: The Oriental Insurance Company Ltd.

Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in

Phone number 91 11 43659595

Vendor 6: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
householders insurance, and Janata personal accident
Business description insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
-2018

insurance, machinery insurance, electronic equipment


insurance, commercial risk insurance, workmen
54

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

55
DIVESTMENTS

compensation insurance, product liability insurance, and


public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

Vendor 7: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


-2018

Business description insurance company in India. Its offers various products


which include insurance plans, pension plans, unit plans,
55

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

56
DIVESTMENTS

special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Vendor 8: General Insurance Corporation of India

Company type Public

General Insurance Corporation of India (GIC) is engaged in


providing reinsurance services to the general insurers in
India. Its reinsurance portfolio includes oil and energy,

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Business description aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the
UAE, Malaysia, South Africa and Russia. It is headquartered
in Mumbai, India.

Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending

Address Suraksha, 170 Jamshedji Tata Road

Country India

Website www.gicofindia.com

Phone number 91 22 2286 7000


-2018

56

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

57
DIVESTMENTS

Deal Report: Orbis Power Venture and India Power Corporation Acquires 93% Stake in
DPSC from Andrew Yule, Life Insurance Corporation of India and United India Insurance

Deal in brief

Orbis Power Venture Private Limited, power generation company and India Power Corporation Limited., a
power generation company, have acquired 93% stake in DPSC Limited (formerly Dishergarh Power Supply
Co. Ltd.), a company engaged in generation, transmission and distribution of electric energy, from Andrew
Yule & Company Ltd, Life Insurance Corporation of India (LIC) and The United India Insurance Co Ltd.

Target DPSC Limited

Acquirer 1 India Power Corporation Limited

Acquirer 2 Orbis Power Venture Private Limited

Seller/Vendor 1 The United India Insurance Company Limited

Seller/Vendor 2 Life Insurance Corporation of India

Seller/Vendor 3 Andrew Yule & Company Ltd

Deal status Completed

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 93

Date of completion Nov 30, 2009

Company information: Target, acquirer, and seller/vendor

Target: DPSC Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol DPSCLTD

DPSC Limited (formerly Dishergarh Power Supply Co. Ltd.)


Business description
is engaged in power generation.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Industry
Energy and Utilities-->Utilities-->Power Generation
Energy and Utilities-->Utilities-->Utilities Networks--
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
-2018

>Transmission

57

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

58
DIVESTMENTS

Address Plot No.-X-1, 2 & 3 Block EP, Sector-V

City Kolkata

State West Bengal

Country India

Website www.dpscl.com

Phone number 91 33 23577016

Acquirer 1: India Power Corporation Limited

Company type Private

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Industrial Goods and Machinery-->Power Engineering--
>Transmission And Distribution
Industrial Goods and Machinery-->Power Engineering--
>Transmission And Distribution
Industrial Goods and Machinery-->Power Engineering--
>Power Generation

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Industry Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Solar
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Energy and Utilities-->Utilities-->Utilities Networks--
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Utilities-->Wholesale Energy
Energy and Utilities-->Utilities-->Power Generation

Address 2nd Floor, Plot no. X – 1, 2 & 3, Block – EP, Sector – V

City Kolkata

State West Bengal

Country India

Website www.indiapower.com

Phone number 91 33 66094300

Acquirer 2: Orbis Power Venture Private Limited


-2018

Company type Private


58

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

59
DIVESTMENTS

Industry Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services

Address Mirania Gardens, 10B, Topsia Road (East)

City Kolkata

State West Bengal

Country India

Phone number 91 33 39873903

Vendor 2: Life Insurance Corporation of India

Company type Private

Life Insurance Corporation of India (LIC), owned by the


Government of India, is a provider of life insurance. The
company offers various life insurance plans such as
individual plans, pension plans, special plans, unit plans,
group schemes, child plans and health insurance plans. LIC
operates through zonal offices located in Mumbai, Kolkata,
Chennai, Hyderabad, Delhi, Kanpur, Bhopal and Patna. It

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
offers insurance products in India through associates and
Business description agents. Internationally, LIC and its associates have
operations in Fiji, Mauritius, the UK, Bahrain, Dubai, Abu
Dhabi, Kuwait, Qatar, Oman, Nepal, Sri Lanka, Saudi Arabia
and Kenya. LIC is headquartered in Mumbai, Maharashtra,
India.

For the FY2016, the company reported net earned premiums


of INR47 million, reflecting a decrease of 2% comparatively
to the FY2015.

Financial Services-->Life and Pensions-->Life and Protection


Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Construction and Real Estate-->Real Estate Transactions
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
-2018

Address Yogakshema, Jeevan Bima Marg

59

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

60
DIVESTMENTS

City Mumbai

State Maharashtra

Country India

Website www.licindia.in

Vendor 3: Andrew Yule & Company Ltd

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 526173

Andrew Yule & Company Ltd. (Andrew Yule) is a clean


technology company that provides engineering and
environment products. The company offers engineering and
environment equipment; lubricants, transformers and switch
gears; turnkey projects, lamp filaments and
telecommunication systems. Its engineering and
environment equipment include industrial fans and blowers;
Business description
air pollution control systems, tea processing machinery and
effluent and water treatment systems. Andrew Yule offers

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
telecommunication systems such as digital microwave radio,
fibre optic telecommunications and programmable digital
MUX. The company’s lubricants comprise automative
lubricants, industrial lubricants and greases. Andrew Yule is
headquartered in Kolkata, West Bengal, India.

Financial Services-->General Insurance, Property and


Casualty-->Commercial Insurance
Environmental and Waste Management Services
Industrial Goods and Machinery-->Power Engineering--
>Transmission And Distribution
Industry
Industrial Goods and Machinery-->Power Engineering--
>Transmission And Distribution
Environmental and Waste Management Services-->Sewage
Treatment Facilities
Agriculture and Forestry-->Agriculture-->Tea Growing
Technology and Services

Address 8,YULE HOUSE, Dr. Rajendra Prasad Sarani

City KOLKATA

State Andhra Pradesh

Country India

Website www.andrewyule.com

Phone number 91 33 22428210


-2018

60

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

61
DIVESTMENTS

Deal Report: SREI Infrastructure acquires 57.17% stake in Dishergarh Power Supply
Company (DPSC)

Deal in brief

SREI Infrastructure Finance Limited has acquired a 57.17% stake in Dishergarh Power Supply Company,
Ltd. (DPSC), a company engaged in generation, transmission and distribution of power, from Andrew Yule
& Co., Ltd. (7.12%), The Life Insurance Corporation of India (LIC) (30.61%), United India Insurance
Company Limited (11.36%), Bengal Coal Company, Ltd. (3.38%) and Katras Jherriah Coal Company, Ltd.
(4.70%). The transaction is valued at approximately INR1,720 million ($37 million). All the companies are
based in India.

SREI Infrastructure is an infrastructure equipment finance and infrastructure project finance company, and
a non-banking financial institution.

Announcement (February 2, 2009):

SREI Infrastructure plans to acquire a 57.17% stake in DPSC from Andrew Yule, LIC, United India
Insurance Company, Bengal Coal Company and Katras Jherriah Coal Company.

CESC Limited, Reliance Energy Limited, Patton International, Ltd., Coal India Limited, JSW Energy Limited
and Jessop & Co. Ltd. are also in the race to acquire the stake.

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Andrew Yule has appointed Amarchand & Mangaldas & Suresh A. Shroff & Co. as legal advisor. Deloitte
Touche Tohmatsu would evaluate the bids.

Target DPSC Limited

Acquirer SREI Infrastructure Finance Limited

Seller/Vendor 1 Katras Jherriah Coal Company, Ltd.

Seller/Vendor 2 The United India Insurance Company Limited

Seller/Vendor 3 Life Insurance Corporation of India

Seller/Vendor 4 Bengal Coal Company, Ltd.

Seller/Vendor 5 Andrew Yule & Co Ltd.

Deal status Completed

Deal value (estimated) ($m) 37

Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 57.17

Date of announcement Feb 02, 2009

Date of completion Jan 28, 2010


-2018

61

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

62
DIVESTMENTS

Company information: Target, acquirer, and seller/vendor

Target: DPSC Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol DPSCLTD

DPSC Limited (formerly Dishergarh Power Supply Co. Ltd.)


Business description
is engaged in power generation.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Industry
Energy and Utilities-->Utilities-->Power Generation
Energy and Utilities-->Utilities-->Utilities Networks--
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission

Address Plot No.-X-1, 2 & 3 Block EP, Sector-V

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
City Kolkata

State West Bengal

Country India

Website www.dpscl.com

Phone number 91 33 23577016

Acquirer: SREI Infrastructure Finance Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol SREINFRA

Srei Infrastructure Finance Limited (Srei) is an infrastructure-


focused public sector non-banking financial service provider.
The company offers a range of infrastructure solutions,
including financing, advisory services and development. Its
product includes term loans, syndicate loans, corporate
loans and working capital loans. The company also offers
services, including infrastructure equipment financing and
Business description leasing, infrastructure project financing, project advisory and
development, insurance broking, venture capital, and capital
market services. It also invests in various sectors, including
telecom infrastructure, transportation, power, and SEZ and
industrial parks. Srei serves its customers through a network
of branches across India. It operates in Russia, Germany,
Singapore, Mauritius, and Nigeria. Srei is headquartered in
-2018

Kolkata, India.
62

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

63
DIVESTMENTS

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Exploration
Financial Services
Financial Services-->Institutional Investment Management
Financial Services-->Institutional Investment Management
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
Industry >Project, Asset and Structured Finance
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking
Financial Services-->Institutional Investment Management
Construction and Real Estate-->Heavy Construction--
>Bridge Construction
Energy and Utilities-->Natural Resources-->Upstream
Energy
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production

Address 6A, Kiran Shankar Roy Road

City Kolkata

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
State West Bengal

Country India

Website www.srei.com

Phone number 91 33 64990230

Vendor 1: Katras Jherriah Coal Company, Ltd.

Company type Private

Katras Jherriah Coal Company, Ltd. is a coal mining


Business description
company.

Industry Energy and Utilities-->Commodity-->Coal


Metals and Mining-->Coal Mining

State West Bengal

Country India

Vendor 3: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
-2018

special plans, and group schemes.

63

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

64
DIVESTMENTS

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Vendor 4: Bengal Coal Company, Ltd.

Company type Private

Business description Bengal Coal Company, Ltd. is a coal mining company.

Industry Energy and Utilities-->Commodity-->Coal


Metals and Mining-->Coal Mining

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Country India

Vendor 5: Andrew Yule & Co Ltd.

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 526173

Andrew Yule & Co (AYCL) is an India-based company,


engaged in the manufacturing and marketing of tea,
electrical and engineering equipment. The company is also
Business description engaged in the activity of printing through its subsidiary,
Hooghly Printing. The company primarily operates India,
where it is headquartered in Kolkata and employs around
14,860 people.

Agriculture and Forestry-->Agriculture-->Tea Growing


Industry General Business
Industrial Goods and Machinery-->Electrical Components
and Equipment

Address Yule House, 8 Dr Rajendra Prasad Sarani

Country India

Website www.andrewyule.com

Phone number 91 33 2242 8210


-2018

64

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

65
DIVESTMENTS

Advisor information

Vendors 5: Andrew Yule & Co Ltd.

Legal advisors

Amarchand & Mangaldas & Suresh A. Shroff & Co

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
-2018

65

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

66
APPENDIX

APPENDIX
Contact Us

We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com

About MarketLine Financial Deals Database

• Financial Deals is the most extensive Deals database currently available in the market

• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
– private placement
– partnership deal

• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms

• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.

• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.

• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
-2018

investment banks, and industry experts.

66

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

67
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

67

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

68
APPENDIX

Deal Definition and Methodology

Deal type definition

Merger

A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:

 All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.

 Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.

 The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.

 The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.

 No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.

Acquisition

Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:

 Minority acquisition: The acquisition of less than 50% equity stake in the target

 Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target

 100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target

 Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity

Private equity

Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:

 Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company

 Secondary buyout: PE firm or a group of PE firms acquiring a company from a PE firm


68

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

69
APPENDIX
 Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds

 Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.

 Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team

 Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed

 Exit: PE firm selling its stake in a portfolio company

Private placement

A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Venture financing

Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:

 Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept

 Start-up: Financing provided to companies for developing their product/service and to


purchase the necessary assets for their production/operation

 Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products

 Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities

 Exit: This node is assigned when a venture capital is selling its stake in a portfolio company

Initial Public Offering

 Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:

 Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO

 Pricing: When the company fixes the issue price for its offering

69

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

70
APPENDIX
 Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering

 Withdrawn: When the company withdraws its IPO

 Postponed: When the company postpones its IPO

Partnership

A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:

 Joint Venture (JV): Two or more companies forming a new entity to undertake an activity

 Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.

 Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
customer base is not involved in the product/service development or any other obligations
relating to such product/service

 Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.

Deal status details

Financial Deals captures deal status according to following stages:

 Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
 Announced: Either party involved in the transaction announces the deal
 Completed: Involved parties complete the transaction
 Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
 Dead rumor: Rumor denied by either of the parties involved in the transaction

Deal value

Deal value is the consideration paid by the acquirer for acquiring the target.

Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.

All deals values which are mentioned as approximate consideration are tagged as estimated values.

Deal value criteria for filtering deals


70

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

71
APPENDIX

For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.

Deal payment details


Deal payment is captured in the following fields:

Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:

 Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer

 Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer

 Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer

 Quantity type: It indicates the consideration by payment mode in terms of value and
percentage

% acquired: % acquired indicates the stock acquired in percentage terms

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Share price paid: Price per share offered by the acquirer to the target

Debt-related fields
Below is the list of fields captured:

Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:

 Lead: Represents the lead debt provide


 Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers

Debt amount: Amount of debt raised by the acquirer to finance the acquisition

Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:

 Bank facilities: These are general loans provided by banks to companies.

 Senior: Debt that has priority for repayment in liquidation.

 Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.

 Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.

 Other debt: Any other debt facility other than the above mentioned debt categories.

71

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

72
APPENDIX

Securities issued to finance deal


Below is a list of category and sub-category of securities issued by the acquirer, captured in FD:

Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:

 Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder

 Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio

 Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date

 Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)

 Placing: General term to describe the process of raising money via the issue of new shares

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public

 Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period

 Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings

 Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).

Financial and operational information

Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:

Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.

No. of employees: Number of employees at the fiscal year end


Local currency: The currency in which the company is reporting its financial statements

72

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

73
APPENDIX

Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers

Revenue (banking): This value is sum of interest income and non interest income

Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.

EBITDA: Earnings before interest, taxes, depreciation and amortization

Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax

Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.

Enterprise value: Enterprise value is calculated by adding a company’s market capitalization,


preferred stock, minority interest, and outstanding debt together and then subtracting out the cash
and cash equivalents found on the balance sheet as on the fiscal year end

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Shares issued: Number of shares the company has issued out of its authorized capital

Market capitalization: Market capitalization is calculated by taking the number of outstanding


shares of common stock multiplied by the market price-per-share as on fiscal year end

Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.

Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth

Net assets-share ratio: It is defined as net assets divided by number of shares outstanding

Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares

Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.

Deal multiples

Financial Deals captures the following four valuation multiples:


 EV/revenues
 EV/EBIT
 EV/EBITDA
 EV/total assets

73

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

74
APPENDIX

Advisor information

Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:

Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.

Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:

 Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts

 Accounting: Financial advisor who looks into the accounting matters for a deal

 Tax: Financial advisor who looks into the tax matters for a deal

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Corporate Finance: Financial advisor who looks into the financial decisions of a corporation

 Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue

 Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body

 Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted

 Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other

Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities

Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders

74

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

75
APPENDIX

About MarketLine

In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.

At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.

Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.

MarketLine is a wholly owned subsidiary of Informa.

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

75

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

76
APPENDIX

The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

MARKETLINE | 119 FARRINGDON ROAD | LONDON,


UNITED KINGDOM, EC1R 3DA
76
T: + 44 161 238 4040| F: + 44 870 134 4371
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
E: REACHUS@MARKETLINE.COM
77
MarketLine Financial Deals

Vendor, acquirer, target and partner report for The Oriental Insurance Company Ltd. and its
subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint ventures,
Alliances and Investments

The Oriental Insurance Company Ltd. –


Mergers & Acquisitions (M&A), Partnerships &
Alliances and Investments

REFERENCE CODE: 92E7D17C-95D2-43FB-A172-F8500C5FBF55


PUBLICATION DATE: September 2018
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

78
COMPANY OVERVIEW AND KEY FACTS

COMPANY OVERVIEW AND KEY FACTS

THE ORIENTAL INSURANCE COMPANY LTD.

The Oriental Insurance Company Ltd. (Oriental Insurance), a wholly owned subsidiary of Oriental Government
Security Life Assurance Company Ltd, provides various general insurance services in the urban and rural sectors in
India. The company designs insurance coverage for projects, including power plants, petrochemical, steel and
chemical plants among otehrs. Oriental Insurance offers motor insurance policies, personal accident policy, Janata
personal accident policy, shopkeeper policy, householder policy, Nagarik suraksha policy and health insaurance
policies among others. It operates in across India and also has overseas operations in Nepal, Kuwait and Dubai.
Oriental Insurance is headquartered in New Delhi, India.

Key facts

Address Oriental House, A 25 27 Asaf Ali Road

State Delhi

Country India

Telephone 91 11 43659595

Website www.orientalinsurance.org.in

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
-

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

79
COMPANY OVERVIEW AND KEY FACTS

The Oriental Insurance Company Ltd. activity by deal type - The Oriental Insurance Company Ltd. M&A activity by
volume (trailing twelve months (TTM)) geography (TTM)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type Volume Geography Volume


Acquisition 1 North America -
Capital raising - Europe -

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Corporate venturing - Asia-Pacific 1
Divestments - Middle East and Africa -
Partnership - South and Central America -
Private equity -

The Oriental Insurance Company Ltd. activity by deal type - The Oriental Insurance Company Ltd. M&A average deal size
volume (2014-YTD2018) - value ($m)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) - - - - 1 2014 - -
Capital raising - - - 1 - 2015 - -
(CR) 2016 - -
2017 - -
2018 1 -
Note: Zero deal value indicates transactions with undisclosed deal values

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

80
TABLE OF CONTENTS

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS ............................................ 2

TABLE OF CONTENTS .......................................................................... 4

LIST OF TABLES .................................................................................... 5

LIST OF FIGURES .................................................................................. 5

TARGETS AND PARTNERS .................................................................. 6

MERGERS & ACQUISITIONS ................................................................ 7


Mergers and Acquisitions – Overview ............................................................................................... 7

Mergers and Acquisitions – Deal reports .......................................................................................... 8

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
CORPORATE VENTURING .................................................................. 12
Corporate Venturing – Deal reports ................................................................................................. 12

CAPITAL RAISING ............................................................................... 19


Capital Raising – Overview ............................................................................................................... 19

Capital Raising – Deal reports .......................................................................................................... 20

Divestments – Deal reports ............................................................................................................... 22

APPENDIX............................................................................................. 29
Contact Us ......................................................................................................................................... 29

About MarketLine Financial Deals Database ................................................................................... 29

Deal Definition and Methodology ..................................................................................................... 31

About MarketLine ............................................................................................................................... 38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

81
TABLE OF CONTENTS

LIST OF TABLES

Table 1: The Oriental Insurance Company Ltd. M&A volume and value trend (2014-YTD2018) 7

Table 2: The Oriental Insurance Company Ltd. M&A activity by geography (2014-YTD2018) 7

Table 3: The Oriental Insurance Company Ltd. capital raising volume and value trend (2014-YTD2018) 19

Table 4: The Oriental Insurance Company Ltd. capital raising by deal type (2014-YTD2018) 19

LIST OF FIGURES

Figure 1: The Oriental Insurance Company Ltd. M&A volume and value trend (2014-YTD2018) 7

Figure 2: The Oriental Insurance Company Ltd. M&A activity by geography (2014-YTD2018) 7

Figure 3: The Oriental Insurance Company Ltd. capital raising volume and value trend (2014-YTD2018) 19

Figure 4: The Oriental Insurance Company Ltd. capital raising by deal type (2014-YTD2018) 19

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

82
TARGETS AND PARTNERS

TARGETS AND PARTNERS


The Oriental Insurance Company Ltd. targets and partners (2014 -YTD2018)

The Oriental Insurance Company Ltd.-Target/Partner


Deal Date Deal type Deal value ($m)
name

National Insurance Company Limited (India) Feb 1, 2018 Merger -

The United India Insurance Company Limited (India) Feb 1, 2018 Merger -

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

83
MERGERS & ACQUISITIONS

MERGERS & ACQUISITIONS


Mergers and Acquisitions – Overview

Figure 1: The Oriental Insurance Company Ltd. M&A volume Figure 2: The Oriental Insurance Company Ltd. M&A activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 1: The Oriental Insurance Company Ltd. M&A volume Table 2: The Oriental Insurance Company Ltd. M&A activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 - - North America -

2015 - - Europe -

2016 - - Asia-Pacific 1

2017 - - Middle East and Africa -

2018 1 - South and Central America -

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

84
MERGERS & ACQUISITIONS

Mergers and Acquisitions – Deal reports

Deal Report: Oriental Insurance Company and National Insurance to Merge with United
India Insurance

Deal in brief

Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance
Company Limited., a provider of general insurance for urban and rural customers, to merge with United
India Insurance Co. Ltd., a provider of non-life insurance products and services. All the companies are
based in India.

Upon completion, the merged entity will be listed in stock exchange.

Target 1 The Oriental Insurance Company Ltd.

Target 2 National Insurance Company Limited

Target 3 The United India Insurance Company Limited

Deal status Announced

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category Merger

Date of announcement Feb 01, 2018

Company information: Target

Target 2: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Industry
Financial Services-->General Insurance, Property and 8

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

85
MERGERS & ACQUISITIONS

Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

Target 3: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s
personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro
Business description
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
9

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

86
MERGERS & ACQUISITIONS

rural policies, travel policies, package policies, and business


policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss

Address 24, Whites Road

City Chennai

State Tamil Nadu


10

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

87
MERGERS & ACQUISITIONS

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

11

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

88
CORPORATE VENTURING

CORPORATE VENTURING
Corporate Venturing – Deal reports

Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy

Deal in brief

Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.

Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
on the same terms and conditions.

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target Reliance Energy Limited

Acquirer 1 Reliance Group

Acquirer 2 The United India Insurance Company Limited

Acquirer 3 The Oriental Insurance Company Ltd.

Acquirer 4 New India Assurance Co., Ltd.

Acquirer 5 General Insurance Corporation of India

Acquirer 6 Life Insurance Corporation of India

Acquirer 7 National Insurance Company Limited

Deal status Announced

Deal value (estimated) ($m) 2,000

Deal category Private placement

Offer price ($) 45.72

Offer price (Indian Rupee) (m) 1,812

Date of announcement Dec 02, 2007

Deal rationale

The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas. 12

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

89
CORPORATE VENTURING

Deal financials

Valuation multiples (Reliance Energy Limited)

EV/Revenues 2.41

EV/Operating profit 14.15

EV/EBITDA 11.09

EV/Total assets 1.03

Bid premium (Reliance Energy Limited)

Bid premium (%) 5

Security type information

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type Common stock

Company information: Target and acquirer

Target: Reliance Energy Limited

Company type Private

Reliance Energy Limited is an integrated power utility


company enagaged in the generation, transmission,
distribution, and trading of power in India. It operates gas,
Business description
coal, wind, and hydro-based power generation projects with
aggregate capacity of approximately 13,510 megawatts. The
company is headquartered at Maharashtra, India.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Exploration
Industry Energy and Utilities-->Utilities-->Utilities Networks--
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy
Energy and Utilities-->Natural Resources-->Upstream 13

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

90
CORPORATE VENTURING

Energy-->Production

Address Reliance Energy centre, Santacruz (East)

City Mumbai

State Maharashtra

Country India

Website www.rel.co.in

Phone number 91 22 30099999

Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 65,841.10 1,516.32

Operating profit 11,226.92 258.56

EBITDA 14,330.78 330.04

Post tax profit 8,014.50 184.57

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Key ratios

Operating margin (%) 17.05

Acquirer 1: Reliance Group

Company type Private

Reliance Group is a privately-held industrial conglomerate


engaged in providing services that range from
communications and financial services, to generation,
transmission and distribution of power, infrastructure and
entertainment. The group operates through its subsidiaries,
Business description
Reliance Capital Limited, Reliance Communications Limited,
Reliance Infrastructure, Reliance Entertainment and
Reliance Power Limited. Reliance Group operates in Asia
Pacific, Africa, the Americas and Europe. It is headquartered
in Mumbai, India, and employs around 1,00,000 people.

General Business-->Industrial Conglomorates


Transport and Logistics-->Passenger Transportation-->Road
Industry
Construction and Real Estate
Financial Services
Aerospace and Defense-->Naval Ships

Address Nariman Point, Mumbai 400 021

Country India

Website www.relianceadagroup.com

Phone number 91 22 2278 5000

14

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

91
CORPORATE VENTURING

Acquirer 2: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s
personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
Business description rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Industry Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
15

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

92
CORPORATE VENTURING

Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss

Address 24, Whites Road

City Chennai

State Tamil Nadu

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

Acquirer 4: New India Assurance Co., Ltd.

Company type Private

New India Assurance Co., Ltd. provides nonlife insurance

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Acquirer 5: General Insurance Corporation of India

Company type Public

General Insurance Corporation of India (GIC) is engaged in


providing reinsurance services to the general insurers in
India. Its reinsurance portfolio includes oil and energy,
Business description aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the
UAE, Malaysia, South Africa and Russia. It is headquartered
in Mumbai, India.
16

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

93
CORPORATE VENTURING

Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending

Address Suraksha, 170 Jamshedji Tata Road

Country India

Website www.gicofindia.com

Phone number 91 22 2286 7000

Acquirer 6: Life Insurance Corporation of India

Company type Private

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
The Life Insurance Corporation of India (LIC) is a life
insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Acquirer 7: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
Business description
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance, 17

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

94
CORPORATE VENTURING

dog insurance, brackish water prawn insurance, silkworm


insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

18

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

95
CAPITAL RAISING

CAPITAL RAISING

Capital Raising – Overview

Figure 3: The Oriental Insurance Company Ltd. capital Figure 4: The Oriental Insurance Company Ltd. capital
raising volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Table 3: The Oriental Insurance Company Ltd. capital raising Table 4: The Oriental Insurance Company Ltd. capital raising
volume and value trend (2014-YTD2018) by deal type (2014-YTD2018)

Year Volume Value ($m) Deal Type Volume

2014 - - Public offering 1

2015 - -

2016 - -

2017 1 -

2018 - -

19

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

96
CAPITAL RAISING

Capital Raising – Deal reports

Deal Report: Government of India to divest 25% stake in Oriental Insurance

Deal in brief

According to Moneycontrol, The Government of India (GOI) has agreed to divest a 25% stake in The
Oriental Insurance Company Limited, an India-based non-life insurance company, through listing the
company on stock exchanges. The listing will be either by fresh equity or offer for sale.

Concurrently, GOI has agreed to sell a 25% stake in each of New India Assurance Co., Ltd., United India
Insurance Co., Ltd., National Insurance Company Limited and General Insurance Corporation of India.

Target The Oriental Insurance Company Ltd.

Seller/Vendor Government of India

Deal status Announced

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category IPO

Deal sub-category Filing , ipo

% to Public 25

Date of announcement Jan 18, 2017

Company information: Target and seller/vendor

Vendor: Government of India

Company type Private

Government and Non-Profit Organisations


Government and Non-Profit Organisations-->Governmental
Organizations
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Industry Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels 20

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

97
CAPITAL RAISING

Environmental and Waste Management Services-->Sewage


Treatment Facilities
Construction and Real Estate-->Heavy Construction
Construction and Real Estate-->Real Estate Transactions
Energy and Utilities-->Utilities-->Power Generation
Transport and Logistics-->Transport Infrastructure--
>Highway Operators
Transport and Logistics-->Transport Infrastructure
Transport and Logistics-->Transport Infrastructure-->Port
and Harbor Operations
Transport and Logistics-->Transport Infrastructure-->Rail
Infrastructure
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

State Delhi

Country India

21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

98
DIVESTMENTS

Divestments – Deal reports

Deal Report: IDBI to acquire 81% stake in Stock Holding Corporation

Deal in brief

IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.

IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.

The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.

Target Stock Holding Corporation of India Limited

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer IDBI Bank Limited

Seller/Vendor 1 Specified Undertaking of Unit Trust of India

Seller/Vendor 2 IFCI Limited

Seller/Vendor 3 The United India Insurance Company Limited

Seller/Vendor 4 New India Assurance Co., Ltd.

Seller/Vendor 5 The Oriental Insurance Company Ltd.

Seller/Vendor 6 National Insurance Company Limited

Seller/Vendor 7 Life Insurance Corporation of India

Seller/Vendor 8 General Insurance Corporation of India

Deal status Announced

Deal value (estimated) ($m) 259.94 (min)

Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 81

Date of announcement Nov 01, 2012

Company information: Target, acquirer, and seller/vendor

22

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

99
DIVESTMENTS

Target: Stock Holding Corporation of India Limited

Company type Private

Stock Holding Corporation of India Limited (SHCIL) is a


Business description provider of custodial and depository services, and other
financial services.

Financial Services-->Capital Markets and Trading


Industry
Financial Services-->Savings and Investments-->Mutual
Funds

Address SHCIL House, Plot No.P-51, TTC Industrial Area

City Mumbai

State Maharashtra

Country India

Acquirer: IDBI Bank Limited

Company type Private

IDBI Bank is a financial holding company. The company,

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->Payments
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management

Address IDBI Tower, WTC Complex, Cuffe Parade, Colaba

City Mumbai

State Maharashtra

Country India

Website www.idbi.com

Phone number 91 22 2218 9111

Vendor 1: Specified Undertaking of Unit Trust of India

Company type Private

Vendor 2: IFCI Limited

23

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

100
DIVESTMENTS

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500106

IFCI is an India-based financial institution that offers a


variety of financial products and services. The company
offers a range of financial products that includes debt
products and products related to the equity and other
Business description business segments. IFCI also provides corporate advisory
services, infrastructure advisory services, and monitors
public issues. The company also acts as a debenture trustee
for debentures issued by other companies. The company
operates in India, where it is headquartered in New Delhi.

Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Address IFCI Tower, 61 Nehru Place

City New Delhi

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State Delhi

Country India

Website www.ifciltd.com

Phone number 91 11 4179 2800

Vendor 3: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s
personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
Business description rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

24

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

101
DIVESTMENTS

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss

Address 24, Whites Road

City Chennai

State Tamil Nadu

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

Vendor 4: New India Assurance Co., Ltd.

Company type Private

25

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

102
DIVESTMENTS

New India Assurance Co., Ltd. provides nonlife insurance


services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Vendor 6: National Insurance Company Limited

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Industry Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
26

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

103
DIVESTMENTS

Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

Vendor 7: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

27

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

104
DIVESTMENTS

Vendor 8: General Insurance Corporation of India

Company type Public

General Insurance Corporation of India (GIC) is engaged in


providing reinsurance services to the general insurers in
India. Its reinsurance portfolio includes oil and energy,
Business description aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the
UAE, Malaysia, South Africa and Russia. It is headquartered
in Mumbai, India.

Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending

Address Suraksha, 170 Jamshedji Tata Road

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country India

Website www.gicofindia.com

Phone number 91 22 2286 7000

28

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

105
APPENDIX

APPENDIX
Contact Us

We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com

About MarketLine Financial Deals Database

• Financial Deals is the most extensive Deals database currently available in the market

• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
– partnership deal

• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms

• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.

• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.

• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.

29

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

106
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

30

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

107
APPENDIX

Deal Definition and Methodology

Deal type definition

Merger

A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:

 All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.

 Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.

 The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.

 No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.

Acquisition

Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:

 Minority acquisition: The acquisition of less than 50% equity stake in the target

 Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target

 100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target

 Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity

Private equity

Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:

 Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company

 Secondary buyout: PE firm or a group of PE firms acquiring a company from a PE firm


31

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

108
APPENDIX
 Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds

 Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.

 Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team

 Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed

 Exit: PE firm selling its stake in a portfolio company

Private placement

A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.

Venture financing

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:

 Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept

 Start-up: Financing provided to companies for developing their product/service and to


purchase the necessary assets for their production/operation

 Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products

 Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities

 Exit: This node is assigned when a venture capital is selling its stake in a portfolio company

Initial Public Offering

 Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:

 Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO

 Pricing: When the company fixes the issue price for its offering

32

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

109
APPENDIX
 Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering

 Withdrawn: When the company withdraws its IPO

 Postponed: When the company postpones its IPO

Partnership

A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:

 Joint Venture (JV): Two or more companies forming a new entity to undertake an activity

 Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.

 Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.

Deal status details

Financial Deals captures deal status according to following stages:

 Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
 Announced: Either party involved in the transaction announces the deal
 Completed: Involved parties complete the transaction
 Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
 Dead rumor: Rumor denied by either of the parties involved in the transaction

Deal value

Deal value is the consideration paid by the acquirer for acquiring the target.

Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.

All deals values which are mentioned as approximate consideration are tagged as estimated values.

Deal value criteria for filtering deals


33

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

110
APPENDIX

For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.

Deal payment details


Deal payment is captured in the following fields:

Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:

 Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer

 Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer

 Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer

 Quantity type: It indicates the consideration by payment mode in terms of value and
percentage

% acquired: % acquired indicates the stock acquired in percentage terms

Share price paid: Price per share offered by the acquirer to the target

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Debt-related fields
Below is the list of fields captured:

Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:

 Lead: Represents the lead debt provide


 Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers

Debt amount: Amount of debt raised by the acquirer to finance the acquisition

Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:

 Bank facilities: These are general loans provided by banks to companies.

 Senior: Debt that has priority for repayment in liquidation.

 Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.

 Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.

 Other debt: Any other debt facility other than the above mentioned debt categories.

34

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

111
APPENDIX

Securities issued to finance deal


Below is a list of category and sub-category of securities issued by the acquirer, captured in FD:

Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:

 Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder

 Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio

 Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date

 Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)

 Placing: General term to describe the process of raising money via the issue of new shares

 Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period

 Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings

 Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).

Financial and operational information

Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:

Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.

No. of employees: Number of employees at the fiscal year end


Local currency: The currency in which the company is reporting its financial statements

35

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

112
APPENDIX

Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers

Revenue (banking): This value is sum of interest income and non interest income

Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.

EBITDA: Earnings before interest, taxes, depreciation and amortization

Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax

Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.

Enterprise value: Enterprise value is calculated by adding a company’s market capitalization,


preferred stock, minority interest, and outstanding debt together and then subtracting out the cash
and cash equivalents found on the balance sheet as on the fiscal year end

Shares issued: Number of shares the company has issued out of its authorized capital

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Market capitalization: Market capitalization is calculated by taking the number of outstanding
shares of common stock multiplied by the market price-per-share as on fiscal year end

Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.

Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth

Net assets-share ratio: It is defined as net assets divided by number of shares outstanding

Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares

Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.

Deal multiples

Financial Deals captures the following four valuation multiples:


 EV/revenues
 EV/EBIT
 EV/EBITDA
 EV/total assets

36

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

113
APPENDIX

Advisor information

Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:

Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.

Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:

 Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts

 Accounting: Financial advisor who looks into the accounting matters for a deal

 Tax: Financial advisor who looks into the tax matters for a deal

 Corporate Finance: Financial advisor who looks into the financial decisions of a corporation

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue

 Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body

 Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted

 Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other

Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities

Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders

37

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

114
APPENDIX

About MarketLine

In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.

At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.

Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.

MarketLine is a wholly owned subsidiary of Informa.

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

115
APPENDIX

The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

MARKETLINE | 119 FARRINGDON ROAD | LONDON,


UNITED KINGDOM, EC1R 3DA
39
T: + 44 161 238 4040| F: + 44 870 134 4371
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
E: REACHUS@MARKETLINE.COM
116
MarketLine Financial Deals

Vendor, acquirer, target and partner report for General Insurance Corporation of India and its
subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint ventures,
Alliances and Investments

General Insurance Corporation of India –


Mergers & Acquisitions (M&A), Partnerships &
Alliances and Investments

REFERENCE CODE: E3EA5399-6832-461A-82AF-F50AA365CD15


PUBLICATION DATE: September 2018
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

117
COMPANY OVERVIEW AND KEY FACTS

COMPANY OVERVIEW AND KEY FACTS

GENERAL INSURANCE CORPORATION OF INDIA

General Insurance Corporation of India (GIC) is engaged in providing reinsurance services to the general insurers in
India. The company, through its subsidiaries is involved in providing reinsuring solutions for Afro-Asian region. GIC’s
reinsurance portfolio includes oil and energy, aviation, spares/rotor wing, fire and Engineering, Liability, property,
marine cargo and hull, agriculture, credit, and miscellaneous. GIC manages its representative office in Moscow. The
company operates in India, the UK, China, Brazil, the UAE, Malaysia, Europe, South Africa and Russia. GIC is
headquartered in Mumbai, Maharashtra, India.

The company reported revenues of (Rupee) INR422,517.3 million for the fiscal year ended March 2018 (FY2018), an
increase of 36.6% over FY2017. In FY2018, the company’s operating margin was 5.5%, compared to an operating
margin of 11.2% in FY2017. In FY2018, the company recorded a net margin of 7.4%, compared to a net margin of
10.2% in FY2017.

Key facts

Address Suraksha, 170 Jamshedji Tata Road

Country India

Telephone 91 22 2286 7000

Website www.gicofindia.com

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
-

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

118
COMPANY OVERVIEW AND KEY FACTS

General Insurance Corporation of India activity by deal type - General Insurance Corporation of India M&A average deal
volume (2014-YTD2018) size - value ($m)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) - 1 - - - 2014 - -
Capital raising - - - 1 - 2015 1 500

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
(CR) 2016 - -
Corporate - - - 1 - 2017 - -
venturing (CV)
2018 - -

TOP DEALS IN (2014 -YTD2018)

Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
($m)

HDFC ERGO General Insurance Company Private


Jan 14, 2017 Completed 51.26
Limited (India) placement

SZ DJI Technology Co., Ltd. (China) Sep 24, 2015 Announced Private equity 500

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

119
TABLE OF CONTENTS

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS ............................................ 2

TABLE OF CONTENTS .......................................................................... 4

LIST OF TABLES .................................................................................... 5

LIST OF FIGURES .................................................................................. 5

TARGETS AND PARTNERS .................................................................. 6

MERGERS & ACQUISITIONS ................................................................ 7


Mergers and Acquisitions – Overview ............................................................................................... 7

Mergers and Acquisitions – Deal reports .......................................................................................... 8

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
CORPORATE VENTURING .................................................................. 11
Corporate Venturing – Overview ...................................................................................................... 11

Corporate Venturing – Deal reports ................................................................................................. 12

CAPITAL RAISING ............................................................................... 49


Capital Raising – Overview ............................................................................................................... 49

Capital Raising – Deal reports .......................................................................................................... 50

Divestments – Deal reports ............................................................................................................... 52

APPENDIX........................................................................................... 108
Contact Us ....................................................................................................................................... 108

About MarketLine Financial Deals Database ................................................................................. 108

Deal Definition and Methodology ................................................................................................... 110

About MarketLine ............................................................................................................................. 117

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

120
TABLE OF CONTENTS

LIST OF TABLES

Table 1: General Insurance Corporation of India M&A volume and value trend (2014-YTD2018) 7

Table 2: General Insurance Corporation of India M&A activity by geography (2014-YTD2018) 7

Table 3: General Insurance Corporation of India corporate venturing volume and value trend (2014-
YTD2018) 11

Table 4: General Insurance Corporation of India corporate venturing by geography (2014-YTD2018) 11

Table 5: General Insurance Corporation of India capital raising volume and value trend (2014-YTD2018) 49

Table 6: General Insurance Corporation of India capital raising by deal type (2014-YTD2018) 49

LIST OF FIGURES

Figure 1: General Insurance Corporation of India M&A volume and value trend (2014-YTD2018) 7

Figure 2: General Insurance Corporation of India M&A activity by geography (2014-YTD2018) 7

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Figure 3: General Insurance Corporation of India corporate venturing volume and value trend (2014-
YTD2018) 11

Figure 4: General Insurance Corporation of India corporate venturing by geography (2014-YTD2018) 11

Figure 5: General Insurance Corporation of India capital raising volume and value trend (2014-YTD2018) 49

Figure 6: General Insurance Corporation of India capital raising by deal type (2014-YTD2018) 49

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

121
TARGETS AND PARTNERS

TARGETS AND PARTNERS


General Insurance Corporation of India targets and partners (2014 -YTD2018)

General Insurance Corporation of India-


Deal Date Deal type Deal value ($m)
Target/Partner name

HDFC ERGO General Insurance Company Limited


Jan 14, 2017 Private placement 51.26
(India)

SZ DJI Technology Co., Ltd. (China) Sep 24, 2015 Private equity 500

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

122
MERGERS & ACQUISITIONS

MERGERS & ACQUISITIONS


Mergers and Acquisitions – Overview

Figure 1: General Insurance Corporation of India M&A Figure 2: General Insurance Corporation of India M&A
volume and value trend (2014-YTD2018) activity by geography (2014-YTD2018)

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Table 1: General Insurance Corporation of India M&A volume Table 2: General Insurance Corporation of India M&A activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 - - North America -

2015 1 500 Europe -

2016 - - Asia-Pacific 1

2017 - - Middle East and Africa -

2018 - - South and Central America -

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

123
MERGERS & ACQUISITIONS

Mergers and Acquisitions – Deal reports

Deal Report: SZ DJI Technology to raise $500 million in funding

Deal in brief

According to China Money Network, sources reported that SZ DJI Technology Co., Ltd., a China-based
manufacturer of consumer drones, has agreed to raise approximately $500 million from New China Life
Insurance Co., Ltd., General Insurance Corporation of India and New Horizon Capital.

Target SZ DJI Technology Co., Ltd.

Acquirer 1 General Insurance Corporation of India

Acquirer 2 New China Life Insurance Company Ltd.

Acquirer 3 New Horizon Capital

Deal status Announced

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (estimated) ($m) 500

Deal category Private equity

Deal sub-category Minority acquisition , direct investment

Round of financing None

Date of announcement Sep 24, 2015

Company information: Target and acquirer

Target: SZ DJI Technology Co., Ltd.

Company type Private

SZ DJI Technology Co., Ltd. is a manufacturer of consumer


Business description drones for filmmaking, agriculture, conservation, search and
rescue, energy infrastructure, and other sectors.

Industrial Goods and Machinery


Industry
Retailing-->Electricals and Electronics-->Brown Goods
Technology and Services

14th Floor, West Wing, Skyworth Semiconductor Design


Address
Building, No.18 Gaoxin South 4th Ave, Nanshan District

City Shenzhen

Country China

Website www.dji.com
8

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

124
MERGERS & ACQUISITIONS

Acquirer 2: New China Life Insurance Company Ltd.

Company type Public

Stock exchange HKG (Hong Kong Stock Exchange)

Ticker symbol 1336

New China Life Insurance is engaged in the provision of life


insurance products and services to individual and
institutional customers. It acts as an agent for domestic and
international insurance companies; provides insurance
related consulting services; and conducts capital
Business description management operations. In addition, the company offers
equity investment, micro finance, real estate development
and medical services through its subsidiaries. New China
Life Insurance operates in China and Hong Kong. It is
headquartered in Beijing, China and employs around 52,474
people.

Financial Services
Financial Services-->General Insurance, Property and
Casualty

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Industry
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property

New China Insurance Tower, Number Jia 12 Jianguomenwai


Address
Street

Country China

Website newchinalife.com
9

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

125
MERGERS & ACQUISITIONS

Phone number 86 10 8521 0000

Acquirer 3: New Horizon Capital

Industry Private equity firm, swaps dealer

New Horizon Capital is a Chinese venture capital and private


Business description
equity firm.

Address Suite 903, 9/F, Jin Bao Tower, 89 Jin Bao Street

City Beijing

Country China

Website www.nhfund.com

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

10

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

126
CORPORATE VENTURING

CORPORATE VENTURING
Corporate Venturing – Overview

Figure 3: General Insurance Corporation of India corporate Figure 4: General Insurance Corporation of India corporate
venturing volume and value trend (2014-YTD2018) venturing by geography (2014-YTD2018)

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Table 3: General Insurance Corporation of India corporate Table 4: General Insurance Corporation of India corporate
venturing volume and value trend (2014-YTD2018) venturing by geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 - - North America -

2015 - - Europe -

2016 - - Asia-Pacific 1

2017 1 51.26 Middle East and Africa -

2018 - - South and Central America -

11

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

127
CORPORATE VENTURING

Corporate Venturing – Deal reports

Deal Report: HDFC ERGO General Insurance Company raises $51.26 million in private
placement of debentures

Deal in brief

HDFC ERGO General Insurance Company Limited, an India-based general insurance company, has raised
INR3,500 million ($51.26 million) in a private placement of unsecured, subordinated and redeemable non-
convertible debentures (NCDs) having a face value of INR1 million ($0.015 million) each from ERGO
Insurance Group AG, General Insurance Corporation of India, Life Insurance Corporation of India and other
investors.

The NCDs will have an interest rate of 7.6% annum and a maturity period of 10 years with a call option at
the end of five years.

Target HDFC ERGO General Insurance Company Limited

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 1 ERGO Insurance Group AG

Acquirer 2 General Insurance Corporation of India

Acquirer 3 Life Insurance Corporation of India

Acquirer 4 Undisclosed Investor(s)

Deal status Completed

Deal value ($m) 51.26

Deal value (Indian Rupee)(m) 3,500

Deal category Private placement

Date of completion Jan 14, 2017

Deal rationale

HDFC ERGO intends to use the funds to strengthen solvency margin.

Security type information

Security type Debt

Security type Indian Rupee (m) Value ($m)

Debt investment amount 3,500 51.26


12

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

128
CORPORATE VENTURING

Company information: Target and acquirer

Target: HDFC ERGO General Insurance Company Limited

Company type Private

HDFC ERGO General Insurance Company Limited (HDFC


ERGO) is a privately held general insurance company. The
company provides a range of personal, commercial and rural
insurance products and services for individual, families and
corporate customers. Its portfolio of products includes motor
insurance, health insurance, travel insurance, home
insurance, personal accident insurance, property insurance,
liability insurance, marine insurance, casualty insurance,
specialty insurance and rural insurance. In addition, HDFC
Business description ERGO offers reinsurance, claims and risk consulting
services. The company is a subsidiary of India based
Housing Development Finance Corp. Ltd. HDFC ERGO is
headquartered in Mumbai, India.

The company reported gross written premium of INR34,665

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
million for the fiscal year 2016 (FY2016), representing an
increase of 6.4% over FY2015. Its net written premium was
INR18,980 million in FY2016, an increase of 6.7% over
FY2015.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Industry
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property

Address 1st Floor, 165-166, Backbay Reclamation

City Mumbai

State Maharashtra

Country India

Website www.hdfcergo.com
13

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

129
CORPORATE VENTURING

Phone number 91 22 66383600

Acquirer 1: ERGO Insurance Group AG

Company type Private

ERGO Insurance Group AG is an insurance company that


provides solutions in the life insurance, health insurance,
Business description
legal expenses insurance, property and casualty insurance,
and pension funds segments.

Financial Services
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Industry Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Personal Insurance-->Property
Financial Services-->Institutional Investment Management

Address Victoriaplatz 2

City Duesseldorf

Country Germany

Website www.ergo.com

Phone number 49 211 477 0

Acquirer 3: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com 14

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

130
CORPORATE VENTURING

Phone number 91 22 22021625

Acquirer 4: Undisclosed Investor(s)

Company type Private

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Industry Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
15

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

131
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
16

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

132
CORPORATE VENTURING

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
17

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

133
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
18

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

134
CORPORATE VENTURING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
19

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

135
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
20

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

136
CORPORATE VENTURING

Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

137
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
22

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

138
CORPORATE VENTURING

Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
23

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

139
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
24

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

140
CORPORATE VENTURING

Diagnostics-->Scientific and Technical Instruments


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
25

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

141
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
26

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

142
CORPORATE VENTURING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
27

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

143
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
28

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

144
CORPORATE VENTURING

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
29

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

145
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
30

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

146
CORPORATE VENTURING

Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
31

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

147
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
32

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

148
CORPORATE VENTURING

Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
33

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

149
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
34

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

150
CORPORATE VENTURING

Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
35

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

151
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
36

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

152
CORPORATE VENTURING

Diagnostics-->CNS and Neurological Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
37

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

153
CORPORATE VENTURING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

154
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
39

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

155
CORPORATE VENTURING

Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
40

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

156
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

41

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

157
CORPORATE VENTURING

Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy

Deal in brief

Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.

Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
on the same terms and conditions.

Target Reliance Energy Limited

Acquirer 1 Reliance Group

Acquirer 2 The United India Insurance Company Limited

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 3 The Oriental Insurance Company Ltd.

Acquirer 4 New India Assurance Co., Ltd.

Acquirer 5 General Insurance Corporation of India

Acquirer 6 Life Insurance Corporation of India

Acquirer 7 National Insurance Company Limited

Deal status Announced

Deal value (estimated) ($m) 2,000

Deal category Private placement

Offer price ($) 45.72

Offer price (Indian Rupee) (m) 1,812

Date of announcement Dec 02, 2007

Deal rationale

The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas.

Deal financials

Valuation multiples (Reliance Energy Limited)


42

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

158
CORPORATE VENTURING

EV/Revenues 2.41

EV/Operating profit 14.15

EV/EBITDA 11.09

EV/Total assets 1.03

Bid premium (Reliance Energy Limited)

Bid premium (%) 5

Security type information

Security type Common stock

Company information: Target and acquirer

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target: Reliance Energy Limited

Company type Private

Reliance Energy Limited is an integrated power utility


company enagaged in the generation, transmission,
distribution, and trading of power in India. It operates gas,
Business description
coal, wind, and hydro-based power generation projects with
aggregate capacity of approximately 13,510 megawatts. The
company is headquartered at Maharashtra, India.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Exploration
Energy and Utilities-->Utilities-->Utilities Networks--
Industry
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production

Address Reliance Energy centre, Santacruz (East)

City Mumbai

State Maharashtra
43

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

159
CORPORATE VENTURING

Country India

Website www.rel.co.in

Phone number 91 22 30099999

Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 65,841.10 1,516.32

Operating profit 11,226.92 258.56

EBITDA 14,330.78 330.04

Post tax profit 8,014.50 184.57

Key ratios

Operating margin (%) 17.05

Acquirer 1: Reliance Group

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private

Reliance Group is a privately-held industrial conglomerate


engaged in providing services that range from
communications and financial services, to generation,
transmission and distribution of power, infrastructure and
entertainment. The group operates through its subsidiaries,
Business description
Reliance Capital Limited, Reliance Communications Limited,
Reliance Infrastructure, Reliance Entertainment and
Reliance Power Limited. Reliance Group operates in Asia
Pacific, Africa, the Americas and Europe. It is headquartered
in Mumbai, India, and employs around 1,00,000 people.

General Business-->Industrial Conglomorates


Transport and Logistics-->Passenger Transportation-->Road
Industry
Construction and Real Estate
Financial Services
Aerospace and Defense-->Naval Ships

Address Nariman Point, Mumbai 400 021

Country India

Website www.relianceadagroup.com

Phone number 91 22 2278 5000

Acquirer 2: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


Business description general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s
44

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

160
CORPORATE VENTURING

personal insurance solutions include motor insurance, fire


insurance, health insurance, liability insurance, micro
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
45

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

161
CORPORATE VENTURING

Address 24, Whites Road

City Chennai

State Tamil Nadu

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

Acquirer 3: The Oriental Insurance Company Ltd.

Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
headquartered in New Delhi, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in

Phone number 91 11 43659595

Acquirer 4: New India Assurance Co., Ltd.

Company type Private

New India Assurance Co., Ltd. provides nonlife insurance


Business description
services in India. It offers personal, commercial, industrial,
46

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

162
CORPORATE VENTURING

liability, social, and credit insurance services. The company


operates in India through a ntwork of 26 regional offices, 393
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Acquirer 6: Life Insurance Corporation of India

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Acquirer 7: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
Business description
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
47

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

163
CORPORATE VENTURING

dog insurance, brackish water prawn insurance, silkworm


insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

48

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

164
CAPITAL RAISING

CAPITAL RAISING

Capital Raising – Overview

Figure 5: General Insurance Corporation of India capital Figure 6: General Insurance Corporation of India capital
raising volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Table 5: General Insurance Corporation of India capital raising Table 6: General Insurance Corporation of India capital
volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)

Year Volume Value ($m) Deal Type Volume

2014 - - Public offering 1

2015 - -

2016 - -

2017 1 -

2018 - -

49

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

165
CAPITAL RAISING

Capital Raising – Deal reports

Deal Report: Government of India to divest 25% stake in General Insurance Corporation
of India

Deal in brief

According to Moneycontrol, The Government of India (GOI) has agreed to divest a 25% stake in General
Insurance Corporation of India, an India-based general insurance company, through listing the company on
stock exchanges. The listing will be either by fresh equity or offer for sale.

Concurrently, GOI has agreed to sell a 25% stake in each of New India Assurance Co., Ltd., United India
Insurance Co., Ltd., The Oriental Insurance Company Ltd. and National Insurance Company Limited.

Target General Insurance Corporation of India

Seller/Vendor Government of India

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Announced

Deal category IPO

Deal sub-category Filing , ipo

% to Public 25

Date of announcement Jan 18, 2017

Company information: Target and seller/vendor

Vendor: Government of India

Company type Private

Government and Non-Profit Organisations


Government and Non-Profit Organisations-->Governmental
Organizations
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Industry
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Energy and Utilities-->Utilities-->Power Generation-->Fossil 50

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

166
CAPITAL RAISING

Fuels
Environmental and Waste Management Services-->Sewage
Treatment Facilities
Construction and Real Estate-->Heavy Construction
Construction and Real Estate-->Real Estate Transactions
Energy and Utilities-->Utilities-->Power Generation
Transport and Logistics-->Transport Infrastructure--
>Highway Operators
Transport and Logistics-->Transport Infrastructure
Transport and Logistics-->Transport Infrastructure-->Port
and Harbor Operations
Transport and Logistics-->Transport Infrastructure-->Rail
Infrastructure
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

State Delhi

Country India

51

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

167
DIVESTMENTS

Divestments – Deal reports

Deal Report: IDBI to acquire 81% stake in Stock Holding Corporation

Deal in brief

IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.

IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.

The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.

Target Stock Holding Corporation of India Limited

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer IDBI Bank Limited

Seller/Vendor 1 Specified Undertaking of Unit Trust of India

Seller/Vendor 2 IFCI Limited

Seller/Vendor 3 The United India Insurance Company Limited

Seller/Vendor 4 New India Assurance Co., Ltd.

Seller/Vendor 5 The Oriental Insurance Company Ltd.

Seller/Vendor 6 National Insurance Company Limited

Seller/Vendor 7 Life Insurance Corporation of India

Seller/Vendor 8 General Insurance Corporation of India

Deal status Announced

Deal value (estimated) ($m) 259.94 (min)

Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 81

Date of announcement Nov 01, 2012

Company information: Target, acquirer, and seller/vendor

52

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

168
DIVESTMENTS

Target: Stock Holding Corporation of India Limited

Company type Private

Stock Holding Corporation of India Limited (SHCIL) is a


Business description provider of custodial and depository services, and other
financial services.

Financial Services-->Capital Markets and Trading


Industry
Financial Services-->Savings and Investments-->Mutual
Funds

Address SHCIL House, Plot No.P-51, TTC Industrial Area

City Mumbai

State Maharashtra

Country India

Acquirer: IDBI Bank Limited

Company type Private

IDBI Bank is a financial holding company. The company,

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->Payments
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management

Address IDBI Tower, WTC Complex, Cuffe Parade, Colaba

City Mumbai

State Maharashtra

Country India

Website www.idbi.com

Phone number 91 22 2218 9111

Vendor 1: Specified Undertaking of Unit Trust of India

Company type Private

Vendor 2: IFCI Limited

53

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

169
DIVESTMENTS

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500106

IFCI is an India-based financial institution that offers a


variety of financial products and services. The company
offers a range of financial products that includes debt
products and products related to the equity and other
Business description business segments. IFCI also provides corporate advisory
services, infrastructure advisory services, and monitors
public issues. The company also acts as a debenture trustee
for debentures issued by other companies. The company
operates in India, where it is headquartered in New Delhi.

Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Address IFCI Tower, 61 Nehru Place

City New Delhi

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State Delhi

Country India

Website www.ifciltd.com

Phone number 91 11 4179 2800

Vendor 3: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s
personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
Business description rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

54

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

170
DIVESTMENTS

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss

Address 24, Whites Road

City Chennai

State Tamil Nadu

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

Vendor 4: New India Assurance Co., Ltd.

Company type Private

55

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

171
DIVESTMENTS

New India Assurance Co., Ltd. provides nonlife insurance


services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Vendor 5: The Oriental Insurance Company Ltd.

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in
56

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

172
DIVESTMENTS

Phone number 91 11 43659595

Vendor 6: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

57

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

173
DIVESTMENTS

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

Vendor 7: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

58

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

174
DIVESTMENTS

Deal Report: Daiichi Sankyo acquires 20% stake in Ranbaxy Laboratories through open
offer

Deal in brief

Daiichi Sankyo Company, Limited, a Japan-based developer, manufacturer of pharmaceuticals, has


acquired a 20% stake in Ranbaxy Laboratories Limited, an India-based research-based pharmaceutical
company, through open offer.

Daiichi Sankyo has acquired 92,519,126 shares at a price of INR737 ($17.17) per share. The transaction
is valued at approximately INR68,186.59 million ($1,588.55 million).

Life Insurance Corporation of India, which holds a 15% stake in Ranbaxy, has sold off a 6.91% stake in the
open offer. General Insurance Corporation of India has sold its 1.42% stake in the open offer.

Update on October 3, 2008:

The Cabinet Committee on Economic Affairs (CCEA) has approved the Daiichi Sankyo’s plan to acquire a
controlling stake in Ranbaxy Laboratories Limited.

Update on September 22, 2008:

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Daiichi Sankyo has announced that its open offer to acquire 20% stake in Ranbaxy Laboratories has been
oversubscribed.

Update on September 4, 2008:

The European Commission has approved the proposed acquisition of Ranbaxy Laboratories by Daiichi
Sankyo.

Update on August 5, 2008:

Daiichi Sankyo has revised the schedule of its public offer for the acquisition of a 20% stake in Ranbaxy
Laboratories.

The offer will open on August 16, 2008 and close on September 4, 2008.

Announcement (June 11, 2008):

Daiichi Sankyo Company has made an open offer to acquire 20% stake in Ranbaxy Laboratories. Daiichi
Sankyo will acquire 92.51 million fully paid-up equity shares from the remaining shareholders at a price of
INR737 ($17.17) for each fully paid-up equity share in the open offer. The transaction is valued at
approximately INR68,186.59 million ($1,588.55 million).

The offer will open on August 8, 2008 and close on August 27, 2008.

Daiichi Sankyo has also made an offer to acquire a 34.8% stake in Ranbaxy Laboratories. Under local
stock market rules, Daiichi Sankyo is required to make an open offer for the additional 20% stake in
Ranbaxy Laboratories.

59

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

175
DIVESTMENTS
Rumor (June 6, 2008):

Daiichi Sankyo Company is planning to make an open offer to the public shareholders for 20% stake in
Ranbaxy Laboratories Limited.

ICICI Securities Limited is acting as the manager to the public offer and Nomura Securities Co., Ltd. is
acting as financial advisor to Daiichi. Karvy Computershare Pvt., Ltd. is acting as the registrar to the offer.

Target Ranbaxy Laboratories Limited (Inactive)

Acquirer Daiichi Sankyo Co., Ltd.

Seller/Vendor 1 Undisclosed Investor(s)

Seller/Vendor 2 Life Insurance Corporation of India

Seller/Vendor 3 General Insurance Corporation of India

Deal status Completed

Deal value (estimated) ($m) 1,588.55

Deal category Acquisition

Deal sub-category Minority acquisition

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquired % 20

Date of announcement Jun 11, 2008

Date of completion Oct 17, 2008

Deal rationale

The proposed acquisition of Ranbaxy provides Daiichi Sankyo an opportunity to complement its strong
presence in innovation with a new, strong presence in the fast growing business of non-proprietary
pharmaceuticals.

Deal financials

Valuation multiples (Ranbaxy Laboratories Limited (Inactive))

EV/Revenues 3.36

EV/Operating profit 18.52

EV/EBITDA 16.30

EV/Total assets 2.55

Company information: Target, acquirer, and seller/vendor


60

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

176
DIVESTMENTS

Target: Ranbaxy Laboratories Limited (Inactive)

Company type Private

Pharmaceuticals and Healthcare


Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Pharmaceutical Manufacturers
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Therapy Area--
>Vaccines
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Manufacturing
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Pharmaceutical Manufacturers-->Biotech
Pharmaceuticals and Healthcare-->Pharmaceuticals-->Drug
Delivery
Pharmaceuticals and Healthcare-->Therapy Area
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
Industry >Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
61

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

177
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area--


>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases--
>Hypertension
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases--
>Stroke
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
62

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

178
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area-->Central


Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Multiple Sclerosis
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Epilepsy
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Alzheimer's Disease
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Parkinson's Disease
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Insomnia
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
63

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

179
DIVESTMENTS

Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Migraine
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain-->Fibromyalgia
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain-->Neuropathic Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
64

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

180
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area-->Central


Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry-->Depression
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry-->Bipolar Disorders
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry-->Depression
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry-->Depression
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry-->Schizophrenia
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
65

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

181
DIVESTMENTS

>Immunology and Inflammation-->Dermatology


Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
66

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

182
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area--


>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
67

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

183
DIVESTMENTS

>Immunology and Inflammation-->Gastroenterology


Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Hematology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
68

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

184
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area--


>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology-->Psoriasis
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology-->Psoriasis
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Rheumatology--
>Rheumatoid Arthritis
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Rheumatology--
>Osteoarthritis
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
69

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

185
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area--


>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
70

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

186
DIVESTMENTS

>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
71

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

187
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area--


>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
72

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

188
DIVESTMENTS

>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases-->Malaria
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Community
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Community
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Urinary Tract
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
73

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

189
DIVESTMENTS

>Infectious Diseases-->Antibacterials-->Urinary Tract


Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Urinary Tract
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Hepatitis B
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Human
Immunodeficiency Virus
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Sexual Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Urology-->Benign
Prostatic Hyperplasia
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Urology-->Benign
Prostatic Hyperplasia
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Sexual Health-->Sexual
Dysfunction
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
74

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

190
DIVESTMENTS

>Cardiovascular and Diabetes-->Diabetes and


Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetes
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetes
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Obesity
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health--
>Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
75

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

191
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area-->Other


Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Hematology-->Leukemias
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Hematology-->Lymphomas
Pharmaceuticals and Healthcare-->Therapy Area--
76

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

192
DIVESTMENTS

>Oncology-->Solid Tumors-->Breast Cancer


Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Breast Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Breast Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Brain Cancer-->Glioma
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Gastrointestinal Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Gastrointestinal Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Gastrointestinal Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Gynecological Cancer--
>Ovarian Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Lung Cancer-->Non-Small Cell
Lung Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer-->Prostate
Cancer
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Oncology-->Solid Tumors-->Urological Cancer-->Prostate
Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer-->Prostate
Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer-->Bladder
Cancer
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Conjunctivitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Conjunctivitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Conjunctivitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Keratitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
77

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

193
DIVESTMENTS

Pharmaceuticals and Healthcare-->Therapy Area-->Other


Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Allergic Rhinitis
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Allergic Rhinitis
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Allergic Rhinitis
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Cystic Fibrosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Respiratory-->Chronic Obstructive Pulmonary Disease
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Asthma
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Asthma
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
78

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

194
DIVESTMENTS

>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Poisoning
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Poisoning
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health--
>Hormonal Contraception
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health--
>Endometriosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health

Number of employees 11843

Address A-41 Industrial Area Phase VIII-A, SAS Nagar

State Punjab

Country India

Financial information – (Fiscal year 31-Dec-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 47,783.22 1,211.78

Operating profit 8,678.25 220.08

EBITDA 9,865.56 250.19

Post tax profit 6,177.06 156.65

Key ratios

Operating margin (%) 18.16

Acquirer: Daiichi Sankyo Co., Ltd.

Company type Public


79

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

195
DIVESTMENTS

Stock exchange TYO (Tokyo Stock Exchange)

Ticker symbol 4568

Daiichi Sankyo Co., Ltd. (Daiichi Sankyo or 'the group') is a


Japan-based holding company primarily engaged in the
Business description manufacture and sales of pharmaceuticals. It operates in
Asia, Europe and the Americas. The group is headquartered
in Tokyo, Japan.

Pharmaceuticals and Healthcare


Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Pharmaceutical Manufacturers
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes
Industry
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases

Address 3-5-1, Nihombashi Hon-cho

City CHUO-KU

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State Tokyo

Country Japan

Website www.daiichisankyo.com

Phone number 81 3 62251111

Vendor 1: Undisclosed Investor(s)

Company type Private

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Industry
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and

80

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

196
DIVESTMENTS

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
81

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

197
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
82

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

198
DIVESTMENTS

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
83

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

199
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
84

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

200
DIVESTMENTS

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
85

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

201
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
86

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

202
DIVESTMENTS

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
87

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

203
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
88

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

204
DIVESTMENTS

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
89

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

205
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
90

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

206
DIVESTMENTS

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
91

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

207
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
92

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

208
DIVESTMENTS

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
93

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

209
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
94

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

210
DIVESTMENTS

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
95

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

211
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
96

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

212
DIVESTMENTS

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
97

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

213
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
98

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

214
DIVESTMENTS

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
99

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

215
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
100

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

216
DIVESTMENTS

Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
101

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

217
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
102

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

218
DIVESTMENTS

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
103

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

219
DIVESTMENTS

Diagnostics-->Respiratory and Anesthesia Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
104

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

220
DIVESTMENTS

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
105

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

221
DIVESTMENTS

Diagnostics-->Hematological Devices and Blood Products


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

Vendor 2: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Address Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


106

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

222
DIVESTMENTS

Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Advisor information

Acquirer : Daiichi Sankyo Co., Ltd.

Financial advisors

ICICI Securities Limited (Sub-category: Underwriters)

Nomura Securities Co., Ltd.

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

107

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

223
APPENDIX

APPENDIX
Contact Us

We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com

About MarketLine Financial Deals Database

• Financial Deals is the most extensive Deals database currently available in the market

• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
– private placement
– partnership deal

• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms

• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.

• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.

• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.

108

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

224
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

109

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

225
APPENDIX

Deal Definition and Methodology

Deal type definition

Merger

A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:

 All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.

 Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.

 The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.

 No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.

Acquisition

Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:

 Minority acquisition: The acquisition of less than 50% equity stake in the target

 Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target

 100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target

 Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity

Private equity

Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:

 Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company

 Secondary buyout: PE firm or a group of PE firms acquiring a company from a PE firm


110

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

226
APPENDIX
 Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds

 Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.

 Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team

 Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed

 Exit: PE firm selling its stake in a portfolio company

Private placement

A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.

Venture financing

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:

 Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept

 Start-up: Financing provided to companies for developing their product/service and to


purchase the necessary assets for their production/operation

 Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products

 Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities

 Exit: This node is assigned when a venture capital is selling its stake in a portfolio company

Initial Public Offering

 Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:

 Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO

 Pricing: When the company fixes the issue price for its offering

111

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

227
APPENDIX
 Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering

 Withdrawn: When the company withdraws its IPO

 Postponed: When the company postpones its IPO

Partnership

A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:

 Joint Venture (JV): Two or more companies forming a new entity to undertake an activity

 Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.

 Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.

Deal status details

Financial Deals captures deal status according to following stages:

 Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
 Announced: Either party involved in the transaction announces the deal
 Completed: Involved parties complete the transaction
 Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
 Dead rumor: Rumor denied by either of the parties involved in the transaction

Deal value

Deal value is the consideration paid by the acquirer for acquiring the target.

Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.

All deals values which are mentioned as approximate consideration are tagged as estimated values.

Deal value criteria for filtering deals


112

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

228
APPENDIX

For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.

Deal payment details


Deal payment is captured in the following fields:

Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:

 Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer

 Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer

 Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer

 Quantity type: It indicates the consideration by payment mode in terms of value and
percentage

% acquired: % acquired indicates the stock acquired in percentage terms

Share price paid: Price per share offered by the acquirer to the target

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Debt-related fields
Below is the list of fields captured:

Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:

 Lead: Represents the lead debt provide


 Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers

Debt amount: Amount of debt raised by the acquirer to finance the acquisition

Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:

 Bank facilities: These are general loans provided by banks to companies.

 Senior: Debt that has priority for repayment in liquidation.

 Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.

 Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.

 Other debt: Any other debt facility other than the above mentioned debt categories.

113

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

229
APPENDIX

Securities issued to finance deal


Below is a list of category and sub-category of securities issued by the acquirer, captured in FD:

Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:

 Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder

 Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio

 Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date

 Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)

 Placing: General term to describe the process of raising money via the issue of new shares

 Private placing: Private placing is a process of raising money by the issue of new shares to

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
institutions and private clients rather than to the general public

 Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period

 Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings

 Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).

Financial and operational information

Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:

Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.

No. of employees: Number of employees at the fiscal year end


Local currency: The currency in which the company is reporting its financial statements

114

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

230
APPENDIX

Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers

Revenue (banking): This value is sum of interest income and non interest income

Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.

EBITDA: Earnings before interest, taxes, depreciation and amortization

Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax

Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.

Enterprise value: Enterprise value is calculated by adding a company’s market capitalization,


preferred stock, minority interest, and outstanding debt together and then subtracting out the cash
and cash equivalents found on the balance sheet as on the fiscal year end

Shares issued: Number of shares the company has issued out of its authorized capital

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Market capitalization: Market capitalization is calculated by taking the number of outstanding
shares of common stock multiplied by the market price-per-share as on fiscal year end

Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.

Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth

Net assets-share ratio: It is defined as net assets divided by number of shares outstanding

Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares

Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.

Deal multiples

Financial Deals captures the following four valuation multiples:


 EV/revenues
 EV/EBIT
 EV/EBITDA
 EV/total assets

115

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

231
APPENDIX

Advisor information

Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:

Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.

Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:

 Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts

 Accounting: Financial advisor who looks into the accounting matters for a deal

 Tax: Financial advisor who looks into the tax matters for a deal

 Corporate Finance: Financial advisor who looks into the financial decisions of a corporation

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue

 Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body

 Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted

 Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other

Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities

Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders

116

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

232
APPENDIX

About MarketLine

In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.

At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.

Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.

MarketLine is a wholly owned subsidiary of Informa.

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

117

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

233
APPENDIX

General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

MARKETLINE | 119 FARRINGDON ROAD | LONDON,


UNITED KINGDOM, EC1R 3DA
118
T: + 44 161 238 4040| F: + 44 870 134 4371
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
E: REACHUS@MARKETLINE.COM
234
MarketLine Financial Deals

Vendor, acquirer, target and partner report for Reliance Group and its subsidiaries. Includes
Mergers & Acquisitions, Private equity, Venture capital, Joint ventures, Alliances and
Investments

Reliance Group – Mergers & Acquisitions


(M&A), Partnerships & Alliances and
Investments

REFERENCE CODE: D7CC799C-2959-4897-A5E0-B83C43346CEE


PUBLICATION DATE: September 2018
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

235
COMPANY OVERVIEW AND KEY FACTS

COMPANY OVERVIEW AND KEY FACTS

RELIANCE GROUP

Reliance Group (Reliance) is a industrial conglomerate engaged in providing services that range from
communications and financial services, to generation, transmission and distribution of power, infrastructure,
healthcare sectors, media and entertainment. The group operates through its subsidiaries, Reliance Capital Limited,
Reliance Communications Limited, Reliance Infrastructure, Reliance BigEntertainment, Reliance Naval and
Engineering Ltd and Reliance Power Limited. It operates in Asia Pacific, Africa, the Americas and Europe. Reliance is
headquartered in Mumbai, Maharashtra, India.

Key facts

Address Nariman Point, Mumbai 400 021

Country India

Telephone 91 22 2278 5000

Website www.relianceadagroup.com

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

236
COMPANY OVERVIEW AND KEY FACTS

Reliance Group activity by deal type - volume (2014-YTD2018)

Source: Financial Deals DATAMONITOR

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal type 2014 2015 2016 2017 2018

Partnership (Pship) - - 1 - -

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

237
TABLE OF CONTENTS

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS ............................................ 2

TABLE OF CONTENTS .......................................................................... 4

LIST OF TABLES .................................................................................... 5

LIST OF FIGURES .................................................................................. 5

TARGETS AND PARTNERS .................................................................. 6

MERGERS & ACQUISITIONS ................................................................ 7


Mergers and Acquisitions – Deal reports .......................................................................................... 7

CORPORATE VENTURING .................................................................. 11


Corporate Venturing – Deal reports ................................................................................................. 11

PARTNERSHIP ..................................................................................... 21
Partnership – Overview ..................................................................................................................... 21

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Partnership – Deal reports ................................................................................................................ 22

Divestments – Deal reports ............................................................................................................... 28

APPENDIX............................................................................................. 34
Contact Us ......................................................................................................................................... 34

About MarketLine Financial Deals Database ................................................................................... 34

Deal Definition and Methodology ..................................................................................................... 36

About MarketLine ............................................................................................................................... 43

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

238
TABLE OF CONTENTS

LIST OF TABLES

Table 1: Reliance Group partnership volume and value trend (2014-YTD2018) 21

Table 2: Reliance Group partnership trend by key deal type (2014-YTD2018) 21

LIST OF FIGURES

Figure 1: Reliance Group partnership volume and value trend (2014-YTD2018) 21

Figure 2: Reliance Group partnership trend by key deal type (2014-YTD2018) 21

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

239
TARGETS AND PARTNERS

TARGETS AND PARTNERS


Reliance Group targets and partners (2014 -YTD2018)

Reliance Group-Target/Partner name Deal Date Deal type Deal value ($m)

Jasper Wireless, Inc. (United States) Nov 15, 2016 Partnership -

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

240
TARGETS AND PARTNERS

MERGERS & ACQUISITIONS


Mergers and Acquisitions – Deal reports

Deal Report: Reliance – Anil Dhirubhai Ambani Group acquires 15% stake in new Kerala
airport

Deal in brief

Reliance – Anil Dhirubhai Ambani Group, an Indian diversified business group, has acquired a 15% stake
in a new international airport at Aranmula in Pathanamthitta district of central Kerala, India, for a
consideration of INR2,250 million ($48.3 million).

The airport is promoted by Promoted by KGS Aranmula Airport, Ltd. and the promoters hold a 51% stake
in the project. Aranmula Aviation, Ltd., a company promoted by a consortium of Keralite organizations in
North America and Mount Zion Trust, promoted by businessman Abraham Kalamannil, holds 30% stake.
The state government-owned Kerala Industrial Infrastructure Development Corporation is also likely to
acquire around 10% stake in the project.

Target Undisclosed Company - International Airport - Kerala, India

Acquirer Reliance Group

Deal status Completed

Deal value ($m) 48.30

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (Indian Rupee)(m) 2,250

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 15

Date of completion Sep 04, 2010

Company information: Target and acquirer

Target: Undisclosed Company - International Airport - Kerala, India

Company type Private

The international airport is located at Aranmula in


Business description
Pathanamthitta district of central Kerala, India.

Industry Transport and Logistics


Transport and Logistics-->Transport Infrastructure-->Airports

Address Aranmula

City Pathanamthitta
7

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

241
TARGETS AND PARTNERS

State Kerala

Country India

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

242
TARGETS AND PARTNERS

Deal Report: Anil Dhirubhai Ambani Group to acquire PT Berau Coal

Deal in brief

Reliance Anil Dhirubhai Ambani Group (ADAG), a holding company operating in financial, communications,
infrastructure and entertainment sectors, intends to acquire PT Berau Coal, a company engaged in coal
production in Indonesia.

PT Berau is a three-way joint venture between PT Armadian Tritunggal (51%), a Dutch company dan
Rognar Holding BV (39%) and a Japanese firm Sojitz Corp (10%).

JSW Energy Limited is also considering a proposal to acquire a stake in the PT Berau. Merrill Lynch & Co.,
Inc. is acting as advisor for PT Berau in the transaction.

Target Pt. Berau Coal

Acquirer Reliance Group

Deal status Announced

Deal category Acquisition

Deal sub-category Majority acquisition

Date of announcement Dec 03, 2007

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal rationale

The acquisition of PT Berau is a perfect fit for ADAG's power generation business.

Company information: Target and acquirer

Target: Pt. Berau Coal

Company type Private

Energy and Utilities-->Commodity-->Coal


Industry Metals and Mining
Metals and Mining-->Coal Mining
Metals and Mining-->Coal Mining

Address Jl Pemuda No 40, Tanjung Redeb

City Berau

Country Indonesia

Website www.beraucoal.co.id
9

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

243
TARGETS AND PARTNERS

Phone number 62 - 217264778

Advisor information

Target : Pt. Berau Coal

Financial advisors

Merrill Lynch & Co., Inc.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

10

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

244
CORPORATE VENTURING

CORPORATE VENTURING
Corporate Venturing – Deal reports

Deal Report: Reliance Infrastructure to raise $913 million through placement

Deal in brief

Reliance Infrastructure, Ltd., an energy company, is planning to raise approximately INR43,000 million
($913 million) through a private placement.

Reliance Infrastructure will issue 42.9 million warrants convertible into shares, to Reliance – Anil Dhirubhai
Ambani Group, a diversified holding company, at a price of INR1,000 ($21.44) per share. Both the
companies are based in India.

Under the terms of the agreement, Reliance Infrastructure will receive 25% of the amount on allotment
through an upfront payment of around INR10,750 million ($288 million), and the balance upon the
conversion.

Life Insurance Corporation of India, and other insurance companies will be provided an opportunity to
participate in the proposed offering, on the same terms and conditions.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Following the completion, Reliance – Anil Dhirubhai Ambani Group will increase its stake in Reliance
Infrastructure from 38% to 48%.

Simultaneously, the Board has approved the cancellation of 43 million equity warrants issued to the
promoter group on January 20, 2008. The purchase cost to the promoter group, after taking into
consideration of INR7,830 million ($199.24 million) already received on warrants issued earlier, which now
have been cancelled, to be approximately INR1,183 ($25.4) per share, representing a premium of 83% to
the average price of the preceding three months.

Target Reliance Infrastructure Ltd.

Acquirer Reliance Group

Deal status Announced

Deal value (estimated) ($m) 913

Deal category Private placement

Date of announcement May 24, 2009

Deal rationale

The transaction would allow Reliance Infrastructure to increase its net worth and borrowing ability. It would
11
also allow the company to participate in the infrastructure sector for future growth opportunities.

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

245
CORPORATE VENTURING

Security type information

Security type Convertible debt

Company information: Target and acquirer

Target: Reliance Infrastructure Ltd.

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol RELINFRA

Reliance Infrastructure Ltd. (Reliance Infrastructure or 'the


company') is a utility company engaged in generation,
transmission, distribution and trading of power. It also
provides engineering, procurement and construction (EPC)
Business description services for developing power and road projects. The
company primarily operates in India. It is headquartered in
Navi Mumbai and employed about 7,755 people as on
March 31, 2015.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities
Energy and Utilities-->Commodity-->Coal
Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels
Energy and Utilities-->Utilities-->Power Generation--
>Renewables
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production
Energy and Utilities-->Utilities-->Utilities Networks--
Industry >Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Utilities-->Utilities Retail-->Energy
Services
Energy and Utilities-->Utilities-->Utilities Retail-->Major
Energy User Retail
Energy and Utilities-->Utilities-->Utilities Retail-->Residential
Retail
Energy and Utilities-->Utilities-->Utilities Retail-->SME Retail
Energy and Utilities-->Utilities-->Wholesale Energy--
>Trading and Risk Management

Address H Block 1st Floor, Dhirubhai Ambani Knowledge City

Country India

Website www.rinfra.com/home.html

12

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

246
CORPORATE VENTURING

Phone number 91 22 3009 8181

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

13

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

247
CORPORATE VENTURING

Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy

Deal in brief

Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.

Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
on the same terms and conditions.

Target Reliance Energy Limited

Acquirer 1 Reliance Group

Acquirer 2 The United India Insurance Company Limited

Acquirer 3 The Oriental Insurance Company Ltd.

Acquirer 4 New India Assurance Co., Ltd.

Acquirer 5 General Insurance Corporation of India

Acquirer 6 Life Insurance Corporation of India

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 7 National Insurance Company Limited

Deal status Announced

Deal value (estimated) ($m) 2,000

Deal category Private placement

Offer price ($) 45.72

Offer price (Indian Rupee) (m) 1,812

Date of announcement Dec 02, 2007

Deal rationale

The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas.

Deal financials

Valuation multiples (Reliance Energy Limited)


14

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

248
CORPORATE VENTURING

EV/Revenues 2.41

EV/Operating profit 14.15

EV/EBITDA 11.09

EV/Total assets 1.03

Bid premium (Reliance Energy Limited)

Bid premium (%) 5

Security type information

Security type Common stock

Company information: Target and acquirer

Target: Reliance Energy Limited

Company type Private

Reliance Energy Limited is an integrated power utility

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
company enagaged in the generation, transmission,
distribution, and trading of power in India. It operates gas,
Business description
coal, wind, and hydro-based power generation projects with
aggregate capacity of approximately 13,510 megawatts. The
company is headquartered at Maharashtra, India.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Exploration
Energy and Utilities-->Utilities-->Utilities Networks--
Industry
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production

Address Reliance Energy centre, Santacruz (East)

City Mumbai

State Maharashtra
15

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

249
CORPORATE VENTURING

Country India

Website www.rel.co.in

Phone number 91 22 30099999

Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 65,841.10 1,516.32

Operating profit 11,226.92 258.56

EBITDA 14,330.78 330.04

Post tax profit 8,014.50 184.57

Key ratios

Operating margin (%) 17.05

Acquirer 2: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s
personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
Business description rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
16

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

250
CORPORATE VENTURING

Financial Services-->General Insurance, Property and


Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss

Address 24, Whites Road

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
City Chennai

State Tamil Nadu

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

Acquirer 3: The Oriental Insurance Company Ltd.

Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

Industry Financial Services-->General Insurance, Property and


Casualty 17

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

251
CORPORATE VENTURING

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in

Phone number 91 11 43659595

Acquirer 4: New India Assurance Co., Ltd.

Company type Private

New India Assurance Co., Ltd. provides nonlife insurance


services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

City Mumbai

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Acquirer 5: General Insurance Corporation of India

Company type Public

General Insurance Corporation of India (GIC) is engaged in


providing reinsurance services to the general insurers in
Business description India. Its reinsurance portfolio includes oil and energy,
aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the 18

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

252
CORPORATE VENTURING

UAE, Malaysia, South Africa and Russia. It is headquartered


in Mumbai, India.

Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending

Address Suraksha, 170 Jamshedji Tata Road

Country India

Website www.gicofindia.com

Phone number 91 22 2286 7000

Acquirer 6: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Acquirer 7: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
Business description insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
19

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

253
CORPORATE VENTURING

householders insurance, and Janata personal accident


insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705


20

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

254
PARTNERSHIP

PARTNERSHIP
Partnership – Overview

Figure 1: Reliance Group partnership volume and value Figure 2: Reliance Group partnership trend by key deal type
trend (2014-YTD2018) (2014-YTD2018)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Note: Zero deal value indicates transactions with undisclosed deal values

Table 1: Reliance Group partnership volume and value trend Table 2: Reliance Group partnership trend by key deal type
(2014-YTD2018) (2014-YTD2018)

Year Volume Value ($m) Type of partnership Volume

2014 - - Joint Venture 1

2015 - -

2016 1 -

2017 - -

2018 - -
Note: One patnership agreement can have multiple deal types

21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

255
PARTNERSHIP

Partnership – Deal reports

Deal Report: Reliance forms joint venture with Jasper

Deal in brief

Reliance - Anil Dhirubhai Ambani Group, an India-based diversified holding company, has formed a joint
venture (JV) with Jasper, Inc., a US-based provider of cloud-based Internet of Things (loT) service platform.

The new JV called Unlimit will provide IoT services to Indian enterprises.

Partner 1 Reliance Group

Partner 2 Jasper Wireless, Inc.

Deal status Completed

Deal category Partnership

Deal sub-category Joint venture

Date of completion Nov 15, 2016

Company information: Partners

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Partner 1: Jasper Wireless, Inc.

Company type Private

Jasper Wireless, Inc. is a provider of machine-to-machine


communication services by converging in wireless
technologies and on-demand internet applications. Its
Business description service model features the Jasper Wireless M2M Global
SIM, expert M2M design services, and the Jasper Wireless
M2M Control Center for real-time visibility and control to help
M2M application providers.

Communications
Communications-->Telecoms Market
Industry
Technology and Services
Technology and Services
Technology and Services

Address 501 Macara Avenue, Suite 202

City Sunnyvale

State California

Country United States

Website www.jasperwireless.com
22

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

256
PARTNERSHIP

Phone number 1 408 328 5200

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

23

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

257
PARTNERSHIP

Deal Report: Reliance – Anil Dhirubhai Ambani to form joint venture with Dalian Wanda
Group

Deal in brief

Reliance – Anil Dhirubhai Ambani Group has signed an agreement to form a joint venture (JV) with Dalian
Wanda Group Co., Ltd. to build integrated township projects in India.

Reliance is an India-based diversified holding company and Wanda Group is a China-based developer of
commercial properties, luxury hotels, cultural industries, film screens, and chain stores.

The JV will initially develop 135 acres owned by Reliance Communications, Ltd. in Navi Mumbai, India and
80 acreas with Reliance Infrastructure in Hyderabad, India.

Partner 1 Reliance Group

Partner 2 Dalian Wanda Group Co., Ltd.

Deal status Announced

Deal category Partnership

Deal sub-category Joint venture

Date of announcement Dec 13, 2012

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Partners

Partner 1: Dalian Wanda Group Co., Ltd.

Company type Private

Dalian Wanda Group Co., Ltd. is a developer of commercial


Business description properties, luxury hotels, cultural industries, film screens,
and chain stores.

Industry Construction and Real Estate


Construction and Real Estate-->Real Estate Transactions

Floor 28, Wanda Mansion, No. 9 Jiefang Street, Zhongshan


Address
District

City Dalian

Country China

Website www.wanda.com.cn

Phone number 86 41 1828 22888

24

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

258
PARTNERSHIP

Deal Report: Reliance – Anil Dhirubhai Ambani Group forms joint venture with Krishak
Bharati Cooperative

Deal in brief

Reliance – Anil Dhirubhai Ambani Group (Reliance ADAG), a diversified holding company, has formed a
joint venture with Krishak Bharati Cooperative Limited (KRIBHCO), a manufacturer of urea, ammonia, and
bio-fertilizers. Both the companies are based in India.

The joint venture, Kribhco Reliance Kisan Limited, will market telecom products of Reliance
Communications, both GSM and CDMA, and also distribute products and services of other business
enterprises of Reliance ADAG, including Reliance Capital, Reliance Entertainment, and BIG TV DTH.

KRIBHCO would hold a 60% stake in the joint venture, while the balance 40% would be held by Reliance
ADAG.

Partner 1 Reliance Group

Partner 2 Krishak Bharati Cooperative Limited

Deal status Completed

Deal category Partnership

Deal sub-category Joint venture

Date of completion Jun 09, 2009

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Partners

Partner 1: Krishak Bharati Cooperative Limited

Company type Private

Krishak Bharati Cooperative Limited is a manufacturer of


Business description
urea, ammonia and bio-fertilizers.

Industry Chemicals
Chemicals-->Agrochemicals-->Fertilizer

Address KRIBHCO Bhavan, A-8-10, Sector 1

City Noida

State Uttar Pradesh

Country India

Website www.kribhco.net

Phone number 91 120 253 4613

25

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

259
PARTNERSHIP

Deal Report: DreamWorks to form joint venture with Reliance – Anil Dhirubhai Ambani
Group

Deal in brief

Reliance – Anil Dhirubhai Ambani Group (Reliance ADAG), an India-based diversified holding company,
has agreed to invest $550 million in the joint venture to be formed with DreamWorks Animation SKG, Inc., a
US-based company engaged in developing and producing computer generated animated feature films.
JPMorgan Securities is leading a syndicate of banks to raise approximately $700 million.

The 50:50 joint venture will be launched by January 2009 and will produce 30 to 35 films over the next five
years. The transaction is valued at approximately $1,500 million.

Announcement (September 19, 2008):

DreamWorks Animation SKG, Inc. has signed an agreement with Reliance ADAG to set up a new $1,200
million film company.

Under the terms of the agreement, Reliance will invest about $500 million in equity, while JP Morgan Chase
& Co., Inc. will provide another $700 million in debt towards the new venture.

Update on August 9, 2008:

According to the Wall Street Journal, the proposed joint venture between DreamWorks Animation SKG
and Reliance ADAG to set up a new movie company is nearing completion.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Under the terms of the joint venture, Reliance ADAG is likely to invest $500 million in the new movie
venture and another $500 million in debt through JP Morgan Chase & Co. Dreamworks plans to produce
about six films with Reliance ADAG and is likely to get them distributed by Universal Pictures.

Rumor (June 18, 2008):

According to Hemscott, the Wall Street Journal reported that DreamWorks Animation SKG, Inc. is planning
to enter into a joint venture agreement with Reliance – Anil Dhirubhai Ambani Group, to form a new movie
venture.

The transaction is valued in between $500 million to $600 million.

DreamWorks is planning for another $500 million in debt financing to give the venture enough money and
to make about six films a year.

Partner 1 DreamWorks Animation SKG, Inc.

Partner 2 Reliance Group

Deal status Announced

Deal value (estimated) ($m) 1,500

Deal category Partnership

26

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

260
PARTNERSHIP

Deal sub-category Joint venture

Date of announcement Sep 19, 2008

Deal rationale

The transaction would give Spielberg the cash to finance DreamWorks' departure from Viacom Inc.'s
Paramount Pictures. It would also enable Reliance ADAG to strengthen its media business.

Company information: Partners

Partner 1: DreamWorks Animation SKG, Inc.

Company type Public

Stock exchange NASD(NASDAQ)

Ticker symbol DWA

DreamWorks Animation SKG, Inc. (DreamWorks Animation


or "the company") creates computer generated (CG)
animated feature films, television specials and series and
Business description live entertainment properties and related consumer products.
The company operates primarily in the US, where it is
headquartered in Glendale, California and employed 2,300
people as on December 31, 2015.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Media-->Advertising-->Film and Cinema Advertising
Media
Media-->Broadcasting-->Television Broadcasting
Media-->Motion Pictures and Sound Recording
Media-->Motion Pictures and Sound Recording-->Cinema
Film Production
Media-->Motion Pictures and Sound Recording-->Video
Industry Production
Media-->Motion Pictures and Sound Recording-->Cinema
Film Distribution
Media-->Motion Pictures and Sound Recording-->Video
Distribution
Media-->Multimedia Services
Technology and Services-->Consumer IT-->Consumer
Software
Leisure and Arts

Address Campanile Building, 1000 Flower Street

Country United States

Website www.dreamworksanimation.com

Phone number 1 818 695 5000

27

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

261
DIVESTMENTS

Divestments – Deal reports

Deal Report: Prysmian acquires 51% stake in Ravin Cables

Deal in brief

Prysmian S.p.A., an Italian provider of cables and systems for energy and telecommunications, has
acquired a 51% stake in Ravin Cables Limited, an India-based manufacturer of cables, for a consideration
of approximately EUR26 million.

As part of the transaction, Prysmian subscribed for new shares of Ravin and acquired the remaining stake
from existing shareholders including Tano Capital LLC and Reliance – Anil Dhirubhai Ambani Group.

Singhi Advisors Limited acted as financial advisor and Nishith Desai Associates acted as legal advisor to
Ravin, and Allen & Overy LLP acted as legal advisor to Prysmian on the transaction.

Target Ravin Cables Limited

Acquirer Prysmian S.p.A.

Seller/Vendor 1 Reliance Group

Seller/Vendor 2 Tano Capital, LLC

Deal status Completed

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (estimated) ($m) 37.37 (min)

Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 51

Date of completion Jan 19, 2010

Deal rationale

The acquisition will give Prysmian a manufacturing presence in India and Middle East, particularly in the
value utilities business.

Company information: Target, acquirer, and seller/vendor

Target: Ravin Cables Limited

Company type Private

Business description Ravin Cables Limited is a power cable manufacturer. The


28

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

262
DIVESTMENTS

company offers low tension cables, high tension cables, fire


survival cables and aerial bunched cables. In addition, the
company offers cable laying, cable jointing and termination
services.

Industry Construction and Real Estate-->Special Trade Contractors


Industrial Goods and Machinery-->Wires and Cables

Number of employees 355

Address 302, Akruti Trade Centre, MIDC Road. No.7, Andheri (E)

City Mumbai

State Maharashtra

Country India

Website www.primecabkabel.com

Phone number 91 22 3081 6666

Financial information – (Fiscal year 31-Mar-2009)

Financial parameters Euro (EUR) (m) ($m)

Revenues 45 59.43

EBITDA 4.40 5.81

Key ratios

Operating margin (%) -

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer: Prysmian S.p.A.

Company type Public

Stock exchange BIT (Borsa Italiana)

Ticker symbol PRY

Prysmian S.p.A. (Prysmian or 'the group') is engaged in


offering cables and systems for the energy, and telecom
cables and systems industry. The group offers underground
and submarine power transmission and distribution cables
and systems, special cables, medium and low voltage
Business description
cables, cables and accessories, and optical fibers, among
others. Prysmian operates in Europe, the Middle East, Africa
(EMEA), the Americas, and Asia-Pacific. It is headquartered
in Milan, Italy and employed approximately 19,000 people as
of FY2015.

Industry Industrial Goods and Machinery


Industrial Goods and Machinery-->Wires and Cables

Address Viale Sarca 222, 20126 Milan

Country Italy

29

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

263
DIVESTMENTS

Website prysmiangroup.com

Phone number 39 2 6449 1

Vendor 2: Tano Capital, LLC

Industry Asset management firm, swaps dealer

Tano Capital, LLC is a family office service provider. The


company offers wealth management services to high-net-
worth individuals (HNWIs have a net worth of US$1 million or
more, excluding their primary residence), businesses, and
wealthy families. It offers alternative asset management and
investment services. Tano Capital, LLC invests in
commodities and hard assets such as lead, copper,
platinum, sugar, corn, copper, oil, natural gas, water, and
coffee. The company also invests in the Indian and Chinese
industries including retailing, banking and finance,
Business description
automotive, infrastructure, healthcare, hospitality, media,
steel, cement, real estate, and consumer electronic goods. It
has a presence in the US, Singapore, India, Mauritius,
China, Taiwan, and Japan. The minimum initial investment
generally ranges between US$1 million and US$10 million.
Tano Capital, LLC reported assets under management
(AuM) of US$293.77 million as on December 31, 2015. It
had historical AuM figure of US$379.73 million as on
December 31, 2014. Tano Capital, LLC Capital is
headquartered in San Mateo, California, the US.

Address One Franklin Parkway , Building 970, 2nd Floor

City San Mateo

State California

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country United States

Website www.tanocap.squarespace.com

Phone number 1 650 2120330

Advisor information

Target : Ravin Cables Limited

Financial advisors

Singhi Advisors Limited

Legal advisors

Nishith Desai Associates

Acquirer : Prysmian S.p.A.

Legal advisors

30

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

264
DIVESTMENTS

Allen & Overy LLP, UK (Executive: Mazhar Khan; Office: Dubai; Country: United Arab Emirates)

Allen & Overy LLP, UK (Executive: Victoria Honey; Office: Dubai; Country: United Arab Emirates)

Allen & Overy LLP, UK (Executive: Simon Roderick; Office: Dubai; Country: United Arab Emirates)

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

31

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

265
DIVESTMENTS

Deal Report: George Soros Quantum Fund acquires 3% stake in Reliance Entertainment

Deal in brief

The George Soros Quantum Fund, a fund operated by US-based investment firm Soros Fund Management
LLC, has acquired a 3% stake in Reliance Entertainment Pvt., Ltd., a media and entertainment unit of
Reliance – Anil Dhirubhai Ambani Group, an Indian-based diversified holding company, for INR4,000
million ($100 million).

Target Reliance Big Entertainment Pvt., Ltd.

Acquirer The George Soros Quantum Fund

Seller/Vendor Reliance Group

Deal status Completed

Deal value ($m) 100

Deal value (Indian Rupee)(m) 4,000

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 3

Date of completion Feb 07, 2008

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor

Target: Reliance Big Entertainment Pvt., Ltd.

Company type Private

Reliance Entertainment is a media and entertainment


company. The company distributes movies, music, sports,
gaming, Internet, and mobile portals. The company's Adlabs
Business description
Films Limited is engaged in film processing, production,
exhibition, and digital cinema. It also involved in FM radio
business.

Media
Media-->Broadcasting-->Radio Broadcasting
Media-->Motion Pictures and Sound Recording-->Cinema
Film Production
Media-->Motion Pictures and Sound Recording-->Video
Industry Production
Media-->Motion Pictures and Sound Recording-->Cinema
Film Distribution
Media-->Motion Pictures and Sound Recording-->Video
Distribution
Media-->Motion Pictures and Sound Recording
Media-->Motion Pictures and Sound Recording

32

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

266
DIVESTMENTS

Leisure and Arts

Country India

Acquirer: The George Soros Quantum Fund

Industry Venturecapital

The George Soros Quantum Fund belongs to Soros Fund


Business description
Management Llc, a foreign institutional investor.

Address 888 Seventh Avenue, 33rd Floor

City New York

State New York

Country United States

Phone number 1 212 262 6300

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

33

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

267
APPENDIX

APPENDIX
Contact Us

We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com

About MarketLine Financial Deals Database

• Financial Deals is the most extensive Deals database currently available in the market

• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
– partnership deal

• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms

• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.

• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.

• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.

34

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

268
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

35

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

269
APPENDIX

Deal Definition and Methodology

Deal type definition

Merger

A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:

 All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.

 Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.

 The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.

 The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.

 No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
company except to ensure uniformity of accounting policies.

Acquisition

Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:

 Minority acquisition: The acquisition of less than 50% equity stake in the target

 Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target

 100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target

 Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity

Private equity

Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:

 Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company

 Secondary buyout: PE firm or a group of PE firms acquiring a company from a PE firm


36

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

270
APPENDIX
 Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds

 Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.

 Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team

 Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed

 Exit: PE firm selling its stake in a portfolio company

Private placement

A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.

Venture financing

Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:

 Seed: Financing provided for companies which have still not started marketing their product

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
or services. The purpose of such funding will generally be to assess and develop an initial
business concept

 Start-up: Financing provided to companies for developing their product/service and to


purchase the necessary assets for their production/operation

 Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products

 Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities

 Exit: This node is assigned when a venture capital is selling its stake in a portfolio company

Initial Public Offering

 Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:

 Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO

 Pricing: When the company fixes the issue price for its offering

37

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

271
APPENDIX
 Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering

 Withdrawn: When the company withdraws its IPO

 Postponed: When the company postpones its IPO

Partnership

A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:

 Joint Venture (JV): Two or more companies forming a new entity to undertake an activity

 Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.

 Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service

 Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status details

Financial Deals captures deal status according to following stages:

 Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
 Announced: Either party involved in the transaction announces the deal
 Completed: Involved parties complete the transaction
 Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
 Dead rumor: Rumor denied by either of the parties involved in the transaction

Deal value

Deal value is the consideration paid by the acquirer for acquiring the target.

Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.

All deals values which are mentioned as approximate consideration are tagged as estimated values.

Deal value criteria for filtering deals


38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

272
APPENDIX

For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.

Deal payment details


Deal payment is captured in the following fields:

Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:

 Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer

 Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer

 Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer

 Quantity type: It indicates the consideration by payment mode in terms of value and
percentage

% acquired: % acquired indicates the stock acquired in percentage terms

Share price paid: Price per share offered by the acquirer to the target

Debt-related fields
Below is the list of fields captured:

Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Lead: Represents the lead debt provide
 Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers

Debt amount: Amount of debt raised by the acquirer to finance the acquisition

Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:

 Bank facilities: These are general loans provided by banks to companies.

 Senior: Debt that has priority for repayment in liquidation.

 Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.

 Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.

 Other debt: Any other debt facility other than the above mentioned debt categories.

39

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

273
APPENDIX

Securities issued to finance deal


Below is a list of category and sub-category of securities issued by the acquirer, captured in FD:

Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:

 Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder

 Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio

 Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date

 Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)

 Placing: General term to describe the process of raising money via the issue of new shares

 Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public

 Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period

 Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings

 Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).

Financial and operational information

Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:

Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.

No. of employees: Number of employees at the fiscal year end


Local currency: The currency in which the company is reporting its financial statements

40

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

274
APPENDIX

Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers

Revenue (banking): This value is sum of interest income and non interest income

Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.

EBITDA: Earnings before interest, taxes, depreciation and amortization

Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax

Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.

Enterprise value: Enterprise value is calculated by adding a company’s market capitalization,


preferred stock, minority interest, and outstanding debt together and then subtracting out the cash
and cash equivalents found on the balance sheet as on the fiscal year end

Shares issued: Number of shares the company has issued out of its authorized capital

Market capitalization: Market capitalization is calculated by taking the number of outstanding


shares of common stock multiplied by the market price-per-share as on fiscal year end

Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
as the difference between shares in issue and treasury shares as of the fiscal year end.

Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth

Net assets-share ratio: It is defined as net assets divided by number of shares outstanding

Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares

Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.

Deal multiples

Financial Deals captures the following four valuation multiples:


 EV/revenues
 EV/EBIT
 EV/EBITDA
 EV/total assets

41

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

275
APPENDIX

Advisor information

Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:

Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.

Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:

 Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts

 Accounting: Financial advisor who looks into the accounting matters for a deal

 Tax: Financial advisor who looks into the tax matters for a deal

 Corporate Finance: Financial advisor who looks into the financial decisions of a corporation

 Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue

 Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted

 Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other

Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities

Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders

42

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

276
APPENDIX

About MarketLine

In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.

At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.

Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.

MarketLine is a wholly owned subsidiary of Informa.

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

43

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

277
APPENDIX

Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

MARKETLINE | 119 FARRINGDON ROAD | LONDON,


UNITED KINGDOM, EC1R 3DA
44
T: + 44 161 238 4040| F: + 44 870 134 4371
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
E: REACHUS@MARKETLINE.COM
278
MarketLine Financial Deals

Vendor, acquirer, target and partner report for Edelweiss Financial Services Ltd and its
subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint ventures,
Alliances and Investments

Edelweiss Financial Services Ltd – Mergers &


Acquisitions (M&A), Partnerships & Alliances
and Investments

REFERENCE CODE: 27C125A1-0EE4-4E64-90BF-64BA67A2FC34


PUBLICATION DATE: September 2018
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

279
COMPANY OVERVIEW AND KEY FACTS

COMPANY OVERVIEW AND KEY FACTS

EDELWEISS FINANCIAL SERVICES LTD

Edelweiss Financial Services Ltd (Edelweiss) is a financial services company. It is engaged in financial markets,
franchise business, credit business, asset management services, commodities, life insurance and retail finance. The
company offers various financial products and services which include investment banking, institutional equities,
mutual fund, home loans, insurance broking and retail brokerage services. These financial products and services are
offered corporations, institutions and individuals. The company operates in India. Edelweiss is headquartered in
Mumbai.

The company reported revenues of (Rupee) INR85,809.9 million for the fiscal year ended March 2018 (FY2018), an
increase of 30.2% over FY2017. In FY2018, the company’s operating margin was 16.1%, compared to an operating
margin of 13.9% in FY2017. In FY2018, the company recorded a net margin of 10.4%, compared to a net margin of
9.2% in FY2017.

The company reported revenues of INR24,354.7 million for the first quarter ended June 2018, a decrease of 6.6%
over the previous quarter.

Key facts

Address Edelweiss House, Off CST Road

State Maharashtra

Country India

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Telephone 91 22 40094400

Fax 91 22 40863759

Website www.edelweissfin.com

Exchange / Ticker BOM / 532922

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

280
COMPANY OVERVIEW AND KEY FACTS

Edelweiss Financial Services Ltd activity by deal type - Edelweiss Financial Services Ltd M&A average deal size -
volume (2014-YTD2018) value ($m)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) 1 - 1 - - 2014 1 -
Capital raising - - 1 - - 2015 - -
(CR) 2016 1 -
Corporate - 2 1 2 - 2017 - -

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
venturing (CV)
2018 - -
Divestments (DIV) - 1 - - -
Private equity - 1 - - -
(PE)

Note: Zero deal value indicates transactions with undisclosed deal values

TOP DEALS IN (2014 -YTD2018)

Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
($m)

Private
National Insurance Company Limited (India) Mar 27, 2017 Completed 136.45
placement

Venture
Wonderschool (United States) Jun 19, 2017 Completed 2
financing

Private
Edelweiss Financial Services Ltd (India) May 13, 2016 Announced 374.64
placement

Private
VGN Developers Private Limited (India) Apr 10, 2015 Completed 107.6
placement

Private
Parsvnath Developers Limited (India) Mar 30, 2015 Completed 56.56
placement

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

281
TABLE OF CONTENTS

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS ............................................ 2

TABLE OF CONTENTS .......................................................................... 4

LIST OF TABLES .................................................................................... 6

LIST OF FIGURES .................................................................................. 6

TARGETS AND PARTNERS .................................................................. 7

MERGERS & ACQUISITIONS ................................................................ 8


Mergers and Acquisitions – Overview ............................................................................................... 8

Mergers and Acquisitions – Deal reports .......................................................................................... 9

CORPORATE VENTURING .................................................................. 20

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Corporate Venturing – Overview ...................................................................................................... 20

Corporate Venturing – Deal reports ................................................................................................. 21

PARTNERSHIP ..................................................................................... 60
Partnership – Deal reports ................................................................................................................ 60

CAPITAL RAISING ............................................................................... 63


Capital Raising – Overview ............................................................................................................... 63

Capital Raising – Deal reports .......................................................................................................... 64

DIVESTMENTS ..................................................................................... 94
Divestments – Overview .................................................................................................................... 94

Divestments – Deal reports ............................................................................................................... 95

PRIVATE EQUITY & OWNERSHIP ...................................................... 99


Private Equity and Ownership – Overview ...................................................................................... 99

Private Equity and Ownership – Deal reports ............................................................................... 100

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

282
TABLE OF CONTENTS

APPENDIX........................................................................................... 109
Contact Us ....................................................................................................................................... 109

About MarketLine Financial Deals Database ................................................................................. 109

Deal Definition and Methodology ................................................................................................... 111

About MarketLine ............................................................................................................................. 118

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

283
TABLE OF CONTENTS

LIST OF TABLES

Table 1: Edelweiss Financial Services Ltd M&A volume and value trend (2014-YTD2018) 8

Table 2: Edelweiss Financial Services Ltd M&A activity by geography (2014-YTD2018) 8

Table 3: Edelweiss Financial Services Ltd corporate venturing volume and value trend (2014-YTD2018) 20

Table 4: Edelweiss Financial Services Ltd corporate venturing by geography (2014-YTD2018) 20

Table 5: Edelweiss Financial Services Ltd capital raising volume and value trend (2014-YTD2018) 63

Table 6: Edelweiss Financial Services Ltd capital raising by deal type (2014-YTD2018) 63

Table 7: Edelweiss Financial Services Ltd divestments volume and value trend (2014-YTD2018) 94

Table 8: Edelweiss Financial Services Ltd divestments activity by geography (2014-YTD2018) 94

Table 9: Edelweiss Financial Services Ltd private equity and ownership volume and value trend (2014-
YTD2018) 99

Table 10: Edelweiss Financial Services Ltd private equity and ownership activity by deal type (2014-
YTD2018) 99

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
LIST OF FIGURES

Figure 1: Edelweiss Financial Services Ltd M&A volume and value trend (2014-YTD2018) 8

Figure 2: Edelweiss Financial Services Ltd M&A activity by geography (2014-YTD2018) 8

Figure 3: Edelweiss Financial Services Ltd corporate venturing volume and value trend (2014-YTD2018) 20

Figure 4: Edelweiss Financial Services Ltd corporate venturing by geography (2014-YTD2018) 20

Figure 5: Edelweiss Financial Services Ltd capital raising volume and value trend (2014-YTD2018) 63

Figure 6: Edelweiss Financial Services Ltd capital raising by deal type (2014-YTD2018) 63

Figure 7: Edelweiss Financial Services Ltd divestments volume and value trend (2014-YTD2018) 94

Figure 8: Edelweiss Financial Services Ltd divestments by geography (2014-YTD2018) 94

Figure 9: Edelweiss Financial Services Ltd private equity and ownership volume and value trend (2014-
YTD2018) 99

Figure 10: Edelweiss Financial Services Ltd private equity and ownership by deal type (2014-YTD2018) 99

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

284
TARGETS AND PARTNERS

TARGETS AND PARTNERS


Edelweiss Financial Services Ltd targets and partners (2014 -YTD2018)

Edelweiss Financial Services Ltd-Target/Partner


Deal Date Deal type Deal value ($m)
name

Wonderschool (United States) Jun 19, 2017 Venture financing 2

National Insurance Company Limited (India) Mar 27, 2017 Private placement 136.45

Ambit Alpha Fund (India) Sep 22, 2016 Acquisition -

GOQii (United States) Feb 10, 2016 Venture financing -

VGN Developers Private Limited (India) Apr 10, 2015 Private placement 107.6

Parsvnath Developers Limited (India) Mar 30, 2015 Private placement 56.56

Forefront Capital Management Pvt. Ltd. (India) May 1, 2014 Acquisition -

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

285
MERGERS & ACQUISITIONS

MERGERS & ACQUISITIONS


Mergers and Acquisitions – Overview

Figure 1: Edelweiss Financial Services Ltd M&A volume and Figure 2: Edelweiss Financial Services Ltd M&A activity by
value trend (2014-YTD2018) geography (2014-YTD2018)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 1: Edelweiss Financial Services Ltd M&A volume and Table 2: Edelweiss Financial Services Ltd M&A activity by
value trend (2014-YTD2018) geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 1 - North America -

2015 - - Europe -

2016 1 - Asia-Pacific 2

2017 - - Middle East and Africa -

2018 - - South and Central America -

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

286
MERGERS & ACQUISITIONS

Mergers and Acquisitions – Deal reports

Deal Report: Edelweiss Financial Services to acquire Ambit Alpha Fund

Deal in brief

Edelweiss Financial Services, Ltd., a diversified financial services Group, has agreed to acquire Ambit
Alpha Fund, an alternate investment fund (AIF) managed by Ambit Investment Advisors Pvt., Ltd., a
provider of investment management and advisory services. All the entities are based in India.

Target Ambit Alpha Fund

Acquirer Edelweiss Financial Services Ltd

Seller/Vendor Ambit Investment Advisors Pvt., Ltd.

Deal status Completed

Deal category Acquisition

Deal sub-category Majority acquisition

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Sep 22, 2016

Deal rationale

The transaction will enable Edelweiss to strengthen its global assets management (GAM) business.

Company information: Target, acquirer, and seller/vendor

Target: Ambit Alpha Fund


Ambit Alpha Fund is an alternative investment of Ambit
Business description Investment Advisors Pvt. Ltd. The company is
headquartered in India.

Country India

Website www.ambitfundsindia.com

Vendor: Ambit Investment Advisors Pvt., Ltd.

Company type Private

Ambit Investment Advisors Pvt., Ltd. is a provider of


Business description
investment management and advisory services.

Address Ambit House, 449


9

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

287
MERGERS & ACQUISITIONS

City Mumbai

State Maharashtra

Country India

Website www.ambitfundsindia.com

Phone number 91 22 3982 1819

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

10

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

288
MERGERS & ACQUISITIONS

Deal Report: Edelweiss Fin Services acquires Forefront Capital Management

Deal in brief

Edelweiss Financial Services, Ltd., a provider of diversified financial services, has acquired Forefront
Capital Management Pvt., Ltd., an asset management company. Both the entities are based in India.

Target Forefront Capital Management Pvt. Ltd.

Acquirer Edelweiss Financial Services Ltd

Deal status Completed

Deal category Acquisition

Deal sub-category Majority acquisition

Date of completion May 01, 2014

Deal rationale

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
The acquisition will further strengthen and diversify Edelweiss’s presence in the asset management space,
and provide additional investment solutions to its clients.

Company information: Target and acquirer

Target: Forefront Capital Management Pvt. Ltd.

Industry Asset management firm, quasi-government organization

Forefront Capital Management Pvt. Ltd is a high net worth


focused asset management company. The company
currently manages a wide array of investments focused on
the absolute return space, from value oriented equity
Business description
strategies to multi-asset allocation strategies and has
developed deep expertise in the full spectrum of India
focused asset management - research, advisory,
investments and trade execution.

Address 111 TV Industrial Estate, S.K. Ahire Marg

City Mumbai

State Maharashtra

Country India

Website www.forefrontcap.com

Phone number 91 22 2494 4807

11

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

289
MERGERS & ACQUISITIONS

Deal Report: Edelweiss acquires Millet brand from Groupe Lafuma

Deal in brief

Edelweiss has acquired the Millet brand in Korea from Groupe Lafuma, a France-based manufacturer of
sports and outdoors equipment, for EUR5.8 million.

Target Groupe Lafuma - Millet Brand - Korea

Acquirer Edelweiss Financial Services Ltd

Seller/Vendor Groupe Lafuma

Deal status Completed

Deal value ($m) 7.38

Deal value (Andorra,Euro (EUR))(m) 5.80

Deal category Acquisition

Deal sub-category Asset purchase

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Mar 12, 2009

Company information: Target, acquirer, and seller/vendor

Target: Groupe Lafuma - Millet Brand - Korea

Company type Private

The Millet brand of Groupe Lafuma in Korea manufactures


Business description and retails clothing, shoes, bags, and equipment for
mountaineering, free climbing, and skiing.

Retailing-->Clothing, Footwear, Accessories and Luxury


Goods-->Accessories
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Clothing
Industry
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Footwear
Consumer Packaged Goods-->Other Consumer Products--
>Clothing, Footwear, Accessories and Luxury Goods--
>Clothing

Vendor: Groupe Lafuma

Company type Private

Groupe Lafuma is a manufacturer of sports and outdoors


equipment. Its products include clothing, shoes, bags,
Business description
shoes, and equipment and clothing for sports. The company
is also engaged in retailing its produts through its stores. 12

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

290
MERGERS & ACQUISITIONS

Retailing-->Clothing, Footwear, Accessories and Luxury


Goods-->Accessories
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Clothing
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Footwear
Industry Retailing-->Other Specialist Retailers-->Sporting Goods
Consumer Packaged Goods-->Other Consumer Products--
>Sports Goods
Consumer Packaged Goods-->Other Consumer Products--
>Sports Goods-->Sports Clothing and Footwear
Consumer Packaged Goods-->Other Consumer Products--
>Clothing, Footwear, Accessories and Luxury Goods--
>Clothing

Address BP 60

City Anneyron

Country France

Website www.groupe-lafuma.com

Phone number 33 04 75 31 31 31

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

13

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

291
MERGERS & ACQUISITIONS

Deal Report: Percept Limited raises $35.64 million from private equity firms

Deal in brief

Percept Limited, an entertainment, media, and communications company, has raised INR 1,500 million
($35.64 million) through private equity, from Edelweiss Capital Limited, a financial services company,
Passport Capital LLC, an investment firm, and Indivision India Partners (IIP).

Target Percept Limited

Acquirer 1 Edelweiss Financial Services Ltd

Acquirer 2 Passport Capital, LLC

Acquirer 3 Indivision India Partners

Deal status Completed

Deal value ($m) 35.64

Deal value (Indian Rupee)(m) 1,500

Deal category Private equity

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Majority acquisition

Date of completion May 14, 2008

Deal rationale

The transaction would scale up Percept's content and IPR businesses, and the funds would be used in
building presence and strength in the entertainment, media and communications domain, including creation
of knowledge practices, proprietary tools and assets, and creation of asset and talent ownership. The funds
would also be deployed in acquisitions and partnerships, for the creation of knowledge practices,
proprietary tools and assets, and for asset and talent ownership.

Company information: Target and acquirer

Target: Percept Limited

Company type Private

Percept Limited operates as an entertainment, media, and


communications company in India, Bahrain, and the United
Arab Emirates. The company’ entertainment services include
talent management, sports, and experiential and
entertainment marketing, as well as content creation,
Business description
aggregation, and distribution services. It also provides media
services, such as out-of-home and digital media services, as
well as media management and consultancy, media
concessionaires, and project management services. In
addition, it offers communications services, which include 14

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

292
MERGERS & ACQUISITIONS

advertising, public relations, integrated marketing


communications consultancy, marketing and media buying.
The company was founded in 1984 and is based in Mumbai,
India with additional offices in India and the Middle East.

Media-->Advertising
Media-->Advertising-->Media Buying Services
Industry
Media-->Advertising-->Media Planning and Representation
Business and Consumer Services-->Marketing Services
Business and Consumer Services-->Public Relations

Address P22, Raghuvanshi Estate, 11/12, Senapati Bapat Marg

City Mumbai

State Maharashtra

Country India

Website www.perceptindia.com

Phone number 91 22 3044 8400

Acquirer 2: Passport Capital, LLC

Industry Investment company, nasd member broker/dealer

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Passport Capital, LLC is an employee owned hedge fund
sponsor. The company provides services to pooled
Business description
investment vehicles. The company also invests in public
equity and alternative investments markets across the globe.

Address One Market Street, Steuart Tower

City San Francisco

State California

Country United States

Website www.passportcapital.com

Acquirer 3: Indivision India Partners

Industry Private equity firm, swaps dealer

Indivision India Partners is a Mauritius-based fund focused


Business description
on growth capital private equity.

Country Mauritius

15

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

293
MERGERS & ACQUISITIONS

Deal Report: Edelweiss Capital and Lehman Brothers invests in ECL Finance

Deal in brief

Edelweiss Capital Limited, a financial services company, along with Lehman Brothers Holdings, Inc,
Government of Singapore, Galleon Partners, L.P., and SHUAA Capital p.s.c., have invested approximately
INR4,000 million ($101.87 million) in ECL Finance Limited, a non-banking finance company of Edelweiss
Capital, through a subscription to fresh equity issuance which comprise 23.3% of the post issued capital.

Through this transaction, Edelweiss Capital's shareholding in ECL Finance will reduce to 62.5% from the
existing 74% stake.

Target ECL Finance Limited

Acquirer 1 Government of Singapore

Acquirer 2 Edelweiss Financial Services Ltd

Acquirer 3 SHUAA Capital p.s.c.

Acquirer 4 Lehman Brothers, Inc.

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 5 Galleon Partners, L.P.

Deal status Completed

Deal value (estimated) ($m) 101.87

Deal category Private equity

Acquired % 23.3

Date of completion Jan 17, 2008

Deal rationale

ECL Finance intends to utilize the proceeds for its on going business plans.

Company information: Target and acquirer

Target: ECL Finance Limited

Company type Private

ECL Finance Limited is a provider of non-banking financial


services including financing, money lending, bill discounting,
factoring, and corporate lending with or without securities.
Business description The company also provides corporate finance, structured
finance, loans against property, loans against securities, real
estate finance loans, public issue financing, sme finance and
other financial products. 16

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

294
MERGERS & ACQUISITIONS

Financial Services
Industry Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending

Address Nariman Point, 14th Floor Express Towers

City Mumbai

State Maharashtra

Country India

Acquirer 1: Government of Singapore

Company type Private

Singapore is a democratic parliamentary republic state


operating through a three tier system consisting of a
Legislature, and Judiciary. The major functions of the
government are classified into four divisions, namely, Social
Development, Security and External Affairs, Economic
Development, and Government Administration. The
Business description
government's services are mainly centered towards three
key domains, namely, Citizens and Residents, Businesses

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
and Non-Residents which represents focus and efficiency in
the system with custom made solutions for all three
segments. The government's Prime Minister’s Office (PMO)
is headquartered in Singapore.

Government and Non-Profit Organisations


Government and Non-Profit Organisations-->Governmental
Organizations
Industry Government and Non-Profit Organisations-->Governmental
Organizations
Industrial Goods and Machinery-->Battery Manufacturing
Transport and Logistics-->Transport Infrastructure--
>Highway Operators

Address Orchard Road

City Istana

Country Singapore

Website www.gov.sg

Phone number 65 62358577

Acquirer 3: SHUAA Capital p.s.c.

Company type Private

SHUAA Capital p.s.c. is a financial services firm that offers a


range of asset management, corporate finance advisory,
Business description
capital markets and credit services including lending to
regional SMEs.
17

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

295
MERGERS & ACQUISITIONS

Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management

Address Level 31, Emirates Towers, Sheikh Zayed Road

City Dubai

Country United Arab Emirates

Website www.shuaa.com

Phone number 971 4 330 3600

Acquirer 4: Lehman Brothers, Inc.

Company type Private

Business description Lehman Brothers, Inc. is an investment banking company.

Financial Services

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Private Equity and Venture Capital
Financial Services-->Capital Markets and Trading
Financial Services-->Cards
Industry
Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking
Financial Services-->Institutional Investment Management
Financial Services-->Wealth Management and Private
Banking

Address 745 Seventh Avenue

City New York

State New York

Country United States

Website www.lehman.com

Phone number 1 212 526 7000

Acquirer 5: Galleon Partners, L.P.

Business description Galleon Partners is a New York-based hedge fund.

Address 590 Madison Avenue, 34th Floor

City New York

State New York

Country United States

Website www.galleongrp.com
18

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

296
MERGERS & ACQUISITIONS

Phone number 1 212 371 2939

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

19

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

297
CORPORATE VENTURING

CORPORATE VENTURING
Corporate Venturing – Overview

Figure 3: Edelweiss Financial Services Ltd corporate Figure 4: Edelweiss Financial Services Ltd corporate
venturing volume and value trend (2014-YTD2018) venturing by geography (2014-YTD2018)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 3: Edelweiss Financial Services Ltd corporate venturing Table 4: Edelweiss Financial Services Ltd corporate venturing
volume and value trend (2014-YTD2018) by geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 - - North America 2

2015 2 164.16 Europe -

2016 1 - Asia-Pacific 3

2017 2 138.45 Middle East and Africa -

2018 - - South and Central America -

20

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

298
CORPORATE VENTURING

Corporate Venturing – Deal reports

Deal Report: Wonderschool Secures USD2 Million in Seed Funding

Deal in brief

Wonderschool, a US-based operator of online marketplace helps parents find in-home child care education
programs, has secured USD2 million in seed funding led by First Round Capital with participation from
Cross Culture Ventures, SoftTech VC, Lerer Ventures, FundersClub, Inc. and Edelweiss Financial Services
Ltd.

Chris Bennett and Arrel Gray are the co-founders of Wonderschool.

Target Wonderschool

Acquirer 1 First Round Capital

Acquirer 2 SoftTech VC

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 3 Edelweiss Financial Services Ltd

Acquirer 4 FundersClub, Inc.

Acquirer 5 Cross Culture Ventures - US

Acquirer 6 Lerer Ventures

Deal status Completed

Deal value ($m) 2

Deal value (US Dollar)(m) 2

Deal category Venture financing

Deal sub-category Seed

Round of financing None

Date of completion Jun 19, 2017

Deal rationale

Wonderschool will use the funds to expand in 15 new cities.

Company information: Target and acquirer

21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

299
CORPORATE VENTURING

Target: Wonderschool

Company type Private

Wonderschool is an operator of online marketplace helps


Business description
parents find in-home child care education programs.

Technology and Services-->Consumer IT-->Consumer


Services
Technology and Services-->Consumer IT-->Consumer
Services
Industry
Business and Consumer Services
Business and Consumer Services-->Educational Services
Technology and Services-->Consumer IT-->Consumer
Software
Technology and Services

Address 548 Market Street, #25851

City San Francisco

State California

Country United States

Website www.wonderschool.com

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 1: First Round Capital

Industry Venture capital firm, nasd member broker/dealer

First Round Capital is a seed-stage venture capital firm


dedicated to helping entrepreneurs build remarkable
companies. The company funds pre-revenue companies and
Business description often provides a company's first outside capital. The firm has
invests in seed and early-stage companies operating in
technology, consumer & business services, financial
services, healthcare, education, gaming, and food sectors.

217 Second Street, 5th Floor


Address

City San Francisco

State California

Country United States

Website www.firstround.com

Phone number 1 610 8347686

Acquirer 2: SoftTech VC
Venture capital firm, quasi-government organization, nasd
Industry
member broker/dealer

SoftTech VC is an early stage venture capital firm


specializing in early stage consumer internet and technology
start ups. The firm provides various services, such as
Business description
defining and execution of product, product assessment,
product launch, marketing, business development, and
financing strategy services. It offers its services to the 22

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

300
CORPORATE VENTURING

consumer internet companies, such as startups, industry


leaders, and venture capital firms.

Address 530 Lytton Ave, 2nd Floor

City Palo Alto

State California

Country United States

Website www.softtechvc.com

Acquirer 4: FundersClub, Inc.

Industry Venture capital firm, nasd member broker/dealer

FundersClub Inc. is a venture capital platform that provides


online marketplace to allow accredited investors to become
equity holders in FundersClub-managed venture funds. The
Business description platform combines industry-standard venture funds, with
web-platform that allows members to browse and screen
fund investment opportunities, view investment profiles and
sign legal documents.

Address 1 Bluxome Street, SUITE 405

City San Francisco

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State California

Country United States

Website fundersclub.com

Acquirer 5: Cross Culture Ventures - US

Industry Venture capital firm, nasd member broker/dealer

Cross Culture Ventures is an early-stage venture capital


Business description
firm.

Address 3340 Hillview Avenue

City Palo Alto

State California

Country United States

Website www.crossculturevc.com

Acquirer 6: Lerer Ventures

Industry Nasd member broker/dealer

Address 560 Broadway, Suite 308

City New York

State New York

Country United States 23

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

301
CORPORATE VENTURING

Website www.lererventures.com

Phone number 1 646 738 3407

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

24

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

302
CORPORATE VENTURING

Deal Report: National Insurance Company Raises USD136.45 Million in Subordinated


Debt Offering

Deal in brief

National Insurance Company, Ltd. an India-based non-life insurance company, has raised INR8,930 million
(USD136.45 million) through an issue of subordinated debt to Edelweiss Financial Services, Ltd., ICICI
Securities Limited, AK Trust and other investors.

The ten-year paper with call at five years carries a coupon of 8.35%.

Target National Insurance Company Limited

Acquirer 1 Undisclosed Investor(s)

Acquirer 2 Edelweiss Financial Services Ltd

Acquirer 3 ICICI Securities Limited

Acquirer 4 AK Trust

Deal status Completed

Deal value ($m) 136.45

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (Indian Rupee)(m) 8,930

Deal category Private placement

Date of completion Mar 27, 2017

Security type information

Security type Debt

Company information: Target and acquirer

Target: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
Business description products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
25

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

303
CORPORATE VENTURING

insurance, plantation insurance, and Kisan agriculture


pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

Acquirer 1: Undisclosed Investor(s)


26

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

304
CORPORATE VENTURING

Company type Private

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Industry Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
27

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

305
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
28

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

306
CORPORATE VENTURING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
29

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

307
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
30

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

308
CORPORATE VENTURING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
31

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

309
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
32

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

310
CORPORATE VENTURING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
33

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

311
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Healthcare-->Healthcare


Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
34

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

312
CORPORATE VENTURING

Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
35

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

313
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
36

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

314
CORPORATE VENTURING

Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
37

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

315
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

316
CORPORATE VENTURING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
39

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

317
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
40

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

318
CORPORATE VENTURING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
41

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

319
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
42

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

320
CORPORATE VENTURING

Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
43

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

321
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
44

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

322
CORPORATE VENTURING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
45

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

323
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
46

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

324
CORPORATE VENTURING

Diagnostics-->Renal, Urology and Reproductive Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
47

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

325
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
48

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

326
CORPORATE VENTURING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
49

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

327
CORPORATE VENTURING

Diagnostics-->Patient Monitoring Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
50

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

328
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
51

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

329
CORPORATE VENTURING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
52

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

330
CORPORATE VENTURING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

Acquirer 3: ICICI Securities Limited

Company type Private

ICICI Securities Limited is an investment banking firm of


ICICI Bank. It provides end-to-end solutions (including web-
based services) through the non-banking distribution
Business description channel to the retail and corporate customers. It operates in
three segments; corporate finance including equity capital
markets advisory services, institutional equities, retail and
financial product distribution.

Financial Services
Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Capital Markets and Trading-->Equity
Markets

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Corporate and Investment Banking
Industry Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Private Placements and Financial Sponsors
Financial Services-->Corporate and Investment Banking--
>Capital Raising

Address ICICI Centre, H.T. Parekh Marg, Churchgate

City Mumbai

State Maharashtra

Country India

Website www.icicisecurities.com

Phone number 91 22 22882460

Acquirer 4: AK Trust

Company type Private

Industry
Financial Services

53

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

331
CORPORATE VENTURING

Deal Report: GOQii secures funding

Deal in brief

GOQii, a US-based wearable technology company that provides wrist band that measures the user’s
activities, has secured funding from the venture capital arm of Edelweiss Financial Services, Ltd., an India-
based diversified financial services group.

Target GOQii

Acquirer Edelweiss Financial Services Ltd

Deal status Completed

Deal category Venture financing

Round of financing None

Date of completion Feb 10, 2016

Deal rationale

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
GOQii will use the funds to scale up its operations in the US and China.

Security type information

Security type VCInvestment

Company information: Target and acquirer

Target: GOQii

Company type Private

GOQii is a wearable technology company that provides wrist


Business description
band that measures the user’s activities.

Consumer Packaged Goods-->Other Consumer Products--


>Electronic Consumer Goods
Pharmaceuticals and Healthcare-->Medical Devices and
Industry
Diagnostics
Communications-->Devices
Retailing-->Electricals and Electronics-->Brown Goods
Technology and Services

Address 135 Commonwealth Drive


54

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

332
CORPORATE VENTURING

City Menlo Park

State California

Country United States

Website www.goqii.com

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

55

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

333
CORPORATE VENTURING

Deal Report: VGN Developers raises $107.6 million in private placement

Deal in brief

VGN Developers Private Limited, an India-based real estate developer and residential apartment builder,
has raised INR6,700 million ($107.6 million) from Piramal Capital and Edelweiss Financial Services through
non-convertible debentures.

Target VGN Developers Private Limited

Acquirer 1 Edelweiss Financial Services Ltd

Acquirer 2 Piramal Capital

Deal status Completed

Deal value ($m) 107.60

Deal value (Indian Rupee)(m) 6,700

Deal category Private placement

Date of completion Apr 10, 2015

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type information

Security type Debt

Security type Indian Rupee (m) Value ($m)

Debt investment amount 6,700 107.60

Company information: Target and acquirer

Target: VGN Developers Private Limited

Company type Private

VGN Developers Private Limited is a real estate developer


Business description
and residential apartment builder.

Construction and Real Estate


Industry Construction and Real Estate-->Building Construction
Construction and Real Estate-->Special Trade Contractors
Construction and Real Estate-->Real Estate Transactions

Address No.15, Wallace Garden, 2nd Street, Nungambakkam

City Chennai 56

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

334
CORPORATE VENTURING

State Tamil Nadu

Country India

Website www.vgn.in

Phone number 91 44 43439900

Acquirer 2: Piramal Capital

Company type Private

Piramal Capital is a financial services unit of Piramal


Business description
Enterprises Limited, a pharmaceutical company.

Industry
Financial Services

Country India

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

57

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

335
CORPORATE VENTURING

Deal Report: Parsvnath Developers raises $56.56 million in private placement

Deal in brief

Parsvnath Developers Limited, an India-based real estate developer, has raised INR3,550 million ($56.56
million) by issuing 7,100 unlisted, secured, redeemable, non-convertible debentures at a face value of
INR0.5 million ($0.007 million) in a private placement.

According to the Economic Times, the funds have been raised from Edelweiss Capital Limited, an India-
based financial services company.

Target Parsvnath Developers Limited

Acquirer Edelweiss Financial Services Ltd

Deal status Completed

Deal value ($m) 56.56

Deal value (Indian Rupee)(m) 3,550

Deal category Private placement

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Mar 30, 2015

Deal rationale

Parsvnath will use the proceeds to prepay its debt.

Security type information

Security type Debt

Security type Indian Rupee (m) Value ($m)

Debt investment amount 3,550 56.56

Company information: Target and acquirer

Target: Parsvnath Developers Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532780


58

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

336
CORPORATE VENTURING

Parsvnath Developers (Parsvnath) is a real estate and


integrated infrastructure developer. The company's portfolio
comprises of residential, commercial (office and retail),
Business description hotels, SEZs (special economic zones), information
technology (IT) parks and third party construction projects.
Parsvnath operates in India and Singapore. It is
headquartered in New Delhi, India.

Construction and Real Estate-->Building Construction--


>Hospital Construction
Construction and Real Estate-->Building Construction--
>Industrial Building Construction
Construction and Real Estate-->Building Construction
Construction and Real Estate-->Building Construction
Construction and Real Estate
Construction and Real Estate-->Real Estate Transactions
Industry Construction and Real Estate-->Real Estate Transactions
Construction and Real Estate-->Real Estate Transactions
Construction and Real Estate-->Real Estate Transactions
Construction and Real Estate-->Real Estate Transactions
Construction and Real Estate-->Real Estate Transactions
Construction and Real Estate-->Real Estate Transactions--
>Non-Residential Property Managers
Construction and Real Estate-->Real Estate Transactions
Construction and Real Estate-->Building Construction--
>Home Construction

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address 6th Floor Arunachal Building, 19 Barakhamba Road

City New Delhi

State Delhi

Country India

Website www.parsvnath.com

Phone number 91 11 43686600

59

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

337
CORPORATE VENTURING

PARTNERSHIP
Partnership – Deal reports

Deal Report: Edelweiss Capital to form life insurance joint venture with Tokio Marine
Holdings

Deal in brief

Edelweiss Capital Limited has entered into an agreement with Tokio Marine Holdings, Inc. to establish a life
insurance joint venture in India to be called Edelweiss Tokio Life Insurance.

Edelweiss Capital is an India-based provider of investment banking, stock broking, wealth management
and asset management services, while Tokio Marine is a Japan-based provider of property and casualty
insurance, reinsurance and life insurance services.

Rumor (August 10, 2009):

According to The Economic Times, industry sources reported that Edelweiss Capital is in talks with Tokio
Marine for a possible life insurance joint venture in India.

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Reportedly, Ernst & Young is acting as financial advisor and Crawford Bayley is acting as legal advisor to
Tokio Marine on their India strategy. AZB & partners is acting as advisor to Edelweiss.

Partner 1 Tokio Marine Holdings, Inc.

Partner 2 Edelweiss Financial Services Ltd

Deal status Announced

Deal category Partnership

Deal sub-category Joint venture

Date of announcement Nov 20, 2009

Company information: Partners

Partner 1: Tokio Marine Holdings, Inc.

Company type Public

Stock exchange TYO(Tokyo Stock Exchange)

Ticker symbol 8766

Tokio Marine Holdings, Inc., (Tokio Marine) is an insurance


holding company. The company, through its subsidiaries,
Business description offers a range of life and non-life insurance products and
services to individuals and corporate customers. Its portfolio
of products includes whole-life insurance, cancer insurance,
60

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

338
CORPORATE VENTURING

annuity insurance, auto insurance, home insurance, travel


and leisure insurance, personal accident insurance, medical
insurance, property insurance, casualty insurance and short-
term insurance. The company also provides various services
such as asset management, security investment
consultation, investment trust management and real estate
management services. It has a presence in various countries
of North America; Central and South America; Europe, Africa
and Middle East; and Asia and Oceania regions. Marine is
headquartered in Tokyo, Japan.

Chemicals
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Industry
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Creditor and Pecuniary
Loss
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Industrial Goods and Machinery-->Chemical Industry
Machinery

Address Tokio Marine Nichido Building Shinkan, 1-2-1 Marunouchi

City Tokyo

State Tokyo

Country Japan
61

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

339
CORPORATE VENTURING

Website www.tokiomarinehd.com

Phone number 81 3 62123333

Advisor information

Partner 1: Tokio Marine Holdings, Inc.

Financial advisors

Ernst & Young AG

Legal advisors

Crawford Bayley & Co. (Executive: Srinivasan)

Partner 2: Edelweiss Financial Services Ltd

Legal advisors

AZB & Partners (Executive: Rajendra Barot)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

62

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

340
CAPITAL RAISING

CAPITAL RAISING

Capital Raising – Overview

Figure 5: Edelweiss Financial Services Ltd capital raising Figure 6: Edelweiss Financial Services Ltd capital raising by
volume and value trend (2014-YTD2018) deal type (2014-YTD2018)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Table 5: Edelweiss Financial Services Ltd capital raising Table 6: Edelweiss Financial Services Ltd capital raising by
volume and value trend (2014-YTD2018) deal type (2014-YTD2018)

Year Volume Value ($m) Deal Type Volume

2014 - - Private placement 1

2015 - -

2016 1 374.64

2017 - -

2018 - -

63

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

341
CAPITAL RAISING

Capital Raising – Deal reports

Deal Report: Edelweiss Financial Services to raise $374.64 million in private placement
of non-convertible debentures

Deal in brief

Edelweiss Financial Services, Ltd., an India-based diversified financial services company, has agreed to
raise INR25,000 million ($374.64 million) in a private placement of non-convertible debentures in one or
more tranches.

Target Edelweiss Financial Services Ltd

Acquirer Undisclosed Investor(s)

Deal status Announced

Deal value ($m) 374.64

Deal value (Indian Rupee)(m) 25,000

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category Private placement

Date of announcement May 13, 2016

Security type information

Security type Debt

Security type Indian Rupee (m) Value ($m)

Debt investment amount 25,000 374.64

Company information: Target and acquirer

Acquirer: Undisclosed Investor(s)

Company type Private

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Industry Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 64

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

342
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and 65

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

343
CAPITAL RAISING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 66

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

344
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and 67

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

345
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment 68

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

346
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Healthcare-->Healthcare


Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare 69

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

347
CAPITAL RAISING

Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 70

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

348
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and 71

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

349
CAPITAL RAISING

Diagnostics-->Patient Monitoring Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy 72

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

350
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 73

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

351
CAPITAL RAISING

Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 74

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

352
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 75

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

353
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices 76

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

354
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 77

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

355
CAPITAL RAISING

Diagnostics-->Disposable Medical Products


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 78

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

356
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 79

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

357
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration 80

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

358
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 81

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

359
CAPITAL RAISING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 82

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

360
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and 83

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

361
CAPITAL RAISING

Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics 84

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

362
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and 85

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

363
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 86

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

364
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 87

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

365
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 88

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

366
CAPITAL RAISING

Diagnostics-->CNS and Neurological Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment 89

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

367
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
90

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

368
CAPITAL RAISING

Deal Report: Edelweiss Capital completes initial public offering

Deal in brief

Edelweiss Capital Ltd., a provider of investment banking, asset management and wealth management
services, has completed its initial public offering (IPO). The company issued 8,386,147 million shares at a
price of INR825 ($20.91) per share, raising gross proceeds of INR6,918.57 million ($175.84 million),
diluting about 11% of its stake through the IPO.

The issue consisted of 8.18 million equity shares and a reservation of 2.04 million equity shares for
employees of the company.

Target Edelweiss Financial Services Ltd

Deal status Completed

Deal value ($m) 175.84

Deal value (Indian Rupee)(m) 6,918.57

Deal category IPO

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Completed , ipo

% to Public 11

No. of shares issued 8,386,147

Offer price ($) 20.91

Offer price (Indian Rupee) (m) 822.72

Date of announcement Aug 21, 2007

Date of completion Dec 12, 2007

Deal rationale

The proceeds of the issue would be used, inter alia, towards enhancement of margin maintenance with
stock exchanges, establishment of additional offices and acquisition of office infrastructure, enhancement
of existing technological capacity and loan prepayment.

91

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

369
CAPITAL RAISING

Deal Report: Lehman leads group of investors to pick 5% in Edelweiss Capital

Deal in brief

A group of investors, led by Lehman Brothers and Thomas Schmidheiny, the chairman of Holcim Group,
are together purchasing a 5% stake in Edelweiss Capital Limited, a financial services company engaged in
securities broking, investment management and private client services. The stake is valued at $50 million.

Target Edelweiss Financial Services Ltd

Acquirer 1 Lehman Brothers, Inc.

Acquirer 2 Thomas Schmidheiny

Deal status Announced

Deal value ($m) 50

Deal value (US Dollar)(m) 50

Deal category Private placement

Acquired % 5

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of announcement Jul 09, 2007

Deal rationale

The proceeds from the pre-IPO placement would be used to expand Edelweiss Capital's mutual fund and
wealth management business.

Security type information

Security type Common stock

Company information: Target and acquirer

Acquirer 1: Lehman Brothers, Inc.

Company type Private

Business description Lehman Brothers, Inc. is an investment banking company.

Industry
Financial Services 92

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

370
CAPITAL RAISING

Financial Services-->Private Equity and Venture Capital


Financial Services-->Capital Markets and Trading
Financial Services-->Cards
Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking
Financial Services-->Institutional Investment Management
Financial Services-->Wealth Management and Private
Banking

Address 745 Seventh Avenue

City New York

State New York

Country United States

Website www.lehman.com

Phone number 1 212 526 7000

Acquirer 2: Thomas Schmidheiny

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

93

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

371
DIVESTMENTS

DIVESTMENTS
Divestments – Overview

Figure 7: Edelweiss Financial Services Ltd divestments Figure 8: Edelweiss Financial Services Ltd divestments by
volume and value trend (2014-YTD2018) geography (2014-YTD2018)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 7: Edelweiss Financial Services Ltd divestments volume Table 8: Edelweiss Financial Services Ltd divestments activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 - - North America -

2015 1 - Europe -

2016 - - Asia-Pacific 1

2017 - - Middle East and Africa -

2018 - - South and Central America -

94

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

372
DIVESTMENTS

Divestments – Deal reports

Deal Report: Tokio Marine to acquire additional 23% stake in Edelweiss Tokio Life
Insurance

Deal in brief

Tokio Marine Holdings, Inc. has agreed to acquire an additional 23% stake in Edelweiss Tokio Life
Insurance Company Limited, a provider of life insurance products and services, from Edelweiss Capital
Limited. Edelweiss Tokio and Edelweiss Capital are based in India.

Tokio Marine is a Japan-based provider of property and casualty insurance, reinsurance and life insurance
services. Edelweiss Capital is engaged in retail finance and debt capital markets, commodities, financial
markets, asset management and life insurance businesses.

Following the transaction, Tokio Marine will hold a 49% stake in Edelweiss Tokio Life Insurance.

Target Edelweiss Tokio Life Insurance Company Limited

Acquirer Tokio Marine Holdings, Inc.

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Seller/Vendor Edelweiss Financial Services Ltd

Deal status Announced

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 23

Date of announcement May 28, 2015

Company information: Target, acquirer, and seller/vendor

Target: Edelweiss Tokio Life Insurance Company Limited

Company type Private

Edelweiss Tokio Life Insurance Company Limited is a life


Business description
insurance company.

Financial Services
Financial Services-->General Insurance, Property and
Industry
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->Life and Pensions-->Life and Protection

Address Edelweiss House, Off C.S.T. Road

City Mumbai
95

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

373
DIVESTMENTS

State Maharashtra

Country India

Website www.edelweisstokio.in

Acquirer: Tokio Marine Holdings, Inc.

Company type Public

Stock exchange TYO (Tokyo Stock Exchange)

Ticker symbol 8766

Tokio Marine Holdings, Inc., (Tokio Marine) is an insurance


holding company. The company, through its subsidiaries,
offers a range of life and non-life insurance products and
services to individuals and corporate customers. Its portfolio
of products includes whole-life insurance, cancer insurance,
annuity insurance, auto insurance, home insurance, travel
and leisure insurance, personal accident insurance, medical
Business description insurance, property insurance, casualty insurance and short-
term insurance. The company also provides various services
such as asset management, security investment
consultation, investment trust management and real estate
management services. It has a presence in various countries
of North America; Central and South America; Europe, Africa

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
and Middle East; and Asia and Oceania regions. Marine is
headquartered in Tokyo, Japan.

Chemicals
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
96

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

374
DIVESTMENTS

Financial Services-->General Insurance, Property and


Casualty-->Personal Insurance-->Creditor and Pecuniary
Loss
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Industrial Goods and Machinery-->Chemical Industry
Machinery

Address Tokio Marine Nichido Building Shinkan, 1-2-1 Marunouchi

City Tokyo

State Tokyo

Country Japan

Website www.tokiomarinehd.com

Phone number 81 3 62123333

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

97

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

375
DIVESTMENTS

Deal Report: Edelweiss Financial to sell 26% stake in Edelweiss Housing Finance

Deal in brief

Edelweiss Financial Services Limited (formerly Edelweiss Capital Limited), a financial services company, is
planning to sell a 26% stake in its housing finance arm Edelweiss Housing Finance, Ltd., a provider of
mortgage loans.

Both the companies are based in India.

Target Edelweiss Housing Finance, Ltd.

Acquirer Undisclosed Company*

Seller/Vendor Edelweiss Financial Services Ltd

Deal status Announced

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of announcement Dec 21, 2012

Company information: Target, acquirer, and seller/vendor

Target: Edelweiss Housing Finance, Ltd.

Company type Private

Edelweiss Housing Finance, Ltd. is a housing finance


Business description
company.

Industry Financial Services


Financial Services-->Retail Banking and Lending

Country India

Acquirer: Undisclosed Company*

Company type Private

98

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

376
PRIVATE EQUITY & OWNERSHIP

PRIVATE EQUITY & OWNERSHIP

Private Equity and Ownership – Overview

Figure 9: Edelweiss Financial Services Ltd private equity and Figure 10: Edelweiss Financial Services Ltd private equity
ownership volume and value trend (2014-YTD2018) and ownership by deal type (2014-YTD2018)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

Table 9: Edelweiss Financial Services Ltd private equity and Table 10: Edelweiss Financial Services Ltd private equity and
ownership volume and value trend (2014-YTD2018) ownership activity by deal type (2014-YTD2018)

Year Volume Value ($m) Deal Type Volume

2014 - - Private equity 1

2015 1 -

2016 - -

2017 - -

2018 - -

99

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

377
PRIVATE EQUITY & OWNERSHIP

Private Equity and Ownership – Deal reports

Deal Report: GIC exists investment in Edelweiss Financial Services

Deal in brief

GIC Private Limited, a Singapore-based investment management firm, has exited its investment in
Edelweiss Financial Services, Ltd., an India-based diversified financial services company.

Target Edelweiss Financial Services Ltd

Acquirer Undisclosed Acquirer

GIC Private Limited (formerly Government of Singapore


Seller/Vendor
Investment Corporation Private Limited)

Deal status Completed

Deal category Private equity

Deal sub-category Exit

Round of financing None

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Jul 24, 2015

Deal financials

Valuation multiples (Edelweiss Financial Services Ltd)

EV/Revenues 6.90

EV/Operating profit 52.52

EV/EBITDA 52.52

EV/Total assets 8.79

Company information: Target, acquirer, and seller/vendor

Edelweiss Financial Services Ltd Financial information – (Fiscal year 31-Mar-2015)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 38,798 618.83

Operating profit 5,099.04 81.33

EBITDA 5,099.04 81.33


100

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

378
PRIVATE EQUITY & OWNERSHIP

Post tax profit 3,287.14 52.43

Net assets 31,562.91 503.43

Market capitalization 50,632.45 807.59

Earnings per share (absolute) 4.09 0.07

Shares in issue (absolute) 791,752,619

Key ratios

Operating margin (%) 13.14

Price earnings ratio 15.64

Net assets-share ratio 39.87

Acquirer: Undisclosed Acquirer

Company type Private

Country North America

Vendor: GIC Private Limited (formerly Government of Singapore Investment Corporation


Private Limited)

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Asset management firm, quasi-government organization,
Industry
nasd member broker/dealer, swaps dealer

GIC Private Limited (formerly Government of Singapore


Investment Corporation Private Limited) is an investment
Business description management firm that provides a range of asset classes,
including real estate, private equity, equities and fixed
income.

Address 168 Robinson Road, #37-01 Capital Tower

City Singapore

Country Singapore

Website www.gic.com.sg

Phone number 65 6889 8888

101

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

379
PRIVATE EQUITY & OWNERSHIP

Deal Report: Carlyle Group acquires 3.85% stake of Edelweiss Financial from Reliance
Growth Fund

Deal in brief

The Carlyle Group, a US-based private equity firm, has acquired a 3.85% stake in Edelweiss Financial
Services Limited (formerly Edelweiss Capital Limited), an India-based financial services company, from
Reliance Growth Fund for INR859 million ($17.53 million) in a bulk deal on the National Stock Exchange of
India.

Target Edelweiss Financial Services Ltd

Acquirer The Carlyle Group L.P.

Seller/Vendor Reliance Growth Fund

Deal status Completed

Deal value ($m) 17.53

Deal value (Indian Rupee)(m) 859

Deal category Private equity

Deal sub-category Minority acquisition

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquired % 3.85

Round of financing None

Date of completion Nov 01, 2011

Company information: Target, acquirer, and seller/vendor

Acquirer: The Carlyle Group L.P.

Industry Asset management firm, quasi-government organization

The Carlyle Group L.P. (Carlyle or ‘the group’) is a US-based


global alternative asset manager with approximately $183
billion of assets under management across 126 funds and
160 fund of funds vehicles as of December 31, 2015. The
group invests on behalf of its investors across four
Business description
segments: corporate private equity, global market strategies,
real assets, and investment solutions. The group operates in
Africa, Asia, Australia, Europe, the Middle East, North
America and South America regions. It is headquartered in
Washington, DC.

Address 1001 Pennsylvania Ave NW

City WASHINGTON

State WashingtonD.C.

Country United States


102

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

380
PRIVATE EQUITY & OWNERSHIP

Phone number 1 202 7295626

Vendor: Reliance Growth Fund

City Mumbai

State Maharashtra

Country India

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

103

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

381
PRIVATE EQUITY & OWNERSHIP

Deal Report: Galleon International Master Fund and Galleon Special Opportunities
Master Fund sell 7.02% stake in Edelweiss Capital

Deal in brief

Galleon International Master Fund and Galleon Special Opportunities Master Fund have sold 5.268 million
shares, representing a 7.02% stake, in Edelweiss Capital Limited, an India-based financial services
company, for INR485 ($10.43) per share or INR2,554.98 million ($54.93 million).

Galleon International Master Fund and Galleon Special Opportunities Master Fund are subsidiaries of
Galleon Group, LLC, a US-based hedge fund.

As of September 2009, Galleon International Master Fund held 4.42% and Galleon Special Opportunities
Master Fund held 2.6% stake in Edelweiss Capital.

Target Edelweiss Financial Services Ltd

Acquirer Undisclosed Acquirers

Seller/Vendor 1 Galleon Special Opportunities Master Fund

Seller/Vendor 2 Galleon International Master Fund

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Completed

Deal value ($m) 54.93

Deal value (Indian Rupee)(m) 2,554.98

Deal category Private equity

Deal sub-category Exit

Acquired % 7.02

Date of completion Nov 20, 2009

Company information: Target, acquirer, and seller/vendor

Edelweiss Financial Services Ltd Financial information – (Fiscal year 31-Mar-2009)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 9,005 173.98

Operating profit 3,919.70 75.73

EBITDA 4,096.71 79.15

Post tax profit 1,864.35 36.02

Net assets 21,140.37 408.44

Market capitalization 19,351.07 373.87


104

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

382
PRIVATE EQUITY & OWNERSHIP

Earnings per share (absolute) 24.88 0.48

Shares in issue (absolute) 74,933,155

Key ratios

Operating margin (%) 43.53

Price earnings ratio 10.38

Net assets-share ratio 282.13

Acquirer: Undisclosed Acquirers

Company type Private

Vendor 1: Galleon Special Opportunities Master Fund

Vendor 2: Galleon International Master Fund

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

105

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

383
PRIVATE EQUITY & OWNERSHIP

Deal Report: Reliance Capital acquires 1.6% stake in Edelweiss Capital from Shuaa
Capital

Deal in brief

Reliance Capital, Ltd. has acquired 1.23 million shares, representing a 1.6% stake, in Edelweiss Capital
Limited, an India-based financial services company, from Shuaa Capital PJSC at INR482 ($10.37 million)
per share, for a total consideration of INR593 million ($12.76 million).

Reliance Capital is an India-based non-banking financial company, while Shuaa Capital is UAE-based
financial services company.

Target Edelweiss Financial Services Ltd

Acquirer Reliance Capital Limited

Seller/Vendor SHUAA Capital p.s.c.

Deal status Completed

Deal value ($m) 12.76

Deal value (Indian Rupee)(m) 593

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 1.6

Date of completion Nov 12, 2009

Company information: Target, acquirer, and seller/vendor

Edelweiss Financial Services Ltd Financial information – (Fiscal year 31-Mar-2009)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 9,005 173.98

Operating profit 3,919.99 75.73

EBITDA 4,096.60 79.15

Post tax profit 1,864.40 36.02

Net assets 21,140.96 408.44

Market capitalization 19,351.52 373.87

Earnings per share (absolute) 24.88 0.48

Key ratios

Operating margin (%) 43.53


106

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

384
PRIVATE EQUITY & OWNERSHIP

Price earnings ratio 10.38

Net assets-share ratio 282.13

Acquirer: Reliance Capital Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol RELCAPITAL

Reliance Capital Limited (RCL) is a financial services


company. The company provides an array of products and
services in the areas of asset management, life and general
insurance, private equity and investments, stock broking,
and depository services. It also provides commercial finance
and home finance, including mortgages, business loans,
loans against property, loans for commercial vehicles and
construction equipment, auto loans, loans against shares,
business loans, and industrial finance. In addition, the
company provides broking and distribution services in the
Business description
fields of stocks commodities and derivatives, investment
banking, portfolio management services, and wealth
management services. Further, it offers asset reconstruction
services. Its operations are spanned across India,
Singapore, Malaysia, the UK, and the UAE. It is a part of

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Reliance Group, a private sector business group based in
India, having operations in telecommunications, financial
services, power, infrastructure, healthcare sectors, and
media and entertainment industries. RCL is headquartered
in Mumbai, Maharashtra, India.

Financial Services-->Capital Markets and Trading


Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Industry Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
107

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

385
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Retail Banking and Lending--


>Consumer Lending-->Motor Finance
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Motor Finance
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Personal Loans
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Retail Banking and Lending--
>Consumer Lending

Reliance Centre, 6th Floor, North Wing, Off Western ,


Address
Express Highway, Santa Cruz East

City MUMBAI

State Andhra Pradesh

Country India

Website www.reliancecapital.co.in

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Phone number 91 22 30336591

Vendor: SHUAA Capital p.s.c.

Company type Private

SHUAA Capital p.s.c. is a financial services firm that offers a


range of asset management, corporate finance advisory,
Business description
capital markets and credit services including lending to
regional SMEs.

Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management

Address Level 31, Emirates Towers, Sheikh Zayed Road

City Dubai

Country United Arab Emirates

Website www.shuaa.com

Phone number 971 4 330 3600

108

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

386
APPENDIX

APPENDIX
Contact Us

We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com

About MarketLine Financial Deals Database

• Financial Deals is the most extensive Deals database currently available in the market

• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
– partnership deal

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms

• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.

• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.

• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.

109

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

387
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

110

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

388
APPENDIX

Deal Definition and Methodology

Deal type definition

Merger

A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:

 All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.

 Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.

 The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.

 The business of the transferor company is intended to be carried on, after the amalgamation,

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
by the transferee company.

 No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.

Acquisition

Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:

 Minority acquisition: The acquisition of less than 50% equity stake in the target

 Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target

 100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target

 Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity

Private equity

Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:

 Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company

 Secondary buyout: PE firm or a group of PE firms acquiring a company from a PE firm


111

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

389
APPENDIX
 Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds

 Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.

 Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team

 Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed

 Exit: PE firm selling its stake in a portfolio company

Private placement

A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.

Venture financing

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:

 Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept

 Start-up: Financing provided to companies for developing their product/service and to


purchase the necessary assets for their production/operation

 Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products

 Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities

 Exit: This node is assigned when a venture capital is selling its stake in a portfolio company

Initial Public Offering

 Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:

 Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO

 Pricing: When the company fixes the issue price for its offering

112

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

390
APPENDIX
 Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering

 Withdrawn: When the company withdraws its IPO

 Postponed: When the company postpones its IPO

Partnership

A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:

 Joint Venture (JV): Two or more companies forming a new entity to undertake an activity

 Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.

 Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.

Deal status details

Financial Deals captures deal status according to following stages:

 Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
 Announced: Either party involved in the transaction announces the deal
 Completed: Involved parties complete the transaction
 Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
 Dead rumor: Rumor denied by either of the parties involved in the transaction

Deal value

Deal value is the consideration paid by the acquirer for acquiring the target.

Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.

All deals values which are mentioned as approximate consideration are tagged as estimated values.

Deal value criteria for filtering deals


113

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

391
APPENDIX

For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.

Deal payment details


Deal payment is captured in the following fields:

Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:

 Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer

 Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer

 Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer

 Quantity type: It indicates the consideration by payment mode in terms of value and
percentage

% acquired: % acquired indicates the stock acquired in percentage terms

Share price paid: Price per share offered by the acquirer to the target

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Debt-related fields
Below is the list of fields captured:

Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:

 Lead: Represents the lead debt provide


 Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers

Debt amount: Amount of debt raised by the acquirer to finance the acquisition

Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:

 Bank facilities: These are general loans provided by banks to companies.

 Senior: Debt that has priority for repayment in liquidation.

 Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.

 Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.

 Other debt: Any other debt facility other than the above mentioned debt categories.

114

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

392
APPENDIX

Securities issued to finance deal


Below is a list of category and sub-category of securities issued by the acquirer, captured in FD:

Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:

 Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder

 Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio

 Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date

 Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)

 Placing: General term to describe the process of raising money via the issue of new shares

 Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period

 Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings

 Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).

Financial and operational information

Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:

Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.

No. of employees: Number of employees at the fiscal year end


Local currency: The currency in which the company is reporting its financial statements

115

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

393
APPENDIX

Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers

Revenue (banking): This value is sum of interest income and non interest income

Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.

EBITDA: Earnings before interest, taxes, depreciation and amortization

Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax

Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.

Enterprise value: Enterprise value is calculated by adding a company’s market capitalization,


preferred stock, minority interest, and outstanding debt together and then subtracting out the cash
and cash equivalents found on the balance sheet as on the fiscal year end

Shares issued: Number of shares the company has issued out of its authorized capital

Market capitalization: Market capitalization is calculated by taking the number of outstanding

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
shares of common stock multiplied by the market price-per-share as on fiscal year end

Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.

Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth

Net assets-share ratio: It is defined as net assets divided by number of shares outstanding

Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares

Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.

Deal multiples

Financial Deals captures the following four valuation multiples:


 EV/revenues
 EV/EBIT
 EV/EBITDA
 EV/total assets

116

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

394
APPENDIX

Advisor information

Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:

Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.

Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:

 Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts

 Accounting: Financial advisor who looks into the accounting matters for a deal

 Tax: Financial advisor who looks into the tax matters for a deal

 Corporate Finance: Financial advisor who looks into the financial decisions of a corporation

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue

 Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body

 Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted

 Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other

Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities

Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders

117

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

395
APPENDIX

About MarketLine

In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.

At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.

Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.

MarketLine is a wholly owned subsidiary of Informa.

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

118

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

396
APPENDIX

Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

MARKETLINE | 119 FARRINGDON ROAD | LONDON,


UNITED KINGDOM, EC1R 3DA
119
T: + 44 161 238 4040| F: + 44 870 134 4371
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
E: REACHUS@MARKETLINE.COM
397
MarketLine Financial Deals

Vendor, acquirer, target and partner report for IFCI Limited and its subsidiaries. Includes
Mergers & Acquisitions, Private equity, Venture capital, Joint ventures, Alliances and
Investments

IFCI Limited – Mergers & Acquisitions (M&A),


Partnerships & Alliances and Investments

REFERENCE CODE: 02722645-677C-4CC8-88F5-F4C4E05DB6EB


PUBLICATION DATE: September 2018
WWW.MARKETLINE.COM
MARKETLINE. THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

398
COMPANY OVERVIEW AND KEY FACTS

COMPANY OVERVIEW AND KEY FACTS

IFCI LIMITED

IFCI Limited (IFCI) is a financial institution that offers a variety of financial products and services. The company offers
a range of financial products that includes debt products and products related to the equity and other business
segments. IFCI offers corporate advisory services, infrastructure advisory services, and monitors public issues. It also
provides balance sheet funding, loan against shares, lease rental discounting and promoter funding. The company
also acts as a debenture trustee for debentures issued by other companies. IFCI is headquartered in New Delhi,
India.

The company reported revenues of (Rupee) INR34,452.4 million for the fiscal year ended March 2018 (FY2018), a
decrease of 3.7% over FY2017. The operating loss of the company was INR17,580.7 million in FY2018, compared to
an operating loss of INR6,779 million in FY2017. The net loss of the company was INR10,050.2 million in FY2018,
compared to a net loss of INR3,775.3 million in FY2017.

Key facts

Address IFCI Tower, 61 Nehru Place

State Delhi

Country India

Telephone 91 11 4179 2800

Fax 91 11 2648 8471

Website www.ifciltd.com

Exchange / Ticker BOM / 500106

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
-

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

399
COMPANY OVERVIEW AND KEY FACTS

IFCI Limited activity by deal type - volume (2014-YTD2018) IFCI Limited M&A average deal size - value ($m)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) 1 - - - - 2014 1 -
Capital raising - - 1 - - 2015 - -
(CR) 2016 - -
Divestments (DIV) 1 2 3 - - 2017 - -
2018 - -
Note: Zero deal value indicates transactions with undisclosed deal values

TOP DEALS IN (2014 -YTD2018)

Deal value
Target/Partner (Country) Announcement date Deal status Deal Type

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
($m)

Private
IFCI Limited (India) Apr 18, 2016 Announced 86.18
placement

National Stock Exchange of India Ltd. (India) Jul 4, 2016 Completed Acquisition 13.13

National Stock Exchange of India Ltd. (India) Apr 4, 2016 Completed Acquisition 8.93

National Stock Exchange of India Ltd. (India) Sep 17, 2015 Completed Acquisition 39.7

National Stock Exchange of India Ltd. (India) Sep 17, 2015 Completed Private equity 39.66

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

400
TABLE OF CONTENTS

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS ............................................ 2

TABLE OF CONTENTS .......................................................................... 4

LIST OF TABLES .................................................................................... 5

LIST OF FIGURES .................................................................................. 5

TARGETS AND PARTNERS .................................................................. 6

MERGERS & ACQUISITIONS ................................................................ 7


Mergers and Acquisitions – Overview ............................................................................................... 7

Mergers and Acquisitions – Deal reports .......................................................................................... 8

CORPORATE VENTURING .................................................................. 22


Corporate Venturing – Deal reports ................................................................................................. 22

CAPITAL RAISING ............................................................................... 38

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Capital Raising – Overview ............................................................................................................... 38

Capital Raising – Deal reports .......................................................................................................... 39

DIVESTMENTS ..................................................................................... 67
Divestments – Overview .................................................................................................................... 67

Divestments – Deal reports ............................................................................................................... 68

PRIVATE EQUITY & OWNERSHIP .................................................... 101


Private Equity and Ownership – Deal reports ............................................................................... 101

APPENDIX........................................................................................... 142
Contact Us ....................................................................................................................................... 142

About MarketLine Financial Deals Database ................................................................................. 142

Deal Definition and Methodology ................................................................................................... 144

4
About MarketLine ............................................................................................................................. 151

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

401
TABLE OF CONTENTS

LIST OF TABLES

Table 1: IFCI Limited M&A volume and value trend (2014-YTD2018) 7

Table 2: IFCI Limited M&A activity by geography (2014-YTD2018) 7

Table 3: IFCI Limited capital raising volume and value trend (2014-YTD2018) 38

Table 4: IFCI Limited capital raising by deal type (2014-YTD2018) 38

Table 5: IFCI Limited divestments volume and value trend (2014-YTD2018) 67

Table 6: IFCI Limited divestments activity by geography (2014-YTD2018) 67

LIST OF FIGURES

Figure 1: IFCI Limited M&A volume and value trend (2014-YTD2018) 7

Figure 2: IFCI Limited M&A activity by geography (2014-YTD2018) 7

Figure 3: IFCI Limited capital raising volume and value trend (2014-YTD2018) 38

Figure 4: IFCI Limited capital raising by deal type (2014-YTD2018) 38

Figure 5: IFCI Limited divestments volume and value trend (2014-YTD2018) 67

Figure 6: IFCI Limited divestments by geography (2014-YTD2018) 67

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

402
TARGETS AND PARTNERS

TARGETS AND PARTNERS


IFCI Limited targets and partners (2014 -YTD2018)

IFCI Limited-Target/Partner name Deal Date Deal type Deal value ($m)

Rajasthan Consultancy Organization, Ltd. (India) Jul 1, 2014 Acquisition -

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

403
MERGERS & ACQUISITIONS

MERGERS & ACQUISITIONS


Mergers and Acquisitions – Overview

Figure 1: IFCI Limited M&A volume and value trend (2014- Figure 2: IFCI Limited M&A activity by geography (2014-
YTD2018) YTD2018)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

Note: Zero deal value indicates transactions with undisclosed deal values

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Table 1: IFCI Limited M&A volume and value trend (2014- Table 2: IFCI Limited M&A activity by geography (2014-
YTD2018) YTD2018)

Year Volume Value ($m) Geography Volume

2014 1 - North America -

2015 - - Europe -

2016 - - Asia-Pacific 1

2017 - - Middle East and Africa -

2018 - - South and Central America -

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

404
MERGERS & ACQUISITIONS

Mergers and Acquisitions – Deal reports

Deal Report: IFCI acquires 49% equity stake in Rajasthan Consultancy (RAJCON)

Deal in brief

IFCI Limited, a provider of long-term finance to the industrial sector, has acquired 49% stake in Rajasthan
Consultancy Organization, Ltd. (RAJCON) from Hardicon Limited, a provider of low-cost industrial
consultancy solutions. All the companies are based in India.

Rajasthan Consultancy is a provider of consultancy services to entrepreneurs and enterprises.

Target Rajasthan Consultancy Organization, Ltd.

Acquirer IFCI Limited

Seller/Vendor Hardicon Limited

Deal status Completed

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 49

Date of completion Jul 01, 2014

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor

Target: Rajasthan Consultancy Organization, Ltd.

Company type Private

Rajasthan Consultancy Organization, Ltd. is a provider of


consultancy services to entrepreneurs and enterprises. The
company provides human resources development service,
Business description project consultancy services, management restructuring
services, infrastructure service, market survey and research,
product and project specific research and impact evaluation
studies.

Business and Consumer Services


Business and Consumer Services-->Consultancy-->IT
Industry
Consultancy
Business and Consumer Services-->Consultancy--
>Management Consultancy

Address Anand Bhawan, Ist Floor, Sansar Chandra Road

City Jaipur
8

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

405
MERGERS & ACQUISITIONS

State Rajasthan

Country India

Website www.rajcon.org

Phone number 0141 4035489

Vendor: Hardicon Limited

Company type Private

Hardicon Limited is a consulting organization that focuses on


Business description
small and medium enterprises (SME) sector.

Business and Consumer Services


Business and Consumer Services-->Consultancy
Industry Business and Consumer Services-->Consultancy--
>Marketing Consultancy
Business and Consumer Services-->Consultancy-->Strategy
Consultancy

City New Delhi

Country India

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

406
MERGERS & ACQUISITIONS

Deal Report: IFCI acquires additional 4.35% stake in Koutons Retail

Deal in brief

IFCI Limited, a provider of long-term finance to the industrial sector, has acquired an additional 4.35%
stake in Koutons Retail India Limited, an apparel manufacturing and retail company. Both the companies
are based in India.

Following the transaction, IFCI will increase its stake in Koutons Retail from 5.89% to 10.24%.

Target Koutons Retail India Limited (Inactive)

Acquirer IFCI Limited

Deal status Completed

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 4.35

Date of completion Apr 08, 2011

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (Koutons Retail India Limited (Inactive))

EV/Revenues 0.89

EV/Operating profit 8.20

EV/EBITDA 7.25

EV/Total assets 0.85

Company information: Target and acquirer

Target: Koutons Retail India Limited (Inactive)

Company type Public

Retailing
Retailing-->By Multi-Channel-->In-Store
Industry Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Accessories
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Clothing 10

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

407
MERGERS & ACQUISITIONS

Retailing-->Clothing, Footwear, Accessories and Luxury


Goods-->Clothing-->Childrenswear
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Clothing-->Menswear
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Clothing-->Womenswear
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Footwear
Retailing-->Department Stores
Consumer Packaged Goods-->Other Consumer Products--
>Clothing, Footwear, Accessories and Luxury Goods--
>Clothing

Address T-60/1, D.C.M. School Lanenew Rohtak Road, Karol Bagh

City New Delhi

State Delhi

Country India

Financial information – (Fiscal year 31-Mar-2010)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 11,423.04 251.31

Operating profit 1,245.55 27.40

EBITDA 1,409.91 31.02

Post tax profit 818.37 18

Net assets 10,014.53 220.32

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Market capitalization 10,587.58 232.93

Earnings per share (absolute) 26.78 0.59

Key ratios

Operating margin (%) 10.90

Price earnings ratio 12.94

Net assets-share ratio 327.79

11

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

408
MERGERS & ACQUISITIONS

Deal Report: IFCI to acquire 7.72% stake in KSK Mahanadi

Deal in brief

IFCI Limited, an Indian provider of long-term finance to the industrial sector, is planning to acquire a 7.72%
stake in KSK Mahanadi, a coal based power project of KSK Energy Ventures Limited, for $56 million.

KSK Mahanadi is being promoted by KSK Energy Ventures, an Indian subsidiary of KSK Power Ventur plc,
a UK-based power project development company.

KSK Mahanadi is being funded through a mix of debt and equity wherein the debt of $2,880 million is being
funded through a consortium of 27 Indian banks and financial institutions.

Target KSK Energy Ventures Limited

Acquirer IFCI Limited

Seller/Vendor KSK Energy Ventures Limited

Deal status Announced

Deal value ($m) 56

Deal value (US Dollar)(m) 56

Deal category Private equity

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Asset purchase

Acquired % 7.72

Date of announcement Sep 20, 2010

Company information: Target, acquirer, and seller/vendor

Target: KSK Energy Ventures Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532997

KSK Energy Ventures (KSK Energy), a subsidiary of KSK


Power Ventur, operates as a power project development
company. It is engaged in developing, operating and
maintaining power plants and hydel power. The company
also provides fuel security services. Its power projects
Business description
include Sai Lilagar and KSK Mahanadi Power, Chhattisgarh;
Sai Regency, Tamilnadu; Sitapuram, Telangana; Sai
Wardha Power, Maharashtra; and VS Lignite and Sai Maithili
Power, Rajasthan. The company operates in India, where it
is headquartered in Hyderabad and employs around 19 12

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

409
MERGERS & ACQUISITIONS

people.

Energy and Utilities


Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation
Industry Business and Consumer Services-->Consultancy
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services

Address 8-2-293/82/A/431/A, Road No. 22

Country India

Website www.ksk.co.in

Phone number 91 40 2355 9922

Vendor: KSK Energy Ventures Limited

Company type Private

KSK Energy Ventures Limited is a wholly-owned subsidiary


of KSK Power Ventur plc which is a power project
Business description development and investment company. KSK Energy
Ventures develops and operates power plant from planning
to actual setup of plant.

Energy and Utilities-->Natural Resources-->Midstream

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry
Energy
Energy and Utilities-->Utilities-->Power Generation

Address 8-2-293/82/A/431/A,Road No:22, Jubilee Hills

City Hyderabad

State Andhra Pradesh

Country India

Website www.ksk.co.in

Phone number 91 40 2355992

13

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

410
MERGERS & ACQUISITIONS

Deal Report: IFCI acquires 5% stake in MCX Stock Exchange from Financial
Technologies

Deal in brief

IFCI Limited has acquired a 5% sake in MCX Stock Exchange Limited, a currency futures exchange, from
Financial Technologies (India), Ltd.(FTIL) for a consideration of approximately INR2,500 million ($51.36
million).

IFCI is a provider of long-term finance to the industrial sector, while FTIL is engaged in providing
transaction automation technologies for equities, derivatives, forex, and commodity markets. All the three
companies are based in India.

The shares were acquired at a price of INR35 ($0.71) per equity share.

Target MCX Stock Exchange Limited

Acquirer IFCI Limited

Seller/Vendor Financial Technologies (India) Ltd.

Deal status Completed

Deal value ($m) 51.36

Deal value (Indian Rupee)(m) 2,500

Deal category Acquisition

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Minority acquisition

Acquired % 5

Date of completion Jul 18, 2009

Company information: Target, acquirer, and seller/vendor

Target: MCX Stock Exchange Limited

Company type Private

MCX Stock Exchange Limited is a currency futures


Business description exchange in India. The company's subsidiary, MCX-Stock
Exchange Clearing Corporation, is a clearing corporation.

Financial Services
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Industry Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign 14

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

411
MERGERS & ACQUISITIONS

Exchange (FX)

Address Suren Road, Andheri (East)

City Mumbai

State Maharashtra

Country India

Website www.mcx-sx.com

Phone number 91 22 6731 9000

Vendor: Financial Technologies (India) Ltd.

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 526881

Financial Technologies (India) (FTIL), a part of Financial


Technologies Group, provides technology solutions for
financial markets across asset classes including equity,
commodities, currencies and bonds. FTIL offers exchange,
brokerage, messaging, consulting and connectivity solutions.
The company also offers services in areas such as clearing
Business description and depository, information dissemination, warehousing and
collateral management, payments processing and financial
market education. The company operates in India, the UAE,
Bahrain, Tanzania, Singapore, Uganda, Kenya, Nigeria,

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Zambia, Botswana, Mauritius, and South Africa. It is
headquartered in Mumbai, India and employs around 872
people.

Financial Services-->Capital Markets and Trading--


>Brokerage
Industry Technology and Services-->Consumer IT-->Consumer
Services
Technology and Services-->Software-->Enterprise
Applications-->Financial Applications

Address FT Tower CTS Number 256 and 257, Suren Road Chakala

Country India

Website www.ftindia.com

Phone number 91 22 6686 1010

15

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

412
MERGERS & ACQUISITIONS

Deal Report: IFCI acquires 17.42% stake in Maytas Infra

Deal in brief

IFCI Limited, a provider of long-term finance and advisory services, has acquired 10.25 million shares,
representing a 17.42% stake, in Maytas Infra Limited, an infrastructure development, construction, and
project management company. Both the companies are based in India.

Target IL&FS Engineering and Construction Company Limited

Acquirer IFCI Limited

Deal status Completed

Deal value (estimated) ($m) 20.81

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 17.42

Date of completion Jan 22, 2009

Deal financials

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Valuation multiples (IL&FS Engineering and Construction Company Limited)

EV/Revenues 2.53

EV/Operating profit 25.02

EV/EBITDA 20.89

EV/Total assets 2.03

Company information: Target and acquirer

Target: IL&FS Engineering and Construction Company Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532907

IL&FS Engineering and Construction Company (IL&FS) is an


infrastructure development, construction and project
Business description
management company. The company is engaged in the
construction, development and maintenance of roads, 16

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

413
MERGERS & ACQUISITIONS

expressways and highways, buildings and industrial


structures, and irrigation canals and dams. The company
operates in India and Saudi Arabia. It is headquartered in
Hyderabad, India.

Construction and Real Estate


Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Construction and Real Estate-->Building Construction--
>Home Construction
Construction and Real Estate-->Building Construction
Construction and Real Estate-->Heavy Construction--
>Bridge Construction
Industry
Construction and Real Estate-->Heavy Construction
Construction and Real Estate-->Heavy Construction--
>Tunnel Construction
Construction and Real Estate-->Heavy Construction-->Oil
Production Platform Construction
Construction and Real Estate-->Heavy Construction--
>Transmission Line Construction
Construction and Real Estate-->Heavy Construction-->Water
Treatment Plant Construction

Address Door Number 8-2-120/113/3, Fourth Floor Sanali Info Park

Country India

Website www.ilfsengg.com

Phone number 91 40 4040 9333

Financial information – (Fiscal year 31-Mar-2008)

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,167.52 505.60

Operating profit 2,038.30 51.10

EBITDA 2,441.57 61.21

Post tax profit 907.50 22.75

Net assets 6,384.53 160.06

Market capitalization 41,133.25 1,031.21

Earnings per share (absolute) 16.79 0.42

Key ratios

Operating margin (%) 10.11

Price earnings ratio 41.63

Net assets-share ratio 108.49

17

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

414
MERGERS & ACQUISITIONS

Deal Report: IFCI acquires 46.65% stake in Foremost Factors from Mohan Exports Group

Deal in brief

IFCI, Ltd., a provider of finance and corporate advisory services, has acquired a 46.65% stake in Foremost
Factors, Ltd. (FFL), a provider of domestic and export factoring facilities, from Mohan Exports Group,
thereby increasing its stake to 96.49% in FFL. IFCI also proposes to acquire the balance shareholding of
3.5% from other shareholders to make it a 100% subsidiary.

Mohan Exports Group is a promoter of the FFL.

Target IFCI Factors Limited (formerly Foremost Factors Limited)

Acquirer IFCI Limited

Seller/Vendor Mohan Exports (India) Pvt. Ltd.

Deal status Completed

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 46.65

Date of completion May 21, 2008

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal rationale

The acquisition allows IFCI to foray into the factoring services.

Company information: Target, acquirer, and seller/vendor

Target: IFCI Factors Limited (formerly Foremost Factors Limited)

Company type Private

IFCI Factors Limited is a provider of domestic factoring and


Business description
international factoring services.

Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Pawan House 2, Zamrudpur Community Centre, Kailash


Address
Colony Extension

City New Delhi

Country India
18

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

415
MERGERS & ACQUISITIONS

Website www.foremostfactors.net

Phone number 91 11 29237543 45

Vendor: Mohan Exports (India) Pvt. Ltd.

Company type Private

Mohan Exports (India) Pvt. Ltd. (MEIPL) is a diversified


company that provides international trade, infrastructure and
industrial projects, exploration of natural resources and
special economic zones. The company provides related
training and capacity building in the areas of engineering
projects and project management, agriculture mechanization
and irrigation, agro processing and dairy animal husbandry,
Business description
fisheries and poultry, medical and health care, education and
vocational training, workshop equipment, water and waste
water construction and material handling. It has its offices in
Democratic Republic of Congo, Republic of Congo, Rwanda,
Burundi, Sierra Leone, Togo, Tanzania, Malawi, Zambia,
Ethiopia, Eritrea, Jordan and Iraq. MEIPL is headquartered
in New Delhi, India.

Agriculture and Forestry-->Agriculture


Agriculture and Forestry-->Support Activities for Agriculture
Business and Consumer Services-->Educational Services
Construction and Real Estate
Industrial Goods and Machinery
Paper and Packaging
Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry Financial Services
Industrial Goods and Machinery
Industrial Goods and Machinery-->Food Product Machinery
Manufacturing
Industrial Goods and Machinery-->Metalworking Machinery
Industrial Goods and Machinery-->Textile Machinery
Manufacturing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare

8 and 9, Mohan House, Community Center, Kailash Colony


Address
Extention

City New Delhi

State Delhi

Country India

Website www.mohanexports.com

Phone number 91 11 29232802

19

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

416
MERGERS & ACQUISITIONS

Deal Report: IFCI proposes to acquire remaining 3.5% stake in Foremost Factors

Deal in brief

IFCI, Ltd., a provider of finance and corporate advisory services, has plans to acquire the balance
shareholding of a 3.5% in Foremost Factors, Ltd. (FFL), a provider of domestic and export factoring
facilities.

Upon the completion of this acquisition, Foremost Factors wil become a 100% subsidiary to IFCI.

On May 21, 2008, IFCI has acquired a 46.65% stake in Foremost Factors from Mohan Exports Group,
thereby increasing its stake to 96.49% in FFL.

Target IFCI Factors Limited (formerly Foremost Factors Limited)

Acquirer IFCI Limited

Deal status Announced

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 3.5

Date of announcement May 21, 2008

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal rationale

The acquisition allows IFCI to foray into the factoring services.

Company information: Target and acquirer

Target: IFCI Factors Limited (formerly Foremost Factors Limited)

Company type Private

IFCI Factors Limited is a provider of domestic factoring and


Business description
international factoring services.

Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Pawan House 2, Zamrudpur Community Centre, Kailash


Address
Colony Extension

City New Delhi

Country India 20

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

417
MERGERS & ACQUISITIONS

Website www.foremostfactors.net

Phone number 91 11 29237543 45

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

21

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

418
CORPORATE VENTURING

CORPORATE VENTURING
Corporate Venturing – Deal reports

Deal Report: South Indian Bank raises $80 million in private placement

Deal in brief

South Indian Bank, Ltd., an India-based provider of retail banking services, has raised INR4,430 million
($80 million) in a qualified institutional placement of 200 million equity shares.

The investors include First Carlyle Ventures Mauritius Private Limited, The Carlyle Group, IFCI Limited,
State Bank of India, SBI Life Insurance Co., Ltd., and SBI Mutual Fund.

The placement of new shares represents 15% stake in South Indian Bank.

As part of the transaction, Carlyle Group acquired 2.04% stake for INR22.13 ($0.39) per share, IFCI
acquired 4.99% stake for INR1,475 million ($26.63 million), while two private equity funds have separately
invested a total of INR1,650 million ($29.8 million) for 5.8% stake between them.

State Bank of India acquired 0.34% for INR100 million ($1.81 million), while SBI Life Insurance acquired
0.67% for around INR200 million ($3.61 million) and SBI Mutual Fund acquired 0.85% for INR250 million
($4.51 million).

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target South Indian Bank Ltd.

Acquirer 1 State Bank of India

Acquirer 2 IFCI Limited

Acquirer 3 SBI Life Insurance Co. Ltd

Acquirer 4 SBI Mutual Fund

Acquirer 5 First Carlyle Ventures Mauritius Private Limited

Acquirer 6 The Carlyle Group L.P.

Deal status Completed

Deal value ($m) 80

Deal value (Indian Rupee)(m) 4,430

Deal category Private placement

Acquired % 15

No. of shares issued 200,000,000


22

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

419
CORPORATE VENTURING

Offer price ($) 0.40

Offer price (Indian Rupee) (m) 22.15

Round of financing None

Date of completion Sep 05, 2012

Deal rationale

The funding will enhance South Indian Bank's paid-up capital.

Deal financials

Valuation multiples (South Indian Bank Ltd.)

EV/Revenues 0.19

EV/Operating profit 1.12

EV/EBITDA 0.92

EV/Total assets 0.02

Security type information

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type Common stock

Security type Indian Rupee (m) Value ($m)

Equity investment amount 4,430 80

Company information: Target and acquirer

Target: South Indian Bank Ltd.

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532218

The South Indian Bank (SIB) offers banking and financial


services, including treasury, corporate and wholesale
Business description banking, retail banking, and other banking operations. SIB
primarily operates in India, where it is headquartered in
Thrissur. 23

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

420
CORPORATE VENTURING

Financial Services-->Retail Banking and Lending


Financial Services-->Payments-->New Payment
Technologies
Financial Services-->Payments-->Bank Transfers
Financial Services-->Payments-->Cash
Financial Services-->Payments-->Cheque
Financial Services-->Retail Banking and Lending
Industry
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Savings and Investments-->Savings
Accounts
Construction and Real Estate-->Real Estate Transactions
Technology and Services
Financial Services-->Savings and Investments

Address T B Road, Mission Quarters

City Thrissur

State Kerala

Country India

Website www.southindianbank.com

Phone number 91 487 2420020

Financial information – (Fiscal year 31-Mar-2012)

Financial parameters Indian Rupee (INR) (m) ($m)

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Revenues 38,304.95 738.90

Operating profit 4,016.60 77.48

EBITDA 5,462.95 105.38

Post tax profit 4,201.15 81.04

Net assets 20,228.17 390.20

Market capitalization 27,832.13 536.88

Earnings per share (absolute) 3.55 0.07

Shares in issue (absolute) 1,133,700,000

Key ratios

Operating margin (%) 10.49

Price earnings ratio 6.92

Net assets-share ratio 17.84

Acquirer 1: State Bank of India


24

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

421
CORPORATE VENTURING

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500112

State Bank of India (SBI or 'the group') is a provider of


banking and financial solutions. The bank provides a wide
range of retail banking, corporate banking and treasury
services to individuals, corporate and institution clients. Its
products include current accounts, savings accounts, term
deposits, recurring deposits, debit cards, credit cards,
prepaid cards, virtual cards, business cards, life and general
insurance. It also provides personal loans, home loans, loan
against property and securities, gold loans, car loans,
education loans, agricultural loans, working capital finance,
project finance, deferred payment guarantees, corporate
Business description term loans, structured finance, dealer financing, channel
financing, equipment leasing, loan syndication and
construction equipment loans. The bank provides various
services such as mobile banking, internet banking, ATM
services, foreign inward remittance, safe deposit locker,
western union money transfer, mobile wallet, trade finance,
merchant banking, project export finance, treasury services,
and offshore banking and cash management services. The
bank operates in Asia, Europe, the Middle East, Africa and
North America regions. The bank is headquartered in
Mumbai, Maharashtra, India.

Financial Services
Financial Services-->Cards-->Card Issuance-->Commercial
Cards

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Cards-->Card Issuance-->Debit Cards
Financial Services-->Cards-->Card Issuance-->Pre-paid
Cards
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking
Financial Services-->Corporate and Investment Banking--
Industry >Treasury and Cash Management
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->Corporate and Investment Banking
Financial Services-->Retail Banking and Lending
Financial Services-->Payments
Financial Services-->Payments-->Bank Transfers
Financial Services-->Payments-->Cash
Financial Services-->Payments-->Cheque
Financial Services-->Payments-->Direct Debit
25

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

422
CORPORATE VENTURING

Financial Services-->Retail Banking and Lending


Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Cards-->Card Issuance-->Debit Cards
Financial Services-->Cards-->Card Issuance-->Pre-paid
Cards
Financial Services-->Retail Banking and Lending-->Current
Accounts
Financial Services-->Retail Banking and Lending-->Current
Accounts
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Motor Finance
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Overdraft and Lines of Credit
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Personal Loans
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Savings and Investments
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Equities

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Wealth Management and Private
Banking
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Technology and Services
Technology and Services

Address State Bank Bhavan, Corporate Centre, Madame Cama Marg

City Mumbai

State Maharashtra

Country India

Website www.sbi.co.in

Phone number 91 22 220266

Acquirer 3: SBI Life Insurance Co. Ltd


26

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

423
CORPORATE VENTURING

Company type Private

SBI Life Insurance Co. Ltd (SBI Life Insurance), a subsidiary


of India-based State Bank of India, is an insurance company
which offers life insurance products and services. The
company provides individual plans such as unit linked plans,
child plans, pension plans, protection plans, and savings
plans. It offers group plans including group employee benefit
retirement and protection plans. SBI Life Insurance also
Business description provides savings protection products, micro insurance plans,
group loan protection products, health plans, and banking
product packages such as housing loans and personal
loans. The company's services include premium calculator,
child education planner, tax calculator, easy plan finder, NRI
services, SMS based services, and premium payment
procedure. It operates throughout India. SBI Life Insurance
is headquartered in Mumbai, Maharashtra, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Industry Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->Financial Services Distributors--

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Insurance Brokers and Intermediaries

Natraj, M.V. Road and Western Express Highway Junction


Address
, Andheri East

City Mumbai

State Maharashtra

Country India

Website www.sbilife.co.in

Phone number 91 22 61910000

Acquirer 4: SBI Mutual Fund

Industry Mutual fund company, quasi-government organization

SBI Mutual Fund is a provider of mutual funds. The company


Business description also provides portfolio management and advisory services
for institutional investors.

Address 191, Maker Tower 'E', Cuffe Parade

City Mumbai

State Maharashtra
27

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

424
CORPORATE VENTURING

Country India

Website www.sbimf.com

Phone number 91 22 22180221-22 / 24-27

Acquirer 5: First Carlyle Ventures Mauritius Private Limited

Industry Investment company

Country Mauritius

Acquirer 6: The Carlyle Group L.P.

Industry Asset management firm, quasi-government organization

The Carlyle Group L.P. (Carlyle or ‘the group’) is a US-based


global alternative asset manager with approximately $183
billion of assets under management across 126 funds and
160 fund of funds vehicles as of December 31, 2015. The
group invests on behalf of its investors across four
Business description
segments: corporate private equity, global market strategies,
real assets, and investment solutions. The group operates in
Africa, Asia, Australia, Europe, the Middle East, North
America and South America regions. It is headquartered in
Washington, DC.

Address 1001 Pennsylvania Ave NW

City WASHINGTON

State WashingtonD.C.

Country United States

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Phone number 1 202 7295626

28

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

425
CORPORATE VENTURING

Deal Report: Gayatri Energy Ventures raises $56.2 million from IFCI

Deal in brief

Gayatri Energy Ventures Private Limited (GEVPL), a wholly-owned subsidiary of heavy construction
company Gayatri Projects Limited, has raised INR2,500 million ($56.2 million) from IFCI Limited, through
issue of compulsory convertible debentures. All the entities involved in the transaction are based in India.

GEVPL is operating and investing in the power sector.

Target Gayatri Energy Ventures Private Limited

Acquirer IFCI Limited

Deal status Completed

Deal value ($m) 56.20

Deal value (Indian Rupee)(m) 2,500

Deal category Private placement

Date of completion May 03, 2011

Deal rationale

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Gayatri Energy will use the proceeds from the offering for bankrolling proposed investments, announced by
GEVPL in the energy domain.

Security type information

Security type Debt

Security type Indian Rupee (m) Value ($m)

Debt investment amount 2,500 56.20

Company information: Target and acquirer

Target: Gayatri Energy Ventures Private Limited

Company type Private

Gayatri Energy Ventures Private Limited is an owner and


Business description
operator of 1,320 mega watt coal fired plant.
29

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

426
CORPORATE VENTURING

Energy and Utilities-->Commodity-->Power


Industry
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels

Address 6-3-1090 TSR Towers, B-1 Raj Bhavan Road

City Hyderabad

State Telangana

Country India

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

30

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

427
CORPORATE VENTURING

Deal Report: Gujarat State Petroleum Corporation (GSPC) to raise $216.7 million in
private placement

Deal in brief

Gujarat State Petroleum Corporation (GSPC), an India-based oil and gas exploration company, is planning
to raise INR9,900 million ($216.7 million) from three financial institutions and seven public sector units in a
private placement.

As part of the transaction, GSPC will divest 5% of the company at INR810 ($17.73) per share.

The two financial institutions IDBI Bank Limited and IFCI Limited invested INR1,500 million ($32.83 million)
and INR1,000 million ($21.89 million), respectively. SBI Capital will invest INR3,000 million ($65.67 million)
in the form of convertible debentures.

The public sector units Gujarat State Fertilizers & Chemicals Limited invested INR1,498.5 million ($32.8
million), Gujarat State Investment Limited INR1,100 million ($24.08 million), Gujarat Industrial Development
Corporation INR1,000 million ($21.89 million). Narmada Valley Fertilizers Company, Gujarat Mineral
Development Corporation Limited, Gujarat Alkalies Chemicals Limited, Gujarat Industrial Investment
Corporation Limited and Gujarat Gas Company Limited together invested INR50 million ($1.09 million).

SBI Capital is acting as financial advisor to GSPC.

Target Gujarat State Petroleum Corporation Limited

Acquirer 1 IDBI Bank Limited

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 2 SBI CAPITAL Co., Ltd.

Acquirer 3 Gujarat Industrial Investment Corporation Limited

Acquirer 4 Gujarat Industrial Development Corporation

Acquirer 5 Gujarat State Fertilizers & Chemicals Limited

Acquirer 6 IFCI Limited

Acquirer 7 Gujarat Mineral Development Corporation Limited

Acquirer 8 Gujarat Narmada Valley Fertilizers & Chemicals Limited

Acquirer 9 Gujarat Alkalies Chemicals Limited

Acquirer 10 Gujarat Gas Company Limited

Deal status Announced

Deal value ($m) 216.70

Deal value (Indian Rupee)(m) 9,900

Deal category Private placement

Acquired % 5
31

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

428
CORPORATE VENTURING

Offer price ($) 17.73

Offer price (Indian Rupee) (m) 810

Date of announcement Jan 16, 2010

Security type information

Security type Common stock

Security type Indian Rupee (m) Value ($m)

Equity investment amount 9,900 216.70

Company information: Target and acquirer

Target: Gujarat State Petroleum Corporation Limited

Company type Private

Gujarat State Petroleum Corporation Limited engages in the


exploration, development, and production of oil and natural
Business description
gas in India. It primarily supplies natural gas to power,
chemicals and fertilizers, and ceramic companies.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities
Energy and Utilities-->Commodity-->Gas
Industry
Energy and Utilities-->Commodity-->Oil
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production

Address Third Floor, GSPC Bhavan, Sector-11

City Gandhinagar

State Gujarat

Country India

Website www.gujaratpetro.com

Phone number 91 079 8501001

Financial information – (Fiscal year 31-Mar-2008)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 41,432.10 1,038.66

Operating profit 6,280 157.43

EBITDA 7,574.71 189.89


32

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

429
CORPORATE VENTURING

Post tax profit 12,813.58 321.22

Key ratios

Operating margin (%) 15.16

Acquirer 1: IDBI Bank Limited

Company type Private

IDBI Bank is a financial holding company. The company,


through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->Payments
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management

Address IDBI Tower, WTC Complex, Cuffe Parade, Colaba

City Mumbai

State Maharashtra

Country India

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Website www.idbi.com

Phone number 91 22 2218 9111

Acquirer 2: SBI CAPITAL Co., Ltd.

Company type Private

SBI CAPITAL Co., Ltd. is a wholly owned subsidiary of SBI


Business description Holdings, Inc. The company's principle business is buy-out
and enterprise revitalization funds management.

Industry Financial Services


Financial Services-->Institutional Investment Management

Address Izumi Garden Tower 1-6-1, Roppongi, Minato-ku

City Tokyo

Country Japan

Acquirer 3: Gujarat Industrial Investment Corporation Limited

Company type Private 33

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

430
CORPORATE VENTURING

Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Address Block No 11-12, Udyog Bhavan

City Gandhinagar

State Gujarat

Country India

Acquirer 4: Gujarat Industrial Development Corporation

Company type Private

Gujarat Industrial Development Corporation provides primary


infrastructure facilities such as land, road, drainage, power,
Business description water supply, street light facilities to industrial units. It also
provides supporting infrastructure such as housing,
commercial space, parks, banks etc.

Industry
Government and Non-Profit Organisations

Address Navsarjan, Opposite Gurukul

City Gondal Road Rajkot

State Gujarat

Country India

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Website www.gidc.gov.in

Phone number 91 281 3225811

Acquirer 5: Gujarat State Fertilizers & Chemicals Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500690

Gujarat State Fertilizers & Chemicals (GSFC) is engaged in


the manufacture and sale of fertilizers and chemicals. The
Business description company offers industrial products and agro products. GSFC
primarily operates in India, where it is headquartered in
Vadodara.

Industry Chemicals
Chemicals-->Agrochemicals-->Fertilizer

Address P O Fertilizer nagar 391 750

City Vadodara
34

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

431
CORPORATE VENTURING

State Gujarat

Country India

Website www.gsfclimited.com

Phone number 91 265 224 2451

Acquirer 7: Gujarat Mineral Development Corporation Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532181

Gujarat Mineral Development (GMDC) is a mineral


exploration company engaged in the mining and mineral
processing of lignite, bauxite, fluorspar multi metal,
manganese, calcined bauxite, silica sand, limestone,
Business description bentonite, and ball clay. It is also engaged in the generation
of thermal power through its Akrimota thermal power project.
The company primarily operates in India, where it is
headquartered in Ahmedabad and employs around 1,594
people.

Energy and Utilities-->Utilities-->Power Generation-->Fossil


Fuels
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Metals and Mining-->Metal Ore Mining

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Metals and Mining-->Metal Ore Mining-->Aluminum Ore
Mining
Metals and Mining-->Coal Mining
Industry
Metals and Mining-->Metal Ore Mining-->Copper Ore and
Nickel Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining-->Metal Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining
Metals and Mining-->Primary Metal Manufacturing

Address Khanij Bhavan, 132 Feet Ring Road

Country India

Website www.gmdcltd.com

Phone number 91 79 2791 3501

Acquirer 8: Gujarat Narmada Valley Fertilizers & Chemicals Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)


35

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

432
CORPORATE VENTURING

Ticker symbol 500670

Gujarat Narmada Valley Fertilizers & Chemicals (GNFC) is


engaged in manufacturing and selling a range of fertilizers
and other chemicals throughout India. The company's
corporate portfolio is spread across various sectors such as
Business description
chemicals/petrochemicals, energy sector,
electronics/telecommunications and information technology.
GNFC operates in India, where it is headquartered in
Bharuch, Gujarat.

Industry Chemicals
Chemicals-->Agrochemicals-->Fertilizer

Address Narmadanagar

City Bharuch

State Gujarat

Country India

Website www.gnfc.in

Phone number 91 2642 247001

Acquirer 9: Gujarat Alkalies Chemicals Limited

Company type Private

Gujarat Alkalies Chemicals Limited is engaged in the


manufacturing of chemicals such as caustic soda, caustic

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
potash, phosphoric acid and others. It manufactures other
basic chemicals, such as sodium cyanide, sodium ferro
Business description
cyanide, chloromethane, hydrochloric acid, potassium
carbonate, phosphoric acid (85%) and hydrogen peroxide,
poly aluminum chloride, anhydrous aluminum chloride and
chlorinated paraffin wax.

Industry
Chemicals

Address P O Petrochemicals 391 346

City Vadodara

State Gujarat

Country India

Website www.gujaratalkalies.com

Phone number 91 265 2232681

Acquirer 10: Gujarat Gas Company Limited

Company type Private

Business description Gujarat Gas Company (GGCL) is engaged in the procuring 36

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

433
CORPORATE VENTURING

and distribution of natural gas. The company supplies its


natural gas to around 413,000 industrial, commercial, and
domestic customers through its pipeline network, and
compressed natural gas to over 200,000 vehicles through its
55 retail outlets. GCCL is a subsidiary of GSPC Distribution
Networks Limited. The company primarily operates in India,
where it is headquartered in Ahmedabad.\r\nThe company
recorded revenues of INR31,128.7 million (approximately
$535.1 million) in the fiscal year ended December 2013, an
increase of 1.5% over 2012. The company's operating profit
was INR4,723.2 million (approximately $81.2 million) in fiscal
2013, an increase of 37.9% over 2012. Its net profit was
INR3,705.3 million (approximately $63.7 million) in fiscal
2013, an increase of 28.4% over 2012.\r\n

Energy and Utilities


Industry Energy and Utilities-->Commodity-->Gas
Energy and Utilities-->Natural Resources-->Midstream
Energy-->Pipelines

Address 2 Shanti Sadan Society, Near Parimal Garden

Country India

Website http://www.gujaratgas.com

Phone number 91 79 2646 2980

Advisor information

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target : Gujarat State Petroleum Corporation Limited

Financial advisors

SBI CAPITAL Co., Ltd. (Sub-category: Corporate Finance)

37

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

434
CAPITAL RAISING

CAPITAL RAISING

Capital Raising – Overview

Figure 3: IFCI Limited capital raising volume and value trend Figure 4: IFCI Limited capital raising by deal type (2014-
(2014-YTD2018) YTD2018)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Table 3: IFCI Limited capital raising volume and value trend Table 4: IFCI Limited capital raising by deal type (2014-
(2014-YTD2018) YTD2018)

Year Volume Value ($m) Deal Type Volume

2014 - - Private placement 1

2015 - -

2016 1 86.18

2017 - -

2018 - -

38

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

435
CAPITAL RAISING

Capital Raising – Deal reports

Deal Report: IFCI to raise $86.18 million in private placement

Deal in brief

IFCI Limited, an India-based provider of long-term finance to the industrial sector, has agreed to raise up to
INR5,750 million ($86.18 million) through an issue of secured, redeemable, non-convertible bonds in the
nature of debentures on a private placement.

The bonds will carry a coupon rate of 8.55% semi-annually, and are of five-and-half-years of tenure. The
bonds will mature on November 3, 2021.

IFCI expects to list the bonds on the BSE, Ltd.

The offering is expected to close on April 29, 2016.

Target IFCI Limited

Acquirer Undisclosed Investor(s)

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Announced

Deal value (estimated) ($m) 86.18

Deal category Private placement

Date of announcement Apr 18, 2016

Security type information

Security type Common stock

Company information: Target and acquirer

Acquirer: Undisclosed Investor(s)

Company type Private


39

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

436
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Industry Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 40

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

437
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 41

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

438
CAPITAL RAISING

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment 42

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

439
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Healthcare-->Healthcare


Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 43

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

440
CAPITAL RAISING

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 44

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

441
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and 45

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

442
CAPITAL RAISING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology 46

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

443
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and 47

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

444
CAPITAL RAISING

Diagnostics-->Respiratory and Anesthesia Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental 48

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

445
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and 49

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

446
CAPITAL RAISING

Diagnostics-->Patient Monitoring Equipment


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 50

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

447
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 51

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

448
CAPITAL RAISING

Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 52

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

449
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and 53

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

450
CAPITAL RAISING

Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 54

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

451
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 55

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

452
CAPITAL RAISING

Diagnostics-->Renal, Urology and Reproductive Devices


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics 56

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

453
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Healthcare-->Healthcare


Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 57

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

454
CAPITAL RAISING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 58

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

455
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and 59

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

456
CAPITAL RAISING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 60

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

457
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 61

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

458
CAPITAL RAISING

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 62

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

459
CAPITAL RAISING

Diagnostics-->Diagnostic Devices and Imaging


Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices 63

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

460
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 64

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

461
CAPITAL RAISING

Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 65

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

462
CAPITAL RAISING

Pharmaceuticals and Healthcare-->Medical Devices and


Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

66

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

463
DIVESTMENTS

DIVESTMENTS
Divestments – Overview

Figure 5: IFCI Limited divestments volume and value trend Figure 6: IFCI Limited divestments by geography (2014-
(2014-YTD2018) YTD2018)

Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Table 5: IFCI Limited divestments volume and value trend Table 6: IFCI Limited divestments activity by geography
(2014-YTD2018) (2014-YTD2018)

Year Volume Value ($m) Geography Volume

2014 1 6.65 North America -

2015 2 79.36 Europe -

2016 3 22.06 Asia-Pacific 6

2017 - - Middle East and Africa -

2018 - - South and Central America -

67

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

464
DIVESTMENTS

Divestments – Deal reports

Deal Report: IFCI sells additional stake in National Stock Exchange

Deal in brief

IFCI Limited, a provider of long-term finance to the industrial sector, has sold additional 225,000 shares of
National Stock Exchange of India, Ltd. (NSE), an operator of electronic stock exchange, at the rate of
INR3,950 per share. Both the companies are based in India.

The transaction is valued at INR888.75 million ($13.2 million).

Target National Stock Exchange of India Ltd.

Acquirer Undisclosed Acquirer

Seller/Vendor IFCI Limited

Deal status Completed

Deal value ($m) 13.13

Deal value (Indian Rupee)(m) 888.17

Deal category Acquisition

Deal sub-category Minority acquisition

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Jul 04, 2016

Company information: Target, acquirer, and seller/vendor

Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
services for multiple markets, including equities, indices,
Business description mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
wholesale debt market, and corporate bonds. NSE operates
in India, where it is headquartered in Mumbai.

Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
68

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

465
DIVESTMENTS

Address Exchange Plaza, Plot number C-1 Block G

Country India

Website www.nseindia.com

Phone number 91 22 2659 8100

Acquirer: Undisclosed Acquirer

Company type Private

Country North America

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

69

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

466
DIVESTMENTS

Deal Report: Soach Global Opportunities Fund acquires stake in National Stock
Exchange of India

Deal in brief

Soach Global Opportunities Fund (SGOF) has acquired a stake in National Stock Exchange of India, Ltd.,
(NSE), an operator of electronic stock exchange, from IFCI Limited, a provider of long-term finance to the
industrial sector, for INR592.5 million ($8.88 million). NSE and IFCI are based in India.

SGOF is a fund managed by Soach Global Corporation Limited, a Hong-Kong based fund management
and advisory group.

IDBI Capital Market Services, Ltd. acted as financial advisor to SGOF on the transaction.

Target National Stock Exchange of India Ltd.

Acquirer Soach Global Opportunities Fund

Seller/Vendor IFCI Limited

Deal status Completed

Deal category Private equity

Deal sub-category Minority acquisition , institutional buy-out (ibo)

Date of completion Apr 11, 2016

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor

Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
services for multiple markets, including equities, indices,
Business description mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
wholesale debt market, and corporate bonds. NSE operates
in India, where it is headquartered in Mumbai.

Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services

Address Exchange Plaza, Plot number C-1 Block G

Country India
70

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

467
DIVESTMENTS

Website www.nseindia.com

Phone number 91 22 2659 8100

Acquirer: Soach Global Opportunities Fund


Soach Global Opportunities Fund is a fund managed by
Business description Soach Global Corporation Limited, a Hong-Kong based fund
management and advisory group.

Country Hong Kong Special Administrative Region of China

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

71

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

468
DIVESTMENTS

Deal Report: IFCI sells stake in National Stock Exchange of India (NSE)

Deal in brief

IFCI Limited, a provider of long-term finance to the industrial sector, has sold 150,000 number of equity
shares of National Stock Exchange of India, Ltd. (NSE), an operator of electronic stock exchange, for
INR592.5 million ($8.93 million) or INR3,950 ($59.59) per equity share. Both the companies are based in
India.

Following the transaction, IFCI will hold a 3.55% stake in NSE.

Target National Stock Exchange of India Ltd.

Acquirer Undisclosed Acquirer

Seller/Vendor IFCI Limited

Deal status Completed

Deal value ($m) 8.93

Deal value (Indian Rupee)(m) 592.50

Deal category Acquisition

Deal sub-category Minority acquisition

Date of completion Apr 04, 2016

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor

Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
services for multiple markets, including equities, indices,
Business description mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
wholesale debt market, and corporate bonds. NSE operates
in India, where it is headquartered in Mumbai.

Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services

Address Exchange Plaza, Plot number C-1 Block G

72

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

469
DIVESTMENTS

Country India

Website www.nseindia.com

Phone number 91 22 2659 8100

Acquirer: Undisclosed Acquirer

Company type Private

Country North America

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

73

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

470
DIVESTMENTS

Deal Report: IFCI sells 1.5% stake in National Stock Exchange of India (NSE)

Deal in brief

According to Livemint, IFCI Limited, a provider of long-term finance to the industrial sector, has sold
675,000 shares, representing a 1.5% stake, in National Stock Exchange of India, Ltd. (NSE), an operator of
electronic stock exchange, to a Mauritius-based fund for approximately INR2,635 million ($39.66 million) or
INR3,900 ($58.71) per equity share. IFCI and NSE are based in India.

IDFC Securities Limited acted as financial advisor to NSE.

Target National Stock Exchange of India Ltd.

Acquirer Undisclosed Fund

Seller/Vendor IFCI Limited

Deal status Completed

Deal value (estimated) ($m) 39.66

Deal category Private equity

Deal sub-category Minority acquisition

Acquired % 1.5

Round of financing None

Date of completion Sep 17, 2015

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor

Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
services for multiple markets, including equities, indices,
Business description mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
wholesale debt market, and corporate bonds. NSE operates
in India, where it is headquartered in Mumbai.

Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services

74

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

471
DIVESTMENTS

Address Exchange Plaza, Plot number C-1 Block G

Country India

Website www.nseindia.com

Phone number 91 22 2659 8100

Acquirer: Undisclosed Fund

Advisor information

Target : National Stock Exchange of India Ltd.

Financial advisors

IDFC Securities Limited

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

75

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

472
DIVESTMENTS

Deal Report: IFCI sells 1.5% stake in National Stock Exchange of India (NSE)

Deal in brief

IFCI Limited, a provider of long-term finance to the industrial sector, has sold its 1.5% stake in National
Stock Exchange of India, Ltd. (NSE), an operator of electronic stock exchange, for INR2,632.5 million
($39.7 million). NSE and IFCI are based in India.

Target National Stock Exchange of India Ltd.

Acquirer Undisclosed Acquirers

Seller/Vendor IFCI Limited

Deal status Completed

Deal value ($m) 39.70

Deal value (Indian Rupee)(m) 2,632.50

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 1.5

Date of completion Sep 17, 2015

Company information: Target, acquirer, and seller/vendor

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
services for multiple markets, including equities, indices,
Business description mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
wholesale debt market, and corporate bonds. NSE operates
in India, where it is headquartered in Mumbai.

Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services

Address Exchange Plaza, Plot number C-1 Block G

Country India

76

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

473
DIVESTMENTS

Website www.nseindia.com

Phone number 91 22 2659 8100

Acquirer: Undisclosed Acquirers

Company type Private

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

77

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

474
DIVESTMENTS

Deal Report: SSG Capital Management acquires 49% stake in Assets Care &
Reconstruction (ACRE)

Deal in brief

SSG Capital Management Limited, a Hong Kong-based provider of asset management and financial
restructuring services, has acquired a 49% stake in Assets Care & Reconstruction Enterprise, Ltd., an
India-based asset reconstruction company, for INR410 million ($6.65 million).

ACRE issued preferential shares at a face value of INR10 ($0.16), with a premium of INR12.50 ($0.20)
which were subscribed only by SSG Capital Management.

As part of the transaction, IFCI Limited and Punjab National Bank have reduced their shareholding in
Assets Care & Reconstruction from 40% to 19% and 30% to 15% respectively.

Target Assets Care & Reconstruction Enterprise, Ltd.

Acquirer SSG Capital Management Limited (SSG Capital Partners)

Seller/Vendor 1 Undisclosed Company*

Seller/Vendor 2 IFCI Limited

Seller/Vendor 3 Punjab National Bank

Deal status Completed

Deal value ($m) 6.65

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (Indian Rupee)(m) 410

Deal category Private equity

Deal sub-category Minority acquisition

Acquired % 49

Date of completion Nov 26, 2014

Company information: Target, acquirer, and seller/vendor

Target: Assets Care & Reconstruction Enterprise, Ltd.

Company type Private

Assets Care & Reconstruction Enterprise, Ltd. is an asset


reconstruction company. It is engaged in the acquisition of
Business description non performing assets from banks/ financial institutions and
their resolution as per the guidelines issued by Reserve
Bank of India.

Industry
Financial Services

78

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

475
DIVESTMENTS

Address 6th Floor ,IFCI Tower,61 Nehru Place, 61 Nehru Place

City New Delhi

Country India

Website acreindia.co

Phone number 91 11 43115600

Acquirer: SSG Capital Management Limited (SSG Capital Partners)

Industry Asset management firm

SSG Capital Management Limited is a provider of asset


Business description
management and financial restructuring services.

Address Suite 6303, The Center, 99 Queen's Road

City Central

Country Hong Kong Special Administrative Region of China

Website www.ssgcapasia.com

Phone number 852 3909 8888

Vendor 1: Undisclosed Company*

Company type Private

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor 3: Punjab National Bank

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol PNB

Punjab National Bank (PNB or 'the group') offers a range of


services such as corporate and personal banking, industrial
finance, agricultural finance, financing of trade and
international banking services. It also offers credit card and
Business description
debit cards; life and non-life insurance agency services; gold
coins; and asset management services. The group operates
through a network of 6,760 branches with presence in 9
countries. It is headquartered in New Delhi, India.

Industry Financial Services-->Retail Banking and Lending


Financial Services-->Institutional Investment Management

Address 7, Bhikhaiji Cama Place

City NEW DELHI

State Andhra Pradesh

Country India
79

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

476
DIVESTMENTS

Website www.pnbindia.in

Phone number 91 11 23719086

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

80

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

477
DIVESTMENTS

Deal Report: IDBI to acquire 81% stake in Stock Holding Corporation

Deal in brief

IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.

IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.

The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.

Target Stock Holding Corporation of India Limited

Acquirer IDBI Bank Limited

Seller/Vendor 1 Specified Undertaking of Unit Trust of India

Seller/Vendor 2 IFCI Limited

Seller/Vendor 3 The United India Insurance Company Limited

Seller/Vendor 4 New India Assurance Co., Ltd.

Seller/Vendor 5 The Oriental Insurance Company Ltd.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Seller/Vendor 6 National Insurance Company Limited

Seller/Vendor 7 Life Insurance Corporation of India

Seller/Vendor 8 General Insurance Corporation of India

Deal status Announced

Deal value (estimated) ($m) 259.94 (min)

Deal category Acquisition

Deal sub-category Majority acquisition

Acquired % 81

Date of announcement Nov 01, 2012

Company information: Target, acquirer, and seller/vendor

Target: Stock Holding Corporation of India Limited

Company type Private

81

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

478
DIVESTMENTS

Stock Holding Corporation of India Limited (SHCIL) is a


Business description provider of custodial and depository services, and other
financial services.

Financial Services-->Capital Markets and Trading


Industry
Financial Services-->Savings and Investments-->Mutual
Funds

Address SHCIL House, Plot No.P-51, TTC Industrial Area

City Mumbai

State Maharashtra

Country India

Acquirer: IDBI Bank Limited

Company type Private

IDBI Bank is a financial holding company. The company,


through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->Payments
Financial Services-->Retail Banking and Lending

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Institutional Investment Management

Address IDBI Tower, WTC Complex, Cuffe Parade, Colaba

City Mumbai

State Maharashtra

Country India

Website www.idbi.com

Phone number 91 22 2218 9111

Vendor 1: Specified Undertaking of Unit Trust of India

Company type Private

Vendor 3: The United India Insurance Company Limited

Company type Private

The United India Insurance Company Limited (UIIC) is a


Business description
general insurance provider. It offers a range of personal and
82

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

479
DIVESTMENTS

commercial general insurance products. The company’s


personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of


INR106,917.3 million in FY2015, compare to INR97,089.3
million in FY2013, representing an annual increase of
10.1%. The net earned premium of the company was
INR88,162.3 million in FY2015, compare to INR76,033
million in FY2014, representing an annual increase of 16%.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and

83

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

480
DIVESTMENTS

Casualty-->Commercial Insurance-->Pecuniary Loss

Address 24, Whites Road

City Chennai

State Tamil Nadu

Country India

Website www.uiic.co.in

Phone number 91 44 28520161

Vendor 4: New India Assurance Co., Ltd.

Company type Private

New India Assurance Co., Ltd. provides nonlife insurance


services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.

Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty

Address 87 Mahatma Gandhi Road

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
City Mumbai

Country India

Website www.niacl.com

Phone number 91 22 2267 461

Vendor 5: The Oriental Insurance Company Ltd.

Company type Private

The Oriental Insurance Company (Oriental Insurance)


provides various general insurance services in the urban and
rural areas of India. The company designs insurance
coverage for projects, including power plants, petrochemical,
steel and chemical plants. Oriental Insurance operates in
Business description
over 31 regional offices and more than 1,800 operating
offices in the cities of India. It also has overseas operations
in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

Industry Financial Services-->General Insurance, Property and


Casualty
84

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

481
DIVESTMENTS

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance

Address Oriental House, A 25 27 Asaf Ali Road

City New Delhi

State Delhi

Country India

Website www.orientalinsurance.org.in

Phone number 91 11 43659595

Vendor 6: National Insurance Company Limited

Company type Private

National Insurance Company Limited (NIC) is an insurance


company. The company’s products portfolio includes motor
insurance, health insurance, rural insurance, commercial
insurance, and industrial insurance. Its personal insurance
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.

Financial Services-->General Insurance, Property and


Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
85

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

482
DIVESTMENTS

Financial Services-->General Insurance, Property and


Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations

Address 3 Middleton Street, Prafulla Chandra Sen Sarani

City Kolkata

State West Bengal

Country India

Website www.nationalinsuranceindia.com

Phone number 91 22 831705

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor 7: Life Insurance Corporation of India

Company type Private

The Life Insurance Corporation of India (LIC) is a life


insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.

Industry Financial Services-->Life and Pensions-->Pensions


Financial Services-->Life and Pensions-->Life and Protection

Central Office, 'Yogakshema',Jeevan Bima Marg, Jeevan


Address
Bima Marg

City Mumbai

State Maharashtra

Country India

Website www.licindia.com

Phone number 91 22 22021625

Vendor 8: General Insurance Corporation of India


86

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

483
DIVESTMENTS

Company type Public

General Insurance Corporation of India (GIC) is engaged in


providing reinsurance services to the general insurers in
India. Its reinsurance portfolio includes oil and energy,
Business description aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the
UAE, Malaysia, South Africa and Russia. It is headquartered
in Mumbai, India.

Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending

Address Suraksha, 170 Jamshedji Tata Road

Country India

Website www.gicofindia.com

Phone number 91 22 2286 7000

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

87

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

484
DIVESTMENTS

Deal Report: Hero Honda and SREI Infrastructure acquire stake in National Stock
Exchange from IFCI and Stock Holding Corporation

Deal in brief

According to VC Circle, The Economic Times reported that Hero Honda Motors Limited, a manufacturer of
two wheeler vehicle, and SREI Infrastructure Finance Limited have acquired a stake in National Stock
Exchange of India, Ltd. (NSE), a demutualized electronic stock exchange, from IFCI, Ltd. and Stock
Holding Corporation of India Limited (SHCIL). All the companies are based in India. SREI is an
infrastructure equipment finance and infrastructure project finance company.

Hero Honda and SREI have acquired 57,200 shares from SHCIL and 12 million shares from IFCI at a price
of INR3,500 ($83.27) per share. The transaction is valued at INR620.2 million ($14.75 million).

IFCI and SHCIL have sold their stake in NSE as capital market regulator Securities and Exchange Board
of India (SEBI) does not allow more than 5% stake. Prior to this transaction, SHCIL had a 7.11% stake in
the NSE.

Target National Stock Exchange of India Ltd.

Acquirer 1 Hero MotoCorp Ltd.

Acquirer 2 SREI Infrastructure Finance Limited

Seller/Vendor 1 IFCI Limited

Seller/Vendor 2 Stock Holding Corporation of India Limited

Deal status Completed

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value ($m) 14.75

Deal value (Indian Rupee)(m) 620.20

Deal category Acquisition

Deal sub-category Minority acquisition

Date of completion Aug 10, 2008

Company information: Target, acquirer, and seller/vendor

Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
Business description
services for multiple markets, including equities, indices,
mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
88

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

485
DIVESTMENTS

wholesale debt market, and corporate bonds. NSE operates


in India, where it is headquartered in Mumbai.

Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services

Address Exchange Plaza, Plot number C-1 Block G

Country India

Website www.nseindia.com

Phone number 91 22 2659 8100

Acquirer 1: Hero MotoCorp Ltd.

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500182

Hero MotoCorp Ltd. (Hero MotoCorp or 'the company') is


engaged in the manufacturing and marketing of motorized
two-wheelers, spare parts, and related services. The
Business description
company primarily operates in India. It is headquartered in
New Delhi, India and employed 7,334 people as on March
31, 2015.

Automotive

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Automotive-->Automobile Distribution
Automotive-->Automobile Distribution-->New Automobile
Distribution
Industry
Automotive-->Parts, Tires and Aftermarket
Automotive-->Parts, Tires and Aftermarket-->Vehicle Parts
Automotive-->Vehicle Manufacturing
Automotive-->Vehicle Manufacturing-->Motorcycles
Retailing-->Other Specialist Retailers

Address 34 Community Centre, Basant Lok

Country India

Website www.heromotocorp.com

Phone number 91 11 2614 2451

Acquirer 2: SREI Infrastructure Finance Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol SREINFRA

Business description Srei Infrastructure Finance Limited (Srei) is an infrastructure-


89

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

486
DIVESTMENTS

focused public sector non-banking financial service provider.


The company offers a range of infrastructure solutions,
including financing, advisory services and development. Its
product includes term loans, syndicate loans, corporate
loans and working capital loans. The company also offers
services, including infrastructure equipment financing and
leasing, infrastructure project financing, project advisory and
development, insurance broking, venture capital, and capital
market services. It also invests in various sectors, including
telecom infrastructure, transportation, power, and SEZ and
industrial parks. Srei serves its customers through a network
of branches across India. It operates in Russia, Germany,
Singapore, Mauritius, and Nigeria. Srei is headquartered in
Kolkata, India.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Exploration
Financial Services
Financial Services-->Institutional Investment Management
Financial Services-->Institutional Investment Management
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
Industry >Project, Asset and Structured Finance
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking
Financial Services-->Institutional Investment Management
Construction and Real Estate-->Heavy Construction--
>Bridge Construction
Energy and Utilities-->Natural Resources-->Upstream
Energy

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production

Address 6A, Kiran Shankar Roy Road

City Kolkata

State West Bengal

Country India

Website www.srei.com

Phone number 91 33 64990230

Vendor 2: Stock Holding Corporation of India Limited

Company type Private

Stock Holding Corporation of India Limited (SHCIL) is a


Business description provider of custodial and depository services, and other
financial services.

Industry Financial Services-->Capital Markets and Trading


Financial Services-->Savings and Investments-->Mutual
90

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

487
DIVESTMENTS

Funds

Address SHCIL House, Plot No.P-51, TTC Industrial Area

City Mumbai

State Maharashtra

Country India

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

91

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

488
DIVESTMENTS

Deal Report: Hindusthan National Glass acquires glass container manufacturing plant
from IFCI

Deal in brief

Hindusthan National Glass & Industries, Ltd., a manufacturer of glass containers, has acquired a glass
container manufacturing plant from IFCI Limited, a provider of long-term finance to the industrial sector.

Target IFCI Limited-Glass Container Manufacturing Plant

Acquirer Hindusthan National Glass & Industries

Seller/Vendor IFCI Limited

Deal status Completed

Deal category Acquisition

Deal sub-category Asset purchase

Date of completion Nov 02, 2007

Company information: Target, acquirer, and seller/vendor

Target: IFCI Limited-Glass Container Manufacturing Plant

Company type Private

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry
Paper and Packaging-->Glass Containers and Packaging

Acquirer: Hindusthan National Glass & Industries

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol HINDNATGLS

Hindusthan National Glass & Industries Ltd. (Hindusthan


National) is a manufacturer of container glass in India. The
company produces container glass products with various
ranges across multi-colored bottle. These products find
application in pharmaceuticals, liquor, beverages, cosmetics
and processed food industries. The company also operates
a network manufacturing facilities at Bahadurgarh,
Business description
Neemrana, Nasik, Rishikesh, Rishra and Puducherry, India.
Its clientele includes Nestle, Dabur, Coca Cola, Unilever,
Lupin, Heinz, Diageo, and Amul. The company conducts
business operations through its subsidiaries including HNG
Global GmbH, HNG Float Glass Limited and AMCL
Machinery Limited. Hindusthan National is headquartered in
Kolkata, West Bengal, India.

92

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

489
DIVESTMENTS

Paper and Packaging


Consumer Packaged Goods-->Other Consumer Products--
>Glues, Adhesives and Tapes
Paper and Packaging-->Glass Containers and Packaging
Paper and Packaging
Industry
Paper and Packaging
Paper and Packaging
Paper and Packaging
Paper and Packaging
Energy and Utilities-->Utilities-->Power Generation
Paper and Packaging-->Plastic Containers and Packaging

Address 2, Red Cross Place

City KOLKATA

Country India

Website www.hngindia.com

Phone number 91 33 22543100

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

93

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

490
DIVESTMENTS

Deal Report: New York Stock Exchange to acquire 5% stake in India's National Stock
Exchange

Deal in brief

Industrial Finance Corporation of India Limited (IFCI Ltd.) that holds 12.44% equity shares of National
Stock Exchange of India Ltd. (NSE), has agreed to sell 31.5 million equity shares (constituting 7% holding)
to four institutional investors including Goldman Sachs, NYSE, General Atlantic and Soft Bank.

Earlier on January 10, 2007, NYSE Group, an operator of two securities exchanges, has signed a
definitive agreement to acquire a 5% equity stake in National Stock Exchange of India. Merrill Lynch & Co.
acted as financial advisor to NYSE Group, Inc. in connection with the transaction.

Target National Stock Exchange of India Ltd.

Acquirer 1 The Goldman Sachs Group, Inc.

Acquirer 2 New York Stock Exchange Group, Inc.

General Atlantic LLC (General Atlantic Service Company,


Acquirer 3
LLC)

Acquirer 4 SoftBank Capital

Seller/Vendor IFCI Limited

Deal status Announced

Deal category Acquisition

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Minority acquisition

Acquired % 5

Date of announcement Mar 31, 2007

Company information: Target, acquirer, and seller/vendor

Target: National Stock Exchange of India Ltd.

Company type Public

National Stock Exchange of India (NSE or the exchange) is


a stock exchange that provides automated screen-based
trading system covering various cities and towns across the
country. The exchange provides various products and
services for multiple markets, including equities, indices,
Business description mutual funds, exchange traded funds, initial public offerings
(IPO), securities lending and borrowing scheme, equity and
currency derivatives, interest rate futures, retail and
wholesale debt market, and corporate bonds. NSE operates
in India, where it is headquartered in Mumbai.

Industry
94

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

491
DIVESTMENTS

Financial Services
Financial Services-->Capital Markets and Trading
Technology and Services

Address Exchange Plaza, Plot number C-1 Block G

Country India

Website www.nseindia.com

Phone number 91 22 2659 8100

Financial information – (Fiscal year 31-Mar-2006)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 4,725.06 106.27

Operating profit 2,678.88 60.25

EBITDA 2,968.34 66.76

Post tax profit 1,914.12 43.05

Net assets 646.49 14.54

Earnings per share (absolute) 42.54 0.09

Key ratios

Operating margin (%) 56.70

Acquirer 1: The Goldman Sachs Group, Inc.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Public

Stock exchange NYSE (New York Stock Exchange)

Ticker symbol GS

The Goldman Sachs Group, Inc. (Goldman Sachs or 'the


group') is one of the leading global investment banking,
securities, and investment management firms that provide a
range of financial services to a diversified client base that
Business description
includes corporations, financial institutions, governments and
high-net-worth individuals. The group primarily operates in
the Americas. It is headquartered in New York City, New
York.

Construction and Real Estate-->Real Estate Transactions


Construction and Real Estate-->Real Estate Transactions
Financial Services
Financial Services-->Private Equity and Venture Capital
Financial Services-->Institutional Investment Management--
Industry
>Hedge Funds
Financial Services-->Institutional Investment Management
Financial Services-->Private Equity and Venture Capital
Financial Services-->Capital Markets and Trading-->Bond
Markets
Financial Services-->Capital Markets and Trading--
95

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

492
DIVESTMENTS

>Brokerage
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Financial Services-->Capital Markets and Trading--
>Commodity Markets
Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Capital Markets and Trading-->Money
Markets
Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking--
>Treasury and Cash Management
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Corporate and Investment Banking
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Corporate and Investment Banking--
>Private Placements and Financial Sponsors
Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Retail Banking and Lending
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Institutional Investment Management--
>Securities Custody
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Wealth Management and Private
Banking
Industrial Goods and Machinery-->Battery Manufacturing
Financial Services-->Capital Markets and Trading
Financial Services-->Retail Banking and Lending-->SME
Banking Services

Address 200 West Street

City New York

State New York


96

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

493
DIVESTMENTS

Country United States

Website www.goldmansachs.com

Phone number 1 212 9021000

Acquirer 2: New York Stock Exchange Group, Inc.

Company type Private

NYSE Group is a provider of securities listing, trading and


market data products and services. It operates two securities
Business description
exchanges: the New York Stock Exchange LLC (NYSE) and
NYSE Arca, Inc. (formerly known as the Pacific Exchange).

Financial Services
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Industry Financial Services-->Capital Markets and Trading
Financial Services-->Capital Markets and Trading-->Bond
Markets
Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Capital Markets and Trading-->Money
Markets

Address 11 Wall Street

City New York

State New York

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country United States

Website www.nyse.com

Phone number 1 212 656 3000

Acquirer 3: General Atlantic LLC (General Atlantic Service Company, LLC)

Industry Private equity firm, swaps dealer

General Atlantic LLC is a growth equity firm that provides


Business description
capital and support for growth companies.

Address 600 Steamboat Road, Suite 105

City Greenwich

State Connecticut

Country United States

Website www.generalatlantic.com

Phone number 1 203 629 8600

Acquirer 4: SoftBank Capital


97

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

494
DIVESTMENTS

Industry Venture capital firm, nasd member broker/dealer

SoftBank Capital is a venture capital firm focused on high


growth technology based businesses. The firm invests
Business description
across all stages of development of a company focusing on
technology and retailing sectors.

38 Glen Avenue
Address

City Newton

State Massachusetts

Country United States

Website www.softbank.com

Advisor information

Acquirer 2: New York Stock Exchange Group, Inc.

Financial advisors

Merrill Lynch & Co., Inc.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

98

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

495
DIVESTMENTS

Deal Report: Hyatt acquires hotel business of Balaji Hotels

Deal in brief

Hyatt group, a US based chain of hotels, has acquired the half-constructed hotel property of Balaji Hotels
and Enterprises Ltd. The consideartion for the transaction is expected to be around INR2000 ($44.95)
million.

Balaji Hotels owes IFCI Limited INR1600 ($35.97)million. Another INR500 ($11.24) million is owed to ICICI
Bank.

Target Balaji Hotels and Enterprises Ltd. - Hotel business

Acquirer Hyatt Corporation

Seller/Vendor IFCI Limited

Deal status Completed

Deal value (estimated) ($m) 45

Deal category Acquisition

Deal sub-category Asset purchase

Date of completion Mar 08, 2007

Company information: Target, acquirer, and seller/vendor

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target: Balaji Hotels and Enterprises Ltd. - Hotel business

Company type Private

The asset being sold includes the half-constructed hotel


property of Balaji Hotels and Enterprises Ltd on the arterial
Anna Salai in Chennai, from IFCI Limited, the main creditor.
Business description
The hotel was designed to be a 320-room 7-star facility.
Also included in the original project was a 250,000 sq.ft.
commercial space.

Industry
Leisure and Arts-->Hotels and Restaurants-->Hotels

Acquirer: Hyatt Corporation

Company type Private

Hyatt Corporation is an owner and operator of hotels and


Business description resorts based in the US. The company offers VIP concierge
floors, restaurants and custom catering services.

Industry
99

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

496
DIVESTMENTS

Leisure and Arts-->Hotels and Restaurants


Leisure and Arts
Leisure and Arts-->Hotels and Restaurants-->Hotels
Industrial Goods and Machinery-->Battery Manufacturing

Address 71 South Wacker Drive, 12th Floor

City Chicago

State Illinois

Country United States

Website www.hyatt.com

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

100

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

497
PRIVATE EQUITY & OWNERSHIP

PRIVATE EQUITY & OWNERSHIP


Private Equity and Ownership – Deal reports

Deal Report: IFCI not to sell 26% stake to bidders

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell a 26% stake in the company.

Ernst & Young (E&Y) appointed as the consultant for the proposed stake sale in IFCI.

Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.;Natixis; Newbridge Asia IV, L.P; Cargill Financial
Services Corporation; Shinsei Bank, Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group
L.P.; and a consortium of WL Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank,
and Housing Development Finance Corporation, Ltd. were in the to acquire the stake in the company.

Target IFCI Limited

Acquirer 1 Cargill Financial Services Corporation

Acquirer 2 Kotak Mahindra Bank Ltd.

Acquirer 3 IDFC Limited

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 4 Shinsei Bank, Limited

Acquirer 5 Natexis Banques Populaires

Acquirer 6 Vedanta Limited

Acquirer 7 General Electric Capital Corporation

Acquirer 8 Standard Chartered Bank

Acquirer 9 Morgan Stanley

Acquirer 10 Housing Development Finance Corporation Limited

Acquirer 11 The Blackstone Group L.P.

Acquirer 12 GS Capital Partners VI Fund

Acquirer 13 Newbridge Asia IV, LP

Acquirer 14 WL Ross & Co, LLC

Acquirer 15 Punjab National Bank

Acquirer 16 J.C. Flowers & Co. LLC

Deal status Terminated

101

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

498
PRIVATE EQUITY & OWNERSHIP

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Date of termination Dec 19, 2007

Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Revenues 20,466.80 471.35

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer 1: Cargill Financial Services Corporation

Company type Private

102

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

499
PRIVATE EQUITY & OWNERSHIP

Industry
Financial Services

Country United States

Acquirer 2: Kotak Mahindra Bank Ltd.

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500247

Kotak Mahindra Bank, a part of the Kotak Mahindra Group,


is engaged in providing a range of banking and financial
services. The bank offers banking and savings, loans and
Business description borrowings, investments and insurance, and corporate and
institutional services. Kotak Mahindra Bank operates in
India, the UK, the US, Mauritius, the UAE and Singapore. It
is headquartered in Mumbai, India.

Industry Financial Services


Financial Services-->Retail Banking and Lending

Address 27BKC, C 27 G Block

Country India

Website www.kotak.com

Phone number 91 22 6166 0000

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 3: IDFC Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532659

IDFC is engaged in financing infrastructure projects in


sectors like energy, telecommunication, transportation,
commercial and industrial projects, including hospitals,
education, tourism and hotels. The group provides project
Business description
financing, investment banking and asset management. The
group operates in India, where it is headquartered in Mumbai
and employs around 225 people.

Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Address Naman Chambers, C-32 G-Block

Country India

Website www.idfc.com
103

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

500
PRIVATE EQUITY & OWNERSHIP

Phone number 91 22 4222 2000

Acquirer 4: Shinsei Bank, Limited

Company type Public

Stock exchange TYO (Tokyo Stock Exchange)

Ticker symbol 8303

Shinsei Bank, Limited (Shinsei Bank) is a financial institution.


The bank offers commercial banking and various financial
services. Its financial products and services include deposit
products, corporate loans, consumer and business loans,
credit cards, insurance services, credit guarantees, leasing
services, mergers and acquisition services, securities trading
services, real estate services, foreign exchange and
Business description
derivatives services. It also provides financing, leasing and
rentals, and alliance services to small and medium
businesses. The bank provides various services related to
foreign exchange, derivatives, equity trading, and other
capital markets transactions. The bank operates through a
network of offices in Japan. Shinsei Bank is headquartered
in Tokyo, Japan.

Financial Services
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Project, Asset and Structured Finance
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking
Financial Services-->Offshore Financial Services
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Industry Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
104

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

501
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Wealth Management and Private


Banking
Industrial Goods and Machinery
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Motor Finance
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Biofuels
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->Savings and Investments
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels

Nihonbashi Muromachi Nomura Bldg., 2-4-3, Nihonbashi


Address
Muro-machi

City Tokyo

State Tokyo

Country Japan

Website www.shinseibank.com

Phone number 81 3 59547530

Acquirer 5: Natexis Banques Populaires

Company type Private

Natexis Banques Populaires is the financing, investment


banking and services arm of Banque Populaire, a leading

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
French financial services group. The company offers
services including traditional banking, corporate and
institutional banking, private equity, wealth management and
asset management. It also undertakes services business
and receivable management business. It primarily operates
in France, the EU, Canada, OCED countries and the US.
Business description
The company is headquartered in Paris, France, and it
employs about 13,000 people.The company recorded
revenues of E3,091 million during the fiscal year ended
December 2005, an increase of 14.2% over 2004. The
operating profit of the company was E1,034 million during
fiscal year 2005, an increase of 22.8% over 2004. The net
profit was E695 million in fiscal year 2005, an increase of
42.4% over 2004.

Financial Services-->Retail Banking and Lending


Industry Financial Services-->Retail Banking and Lending
Financial Services-->Wealth Management and Private
Banking

Acquirer 6: Vedanta Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)


105

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

502
PRIVATE EQUITY & OWNERSHIP

Ticker symbol VEDL

Vedanta Limited (Vedanta), formally known as Sesa Sterlite


Limited, is a diversified metal and mining company. The
company, along with its subsidiaries, focuses on the
exploration, mining, processing and exporting of natural
resources; power; and oil and gas business. Its products
portfolio includes lead, zinc, silver, copper, iron ore,
Business description aluminum, commercial power and oil and gas. It also carries
out the production of pig iron and metallurgical coke. The
company also provides support activities, such as shipping
and shipbuilding. It has operations across India, Ireland,
South Africa, Australia, the Netherlands, Namibia, Sri Lanka
and Liberia. Vedanta is a subsidiary of Vedanta Resources
plc, and headquartered in Panaji, Goa, India.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Energy and Utilities-->Utilities-->Power Generation
Metals and Mining
Metals and Mining-->Metal Ore Mining-->Aluminum Ore
Mining
Metals and Mining-->Metal Ore Mining-->Copper Ore and
Nickel Ore Mining
Industry
Metals and Mining-->Metal Ore Mining-->Iron Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining
Metals and Mining-->Primary Metal Manufacturing-->Non-
Ferrous Metals
Construction and Real Estate-->Heavy Construction

Address Sesa Ghor, 20 Edc Complex, Patto

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
City Panaji

State Goa

Country India

Website www.vedantalimited.com

Phone number 91 832 2460601

Acquirer 7: General Electric Capital Corporation

Company type Private

General Electric Capital Corporation is a diversified financial


services company engaged in commercial finance,
consumer finance, equipment management and insurance.
The company operates in three segments GE Commercial
Finance, GE Money, and GE Infrastructure. GE Commercial
Business description Finance offers a range of financial services worldwide. It
specializes in offering loans, leases, and other financial
services to customers, including manufacturers, distributors,
and end-users for various equipment and capital assets.
These assets include industrial-related facilities and
equipment; commercial and residential real estate; vehicles;
106

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

503
PRIVATE EQUITY & OWNERSHIP

corporate aircraft; and equipment used in many industries,


including the construction, manufacturing, transportation,
telecommunications, and healthcare industries. GE Money is
a provider of financial services to consumers and retailers. It
offers a range of financial products, including private-label
credit cards; personal loans; bank cards; auto loans and
leases; mortgages; debt consolidation; home equity loans;
corporate travel and purchasing cards; deposit and other
savings products; small and medium enterprise lending; and
credit insurance on a global basis. GE Infrastructure is a
provider of essential technologies to developed, developing,
and emerging countries, with products and services in
aviation, energy, oil and gas, transportation, and water and
process technologies. GE Infrastructure also provides
aviation financing as well as energy and water investing,
lending, and leasing.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Industry
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Institutional Investment Management

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address 260 Long Ridge Road

City Stamford

State Connecticut

Country United States

Website www.ge.com/en/

Phone number 1 203 357 4000

Acquirer 8: Standard Chartered Bank

Company type Private

Standard Chartered Bank is engaged in the business of


banking and the provision of other financial services.
Business description Standard Chartered Bank is engaged in personal banking,
small and medium enterprise (SME) banking, corporate
banking, and fund management services.

Financial Services
Industry
Financial Services-->Cards-->Card Issuance
Financial Services-->Retail Banking and Lending
107

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

504
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Retail Banking and Lending


Financial Services-->Institutional Investment Management
Financial Services-->Wealth Management and Private
Banking

Address 1 Basinghall Avenue

City London

Country United Kingdom

Website www.standardchartered.com

Phone number 44 20 7885 8888

Acquirer 9: Morgan Stanley

Company type Public

Stock exchange NYSE (New York Stock Exchange)

Ticker symbol MS

Morgan Stanley (or 'the company') is a global financial


services firm. The company provides investment banking,
financial advisory services, wealth management, asset
management, credit cards and other related consumer
Business description
products and services. Morgan Stanley operates in the
Americas, Europe, Asia Pacific, the Middle East and Africa.
It is headquartered in New York City, New York, and
employed 56,218 people as on December 31, 2015.

Construction and Real Estate-->Real Estate Transactions

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services
Financial Services-->Private Equity and Venture Capital
Financial Services-->Institutional Investment Management--
>Hedge Funds
Financial Services-->Institutional Investment Management
Financial Services-->Private Equity and Venture Capital
Financial Services-->Capital Markets and Trading
Financial Services-->Capital Markets and Trading-->Bond
Markets
Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Industry
Financial Services-->Capital Markets and Trading--
>Commodity Markets
Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Capital Markets and Trading-->Money
Markets
Financial Services-->Retail Banking and Lending
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors
108

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

505
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Financial Services Distributors--


>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Private Placements and Financial Sponsors
Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Offshore Financial Services
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Wealth Management and Private
Banking
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Technology and Services
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->General Insurance, Property and
Casualty
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
109

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

506
PRIVATE EQUITY & OWNERSHIP

Address 1585 Broadway, New York

Country United States

Website www.morganstanley.com

Phone number 1 212 761 4000

Acquirer 10: Housing Development Finance Corporation Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500010

Housing Development Finance Corporation Limited (HDFC


or 'the corporation') is a financial conglomerate offering a
range of financial services, including banking, insurance (life
and non-life), asset management, real estate venture capital,
Business description
and education loans. The corporation primarily operates in
India and has a network of 401 outlets, including 116 offices
of the wholly owned distribution company. HDFC is
headquartered in Mumbai, India.

Construction and Real Estate-->Real Estate Transactions


Construction and Real Estate-->Real Estate Transactions
Financial Services-->Private Equity and Venture Capital
Financial Services-->Cards-->Card Issuance
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Cards-->Card Issuance-->Debit Cards
Financial Services-->Retail Banking and Lending

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
110

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

507
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Retail Banking and Lending


Financial Services-->Payments-->New Payment
Technologies
Financial Services-->Payments-->Cash
Financial Services-->Payments-->Cheque
Financial Services-->Payments-->Direct Debit
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending-->Current
Accounts
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Motor Finance
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Personal Loans
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Savings and Investments
Pharmaceuticals and Healthcare-->Medical Devices and

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Address Ramon House, H. T. Parekh Marg

State Maharashtra

Country India

Website www.hdfc.com

Phone number 91 22 6176 6000

Acquirer 11: The Blackstone Group L.P.


Asset management firm, private equity firm,
Industry
investment/merchant bank, others, swaps dealer

The Blackstone Group L.P. (Blackstone or ‘the company’) is


a US-based investment and advisory firm engaged in asset
management and providing capital markets services. The
company's asset management business includes the
management of private equity funds, real estate funds,
Business description
hedge funds solutions, and non-investment grade credit,
secondary funds and other multi-asset class strategies. The
company operates in North America, Europe and Asia
Pacific. It is headquartered in New York City, New York and
employed around 2,060 people as on December 31, 2015.
111

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

508
PRIVATE EQUITY & OWNERSHIP

Address 345 Park Avenue, New York City

Country United States

Website www.blackstone.com

Phone number 1 212 583 5000

Acquirer 12: GS Capital Partners VI Fund

Industry Privateequity

Goldman, Sachs & Co. is the general partner of GS Capital


Business description
Partners VI Fund.

Address 85 Broad Street

City New York

State New York

Country United States

Website www.gs.com

Phone number 1 212 902 1000

Acquirer 13: Newbridge Asia IV, LP

Industry Private equity firm, swaps dealer

Address 301 Commerce Street, Suite 3300

City Fort Worth

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country United States

Website www.newbridgecapital.com

Phone number 817 871 4000

Acquirer 14: WL Ross & Co, LLC


Private equity firm, swaps dealer, quasi-government
Industry
organization, nasd member broker/dealer

Address 1166 Avenue of the Americas

City New York

State New York

Country United States

Website www.wlross.com

Phone number 1 212 8297320

Acquirer 15: Punjab National Bank

Company type Public


112

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

509
PRIVATE EQUITY & OWNERSHIP

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol PNB

Punjab National Bank (PNB or 'the group') offers a range of


services such as corporate and personal banking, industrial
finance, agricultural finance, financing of trade and
international banking services. It also offers credit card and
Business description
debit cards; life and non-life insurance agency services; gold
coins; and asset management services. The group operates
through a network of 6,760 branches with presence in 9
countries. It is headquartered in New Delhi, India.

Industry Financial Services-->Retail Banking and Lending


Financial Services-->Institutional Investment Management

Address 7, Bhikhaiji Cama Place

City NEW DELHI

State Andhra Pradesh

Country India

Website www.pnbindia.in

Phone number 91 11 23719086

Acquirer 16: J.C. Flowers & Co. LLC

Industry Investment company, swaps dealer

J.C. Flowers & Co. LLC (JCF) is a private equity investment


firm based in the US. The company targets investment

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
across all sub-sectors of the financial services industry. It
focuses on investment in banks, insurance and re-insurance
firms, asset management and brokerage houses, credit card
companies, consumer finance businesses, mortgage firms,
Business description
non-banking financial services and stock exchanges. With
investments worth US$15 billion, including co-investment, in
45 portfolio companies across 16 countries, JCF seeks to
invest in North America, Asia, Western Europe and the US.
The company operates an additional office in London, the
UK. JCF is headquartered in New York, the US.

Address 717 Fifth Avenue, 26th Floor

City New York

State New York

Country United States

Website www.jcfco.com

Phone number 1 212 4046800

Advisor information

113

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

510
PRIVATE EQUITY & OWNERSHIP

Target : IFCI Limited

Financial advisors

Ernst & Young AG

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

114

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

511
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Infrastructure Development Finance
Company

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to Infrastructure Development Finance
Company Limited, a specialized infrastructure finance company.

IFCI has also completely stalled the sale process, in which General Electric Capital Corporation; Kotak
Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Natixis;
Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei Bank, Punjab National Bank and
J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL Ross & Co. LLC, GS Capital
Partners VI Fund, Standard Chartered Bank, and Housing Development Finance Corporation, Ltd. were
interested.

Target IFCI Limited

Acquirer IDFC Limited

Deal status Terminated

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Date of termination Dec 19, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35


115

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

512
PRIVATE EQUITY & OWNERSHIP

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer: IDFC Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 532659

IDFC is engaged in financing infrastructure projects in


sectors like energy, telecommunication, transportation,
commercial and industrial projects, including hospitals,
education, tourism and hotels. The group provides project
Business description
financing, investment banking and asset management. The

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
group operates in India, where it is headquartered in Mumbai
and employs around 225 people.

Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance

Address Naman Chambers, C-32 G-Block

Country India

Website www.idfc.com

Phone number 91 22 4222 2000

116

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

513
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Blackstone Group

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to The Blackstone Group L.P., a private
equity firm.

IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; Shinsei Bank, Punjab National Bank and J.C. Flowers & Co.; Natixis; and a consortium of WL
Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development
Finance Corporation, Ltd. were interested.

Target IFCI Limited

Acquirer The Blackstone Group L.P.

Deal status Terminated

Deal category Private equity

Acquired % 26

Date of termination Dec 19, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

Operating profit 12,373.39 284.96

117

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

514
PRIVATE EQUITY & OWNERSHIP

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Shares in issue (absolute) 638,675,762

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer: The Blackstone Group L.P.


Asset management firm, private equity firm,
Industry
investment/merchant bank, others, swaps dealer

The Blackstone Group L.P. (Blackstone or ‘the company’) is


a US-based investment and advisory firm engaged in asset
management and providing capital markets services. The
company's asset management business includes the
management of private equity funds, real estate funds,
Business description
hedge funds solutions, and non-investment grade credit,
secondary funds and other multi-asset class strategies. The
company operates in North America, Europe and Asia
Pacific. It is headquartered in New York City, New York and
employed around 2,060 people as on December 31, 2015.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address 345 Park Avenue, New York City

Country United States

Website www.blackstone.com

Phone number 1 212 583 5000

118

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

515
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Standard Chartered Bank consortium

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to the consortium of WL Ross & Co.
LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development Finance
Corporation, Ltd.

IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; Shinsei Bank, Punjab National Bank, and J.C. Flowers & Co.; The Blackstone Group L.P.;
and Natixis were interested.

Target IFCI Limited

Acquirer 1 Standard Chartered Bank

Acquirer 2 Housing Development Finance Corporation Limited

Acquirer 3 GS Capital Partners VI Fund

Acquirer 4 WL Ross & Co, LLC

Deal status Terminated

Deal category Private equity

Acquired % 26

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of termination Dec 19, 2007

Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)


119

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

516
PRIVATE EQUITY & OWNERSHIP

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Shares in issue (absolute) 638,675,762

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer 1: Standard Chartered Bank

Company type Private

Standard Chartered Bank is engaged in the business of


banking and the provision of other financial services.
Business description Standard Chartered Bank is engaged in personal banking,

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
small and medium enterprise (SME) banking, corporate
banking, and fund management services.

Financial Services
Financial Services-->Cards-->Card Issuance
Financial Services-->Retail Banking and Lending
Industry
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management
Financial Services-->Wealth Management and Private
Banking

Address 1 Basinghall Avenue

City London

Country United Kingdom

Website www.standardchartered.com

Phone number 44 20 7885 8888

Acquirer 2: Housing Development Finance Corporation Limited

Company type Public

Stock exchange BOM (Bombay Stock Exchange)


120

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

517
PRIVATE EQUITY & OWNERSHIP

Ticker symbol 500010

Housing Development Finance Corporation Limited (HDFC


or 'the corporation') is a financial conglomerate offering a
range of financial services, including banking, insurance (life
and non-life), asset management, real estate venture capital,
Business description
and education loans. The corporation primarily operates in
India and has a network of 401 outlets, including 116 offices
of the wholly owned distribution company. HDFC is
headquartered in Mumbai, India.

Construction and Real Estate-->Real Estate Transactions


Construction and Real Estate-->Real Estate Transactions
Financial Services-->Private Equity and Venture Capital
Financial Services-->Cards-->Card Issuance
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Cards-->Card Issuance-->Debit Cards
Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Industry Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->Retail Banking and Lending
Financial Services-->Payments-->New Payment
Technologies
Financial Services-->Payments-->Cash
Financial Services-->Payments-->Cheque
Financial Services-->Payments-->Direct Debit
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending-->Current
Accounts
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
121

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

518
PRIVATE EQUITY & OWNERSHIP

>Consumer Lending-->Motor Finance


Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Personal Loans
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Savings and Investments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Address Ramon House, H. T. Parekh Marg

State Maharashtra

Country India

Website www.hdfc.com

Phone number 91 22 6176 6000

Acquirer 3: GS Capital Partners VI Fund

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry Privateequity

Goldman, Sachs & Co. is the general partner of GS Capital


Business description
Partners VI Fund.

Address 85 Broad Street

City New York

State New York

Country United States

Website www.gs.com

Phone number 1 212 902 1000

Acquirer 4: WL Ross & Co, LLC


Private equity firm, swaps dealer, quasi-government
Industry
organization, nasd member broker/dealer

Address 1166 Avenue of the Americas

City New York

State New York

Country United States


122

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

519
PRIVATE EQUITY & OWNERSHIP

Website www.wlross.com

Phone number 1 212 8297320

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

123

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

520
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to General Electric Capital

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to General Electric Capital Corporation,
a financial services company.

IFCI has also completely stalled its stake sale process, in which Kotak Mahindra Bank, Ltd.; a consortium
of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Infrastructure Development Finance
Company, Ltd.; Natixis; Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei Bank,
Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL Ross
& Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development Finance
Corporation, Ltd. were interested.

Target IFCI Limited

Acquirer General Electric Capital Corporation

Deal status Terminated

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Date of termination Dec 19, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

124

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

521
PRIVATE EQUITY & OWNERSHIP

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 931,807.35 21,459.50

Earnings per share (absolute) 13.68 0.32

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer: General Electric Capital Corporation

Company type Private

General Electric Capital Corporation is a diversified financial


services company engaged in commercial finance,
consumer finance, equipment management and insurance.
The company operates in three segments GE Commercial
Finance, GE Money, and GE Infrastructure. GE Commercial
Finance offers a range of financial services worldwide. It
specializes in offering loans, leases, and other financial
services to customers, including manufacturers, distributors,
and end-users for various equipment and capital assets.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
These assets include industrial-related facilities and
equipment; commercial and residential real estate; vehicles;
corporate aircraft; and equipment used in many industries,
including the construction, manufacturing, transportation,
Business description telecommunications, and healthcare industries. GE Money is
a provider of financial services to consumers and retailers. It
offers a range of financial products, including private-label
credit cards; personal loans; bank cards; auto loans and
leases; mortgages; debt consolidation; home equity loans;
corporate travel and purchasing cards; deposit and other
savings products; small and medium enterprise lending; and
credit insurance on a global basis. GE Infrastructure is a
provider of essential technologies to developed, developing,
and emerging countries, with products and services in
aviation, energy, oil and gas, transportation, and water and
process technologies. GE Infrastructure also provides
aviation financing as well as energy and water investing,
lending, and leasing.

Financial Services-->Cards-->Card Issuance


Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->General Insurance, Property and
125

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

522
PRIVATE EQUITY & OWNERSHIP

Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Institutional Investment Management

Address 260 Long Ridge Road

City Stamford

State Connecticut

Country United States

Website www.ge.com/en/

Phone number 1 203 357 4000

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

126

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

523
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Kotak Mahindra Bank

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to Kotak Mahindra Bank Limited, a
financial conglomerate.

IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation; a
consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Infrastructure Development
Finance Company, Ltd.; Natixis; Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei
Bank, Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL
Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development
Finance Corporation, Ltd. were interested.

Target IFCI Limited

Acquirer Kotak Mahindra Bank Ltd.

Deal status Terminated

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Date of termination Dec 19, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

127

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

524
PRIVATE EQUITY & OWNERSHIP

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer: Kotak Mahindra Bank Ltd.

Company type Public

Stock exchange BOM (Bombay Stock Exchange)

Ticker symbol 500247

Kotak Mahindra Bank, a part of the Kotak Mahindra Group,


is engaged in providing a range of banking and financial
services. The bank offers banking and savings, loans and
Business description borrowings, investments and insurance, and corporate and
institutional services. Kotak Mahindra Bank operates in

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
India, the UK, the US, Mauritius, the UAE and Singapore. It
is headquartered in Mumbai, India.

Industry Financial Services


Financial Services-->Retail Banking and Lending

Address 27BKC, C 27 G Block

Country India

Website www.kotak.com

Phone number 91 22 6166 0000

128

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

525
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Sterlite Industries and Morgan Stanley

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to a consortium of Sterlite Industries
(India), Ltd., a copper producer, and Morgan Stanley & Co, a financial services company.

General Electric Capital Corporation; Kotak Mahindra Bank, Ltd.; Infrastructure Development Finance
Company Limited; Natixis; Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei Bank,
Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL Ross
& Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development Finance
Corporation, Ltd. were also in the race to acquire the stake in the company.

Target IFCI Limited

Acquirer 1 Morgan Stanley

Acquirer 2 Vedanta Limited

Deal status Terminated

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Date of termination Dec 19, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35


129

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

526
PRIVATE EQUITY & OWNERSHIP

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer 1: Morgan Stanley

Company type Public

Stock exchange NYSE (New York Stock Exchange)

Ticker symbol MS

Morgan Stanley (or 'the company') is a global financial


services firm. The company provides investment banking,
financial advisory services, wealth management, asset
management, credit cards and other related consumer
Business description
products and services. Morgan Stanley operates in the

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Americas, Europe, Asia Pacific, the Middle East and Africa.
It is headquartered in New York City, New York, and
employed 56,218 people as on December 31, 2015.

Construction and Real Estate-->Real Estate Transactions


Financial Services
Financial Services-->Private Equity and Venture Capital
Financial Services-->Institutional Investment Management--
>Hedge Funds
Financial Services-->Institutional Investment Management
Financial Services-->Private Equity and Venture Capital
Financial Services-->Capital Markets and Trading
Financial Services-->Capital Markets and Trading-->Bond
Markets
Financial Services-->Capital Markets and Trading--
Industry >Brokerage
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Financial Services-->Capital Markets and Trading--
>Commodity Markets
Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
130

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

527
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Capital Markets and Trading-->Money


Markets
Financial Services-->Retail Banking and Lending
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Private Placements and Financial Sponsors
Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Offshore Financial Services
Financial Services-->Institutional Investment Management
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Wealth Management and Private
Banking
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Technology and Services
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->General Insurance, Property and
Casualty

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
131

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

528
PRIVATE EQUITY & OWNERSHIP

Diagnostics-->Surgical and Medical Equipment


Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging

Address 1585 Broadway, New York

Country United States

Website www.morganstanley.com

Phone number 1 212 761 4000

Acquirer 2: Vedanta Limited

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol VEDL

Vedanta Limited (Vedanta), formally known as Sesa Sterlite


Limited, is a diversified metal and mining company. The
company, along with its subsidiaries, focuses on the
exploration, mining, processing and exporting of natural
resources; power; and oil and gas business. Its products
portfolio includes lead, zinc, silver, copper, iron ore,
Business description aluminum, commercial power and oil and gas. It also carries
out the production of pig iron and metallurgical coke. The
company also provides support activities, such as shipping
and shipbuilding. It has operations across India, Ireland,
South Africa, Australia, the Netherlands, Namibia, Sri Lanka

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
and Liberia. Vedanta is a subsidiary of Vedanta Resources
plc, and headquartered in Panaji, Goa, India.

Energy and Utilities-->Natural Resources-->Upstream


Energy-->Equipment and Services
Energy and Utilities-->Utilities-->Power Generation
Metals and Mining
Metals and Mining-->Metal Ore Mining-->Aluminum Ore
Mining
Metals and Mining-->Metal Ore Mining-->Copper Ore and
Nickel Ore Mining
Industry
Metals and Mining-->Metal Ore Mining-->Iron Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining
Metals and Mining-->Primary Metal Manufacturing-->Non-
Ferrous Metals
Construction and Real Estate-->Heavy Construction

Address Sesa Ghor, 20 Edc Complex, Patto

City Panaji

State Goa

Country India
132

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

529
PRIVATE EQUITY & OWNERSHIP

Website www.vedantalimited.com

Phone number 91 832 2460601

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

133

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

530
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Natixis

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to Natixis, a provider of banking and
related services.

IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; Shinsei Bank, Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and
a consortium of WL Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and
Housing Development Finance Corporation, Ltd. were interested.

Target IFCI Limited

Acquirer Natexis Banques Populaires

Deal status Terminated

Deal category Acquisition

Deal sub-category Minority acquisition

Acquired % 26

Date of termination Dec 19, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

134

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

531
PRIVATE EQUITY & OWNERSHIP

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer: Natexis Banques Populaires

Company type Private

Natexis Banques Populaires is the financing, investment


banking and services arm of Banque Populaire, a leading
French financial services group. The company offers
services including traditional banking, corporate and
institutional banking, private equity, wealth management and
asset management. It also undertakes services business
and receivable management business. It primarily operates
in France, the EU, Canada, OCED countries and the US.
Business description
The company is headquartered in Paris, France, and it

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
employs about 13,000 people.The company recorded
revenues of E3,091 million during the fiscal year ended
December 2005, an increase of 14.2% over 2004. The
operating profit of the company was E1,034 million during
fiscal year 2005, an increase of 22.8% over 2004. The net
profit was E695 million in fiscal year 2005, an increase of
42.4% over 2004.

Financial Services-->Retail Banking and Lending


Industry Financial Services-->Retail Banking and Lending
Financial Services-->Wealth Management and Private
Banking

135

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

532
PRIVATE EQUITY & OWNERSHIP

Deal Report: Newbridge withdraws bid to acquire 26% stake in IFCI

Deal in brief

Newbridge Asia IV, L.P., a buy-out fund, has withdrawn its bid to acquire a 26% stake in IFCI Limited, a
provider of long-term finance to the industrial sector. The bid has been withdrawn due to the changes in
circumstances.

The other bidders interested in the stake include: General Electric Capital Corporation; Kotak Mahindra
Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Infrastructure
Development Finance Company, Ltd.; The Blackstone Group L.P; Cargill Financial Services Corporation;
a consortium of Shinsei Bank, Ltd., Punjab National Bank and J.C. Flowers & Co. LLC; Natixis; and a
consortium of WL Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing
Development Finance Corporation, Ltd.

Target IFCI Limited

Acquirer Newbridge Asia IV, LP

Deal status Terminated

Deal category Private equity

Acquired % 26

Date of termination Oct 02, 2007

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

Operating profit 12,373.39 284.96

136

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

533
PRIVATE EQUITY & OWNERSHIP

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 27,779.92 639.77

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 13.68 0.32

Shares in issue (absolute) 638,675,762

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer: Newbridge Asia IV, LP

Industry Private equity firm, swaps dealer

Address 301 Commerce Street, Suite 3300

City Fort Worth

Country United States

Website www.newbridgecapital.com

Phone number 817 871 4000

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

137

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

534
PRIVATE EQUITY & OWNERSHIP

Deal Report: IFCI terminates 26% stake sale to Shinsei Bank, Punjab National Bank and
J.C. Flowers

Deal in brief

IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to the consortium of Shinsei Bank,
Punjab National Bank and J.C. Flowers & Co.

IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; The Blackstone Group L.P.; Natixis; and a consortium of WL Ross & Co. LLC, GS Capital
Partners VI Fund, Standard Chartered Bank, and Housing Development Finance Corporation, Ltd. were
interested.

Target IFCI Limited

Acquirer 1 Shinsei Bank, Limited

Acquirer 2 Punjab National Bank

Acquirer 3 J.C. Flowers & Co. LLC

Deal status Terminated

Deal category Private equity

Acquired % 26

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of announcement Sep 17, 2007

Date of termination Dec 19, 2007

Deal financials

Valuation multiples (IFCI Limited)

EV/Revenues 6.64

EV/Operating profit 10.98

EV/EBITDA 10.91

EV/Total assets 0.91

Company information: Target and acquirer

IFCI Limited Financial information – (Fiscal year 31-Mar-2007)


138

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

535
PRIVATE EQUITY & OWNERSHIP

Financial parameters Indian Rupee (INR) (m) ($m)

Revenues 20,466.80 471.35

Operating profit 12,373.39 284.96

EBITDA 12,463.62 287.04

Post tax profit 8,737.09 201.22

Net assets 1,206,249.40 27,779.90

Market capitalization 21,459.51 494.21

Earnings per share (absolute) 0.32 13.68

Shares in issue (absolute) 638,675,762

Key ratios

Operating margin (%) 60.46

Price earnings ratio 2.46

Net assets-share ratio 43.50

Acquirer 1: Shinsei Bank, Limited

Company type Public

Stock exchange TYO (Tokyo Stock Exchange)

Ticker symbol 8303

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Shinsei Bank, Limited (Shinsei Bank) is a financial institution.
The bank offers commercial banking and various financial
services. Its financial products and services include deposit
products, corporate loans, consumer and business loans,
credit cards, insurance services, credit guarantees, leasing
services, mergers and acquisition services, securities trading
services, real estate services, foreign exchange and
Business description
derivatives services. It also provides financing, leasing and
rentals, and alliance services to small and medium
businesses. The bank provides various services related to
foreign exchange, derivatives, equity trading, and other
capital markets transactions. The bank operates through a
network of offices in Japan. Shinsei Bank is headquartered
in Tokyo, Japan.

Financial Services
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Corporate and Investment Banking--
Industry >Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A) 139

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

536
PRIVATE EQUITY & OWNERSHIP

Financial Services-->Corporate and Investment Banking


Financial Services-->Offshore Financial Services
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Wealth Management and Private
Banking
Industrial Goods and Machinery
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Motor Finance
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Biofuels
Financial Services-->General Insurance, Property and
Casualty

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Savings and Investments
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels

Nihonbashi Muromachi Nomura Bldg., 2-4-3, Nihonbashi


Address
Muro-machi

City Tokyo

State Tokyo

Country Japan

Website www.shinseibank.com

Phone number 81 3 59547530

Acquirer 2: Punjab National Bank

Company type Public

Stock exchange NSE (National Stock Exchange of India)

Ticker symbol PNB

Punjab National Bank (PNB or 'the group') offers a range of


Business description
services such as corporate and personal banking, industrial
140

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

537
PRIVATE EQUITY & OWNERSHIP

finance, agricultural finance, financing of trade and


international banking services. It also offers credit card and
debit cards; life and non-life insurance agency services; gold
coins; and asset management services. The group operates
through a network of 6,760 branches with presence in 9
countries. It is headquartered in New Delhi, India.

Industry Financial Services-->Retail Banking and Lending


Financial Services-->Institutional Investment Management

Address 7, Bhikhaiji Cama Place

City NEW DELHI

State Andhra Pradesh

Country India

Website www.pnbindia.in

Phone number 91 11 23719086

Acquirer 3: J.C. Flowers & Co. LLC

Industry Investment company, swaps dealer

J.C. Flowers & Co. LLC (JCF) is a private equity investment


firm based in the US. The company targets investment
across all sub-sectors of the financial services industry. It
focuses on investment in banks, insurance and re-insurance
firms, asset management and brokerage houses, credit card
companies, consumer finance businesses, mortgage firms,
Business description
non-banking financial services and stock exchanges. With
investments worth US$15 billion, including co-investment, in
45 portfolio companies across 16 countries, JCF seeks to

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
invest in North America, Asia, Western Europe and the US.
The company operates an additional office in London, the
UK. JCF is headquartered in New York, the US.

Address 717 Fifth Avenue, 26th Floor

City New York

State New York

Country United States

Website www.jcfco.com

Phone number 1 212 4046800

141

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

538
APPENDIX

APPENDIX
Contact Us

We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com

About MarketLine Financial Deals Database

• Financial Deals is the most extensive Deals database currently available in the market

• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
– partnership deal

• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms

• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.

• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.

• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.

142

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

539
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

143

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

540
APPENDIX

Deal Definition and Methodology

Deal type definition

Merger

A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:

 All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.

 Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.

 The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.

 The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.

 No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquisition

Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:

 Minority acquisition: The acquisition of less than 50% equity stake in the target

 Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target

 100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target

 Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity

Private equity

Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:

 Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company

 Secondary buyout: PE firm or a group of PE firms acquiring a company from a PE firm


144

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

541
APPENDIX
 Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds

 Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.

 Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team

 Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed

 Exit: PE firm selling its stake in a portfolio company

Private placement

A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.

Venture financing

Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:

 Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
business concept

 Start-up: Financing provided to companies for developing their product/service and to


purchase the necessary assets for their production/operation

 Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products

 Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities

 Exit: This node is assigned when a venture capital is selling its stake in a portfolio company

Initial Public Offering

 Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:

 Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO

 Pricing: When the company fixes the issue price for its offering

145

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

542
APPENDIX
 Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering

 Withdrawn: When the company withdraws its IPO

 Postponed: When the company postpones its IPO

Partnership

A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:

 Joint Venture (JV): Two or more companies forming a new entity to undertake an activity

 Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.

 Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service

 Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.

Deal status details

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Deals captures deal status according to following stages:

 Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
 Announced: Either party involved in the transaction announces the deal
 Completed: Involved parties complete the transaction
 Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
 Dead rumor: Rumor denied by either of the parties involved in the transaction

Deal value

Deal value is the consideration paid by the acquirer for acquiring the target.

Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.

All deals values which are mentioned as approximate consideration are tagged as estimated values.

Deal value criteria for filtering deals


146

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

543
APPENDIX

For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.

Deal payment details


Deal payment is captured in the following fields:

Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:

 Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer

 Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer

 Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer

 Quantity type: It indicates the consideration by payment mode in terms of value and
percentage

% acquired: % acquired indicates the stock acquired in percentage terms

Share price paid: Price per share offered by the acquirer to the target

Debt-related fields
Below is the list of fields captured:

Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Lead: Represents the lead debt provide
 Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers

Debt amount: Amount of debt raised by the acquirer to finance the acquisition

Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:

 Bank facilities: These are general loans provided by banks to companies.

 Senior: Debt that has priority for repayment in liquidation.

 Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.

 Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.

 Other debt: Any other debt facility other than the above mentioned debt categories.

147

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

544
APPENDIX

Securities issued to finance deal


Below is a list of category and sub-category of securities issued by the acquirer, captured in FD:

Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:

 Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder

 Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio

 Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date

 Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)

 Placing: General term to describe the process of raising money via the issue of new shares

 Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public

 Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period

 Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
shareholdings

 Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).

Financial and operational information

Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:

Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.

No. of employees: Number of employees at the fiscal year end


Local currency: The currency in which the company is reporting its financial statements

148

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

545
APPENDIX

Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers

Revenue (banking): This value is sum of interest income and non interest income

Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.

EBITDA: Earnings before interest, taxes, depreciation and amortization

Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax

Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.

Enterprise value: Enterprise value is calculated by adding a company’s market capitalization,


preferred stock, minority interest, and outstanding debt together and then subtracting out the cash
and cash equivalents found on the balance sheet as on the fiscal year end

Shares issued: Number of shares the company has issued out of its authorized capital

Market capitalization: Market capitalization is calculated by taking the number of outstanding


shares of common stock multiplied by the market price-per-share as on fiscal year end

Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth

Net assets-share ratio: It is defined as net assets divided by number of shares outstanding

Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares

Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.

Deal multiples

Financial Deals captures the following four valuation multiples:


 EV/revenues
 EV/EBIT
 EV/EBITDA
 EV/total assets

149

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

546
APPENDIX

Advisor information

Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:

Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.

Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:

 Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts

 Accounting: Financial advisor who looks into the accounting matters for a deal

 Tax: Financial advisor who looks into the tax matters for a deal

 Corporate Finance: Financial advisor who looks into the financial decisions of a corporation

 Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue

 Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
 Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted

 Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other

Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities

Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders

150

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

547
APPENDIX

About MarketLine

In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.

At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.

Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.

Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.

MarketLine is a wholly owned subsidiary of Informa.

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

151

© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED

548
APPENDIX

IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018

MARKETLINE | 119 FARRINGDON ROAD | LONDON,


UNITED KINGDOM, EC1R 3DA
152
T: + 44 161 238 4040| F: + 44 870 134 4371
© MARKETLINE THIS PROFILE IS A LICENSED PRODUCT AND IS NOT TO BE PHOTOCOPIED
E: REACHUS@MARKETLINE.COM
549
India - Agriculture Sector update

27 August 2018 Institutional Equities

Highlights from NABARD’s 3-yearly survey


DD MMM YYYY
NABARD released its inaugural All India Financial Inclusion Figure 1: Average monthly household income, with breakdown by source 
Survey (NAFIS) earlier this month, offering interesting insights Source of Income  Agricultural HH Non‐Agricultural HH All HHs 
into financial aspects of agricultural and rural life. We highlight Cultivation  3,140 (35%) NA 1,494 (19%) 
key takeaways, which include: high inequality in rural incomes, Livestock Rearing  711 (8%) NA 338 (4%) 
low ownership of agricultural assets, relatively low dependence Other Enterprises  489 (6%) 851 (12%) 679 (8%) 
on agricultural income, small land-holdings and a strong
Wage Labour  3,025 (34%) 3,940 (54%) 3,504 (43%) 
correlation between larger land-holdings and higher
incomes/access to loans, and negligible coverage of crop Govt./ Pvt. Service  1,444 (16%) 2,326 (32%) 1,906 (24%) 
insurance. All in all, the report offers useful (and sometimes Other Sources  122 (1%) 152 (2 %) 138 (2%) 
surprising) data around notions of rural life. All Sources Combined  8,931 (100%) 7,269 (100%) 8,059 (100%) 
Source: NABARD, IIFL Research; Note: HH = Household 
Survey methodology: The sample size of the survey was 40,327 rural IIFL comment: Income from cultivation contributes only 35% of total income for agricultural HH 
households (with rural defined as centres with a population <50,000,
i.e., Tier III-VI centres) selected through multi-stage stratified random Figure 2: Proportion of households owning high‐value agricultural assets (%) 
sampling from 29 states, 245 districts and 2,016 villages/centres. The
sample size is comparable with the NSSO’s decadal Situation (%)
Assessment Survey (sample = 36,000 HHs). Information is collected 6 5.2
through a structured questionnaire. The reference year is 2016-17. 5
4
Livelihood aspects: 48% of households are agricultural and possess 3
an average land-holding of 1.1 ha. Their average monthly income is 1.8 1.6
2
Rs8,931, of which only 35% comes from cultivation. Only 5.2% 0.8
reported owning tractors for agricultural use, while penetration of drip 1 0.2
irrigation is only 1%. In contrast, penetration of cell phones, TVs and 2- 0

Sprinkler

Harvester
Drip irrigation
Tractor

Power tiller
wheelers is 89%, 56% and 38%, respectively. 80% of households earn

system
<Rs11,000 per month, whereas income rises dramatically for the top
20%, with the 99th percentile at Rs48,833, indicating wide inequalities.

Financial inclusion aspects: 88% of households reported having a


Source: NABARD, IIFL Research 
bank account, and 55% of agricultural households reporting saving
during the year, though mostly at home. Only 10% reported any IIFL comment: Penetration rates are extremely low in drip & sprinkler irrigation systems 
investment, and that too heavily dependent on borrowing. 47% of all
rural households were indebted, with average outstanding of
Rs104,602. Access to credit improves with rising incomes, particularly
from institutional sources. Crop insurance penetration is only 1%.

Abhijit R. Akella, CFA | abhijit.akella@iiflcap.com Mohit Surana | mohit.surana@iiflcap.com |


91 22 4646 4654 91 22 4646 4657
550
Institutional Equities India - Agriculture

About the survey Administration


NABARD conducted the survey through the Academy of Management
Studies (AMS) and under the guidance of an Advisory Committee
The National Bank for Agriculture and Rural Development (NABARD), in consisting of representatives of the RBI, NSSO, ISI, Kolkata, academia
August 2018, released the results of its inaugural NABARD All India and senior officers of NABARD under the overall guidance of the top
Rural Financial Inclusion Survey (NAFIS). The intention behind the management.
national-level survey, which NABARD proposes to replicate every three
years, is to “offer a comprehensive overview of the status of rural Figure 4: Distribution of agricultural households, by size‐class of land possessed 
population in terms of sources of livelihoods, economic status of
households including income, consumption expenditure, and household
assets.” The need for such a survey arose because, according to 1.01‐2.0 ha
NABARD, “existing large sample surveys in this space, conducted by 20%
NSSO such as Situation Assessment Survey (SAS) and All India Debt
Investment survey (AIDIS), are done once in a decade and cover 0.41‐1.0 ha 2.01 ha & 
limited aspects ─ either livelihood related or financial, and not both.” 30% above
13%
Figure 3: Highlights of NAFIS 2016‐17 
Survey coverage 
<0.01 ha
29 states, 245 districts
6%
Tier‐3 to Tier‐6 centres as per RBI classification 
40,327 households  0.01‐0.4 ha
1,87,518 population  31%
Source: NABARD, IIFL Research 
Source: NABARD, IIFL Research; Note: Ha = hectare 
IIFL comment: Land holding sizes remain considerably low; 2/3rds of agricultural HHs possess <1 ha 
Sample
The sample size of the survey is 40,327 rural Households (HHs) selected Figure 5: Breakdown of households surveyed between agricultural and non‐agricultural 
through multi-stage stratified random sampling from 29 states, 245
Type of household  % of total 
districts and 2,016 villages/centres. Districts within each state are
Agricultural households  48% 
stratified on bank branch density. Villages/centres are stratified into
three: i) those having a population of less than 250, ii) villages having a Non‐agricultural households  52% 
bank branch within their boundaries and iii) villages not having a bank Source: NABARD, IIFL Research 
branch within their boundaries. Here, rural area is defined as a centre Note: Agricultural HH is defined as one deriving value of produce of more than Rs5,000 in the 
with population less than 50,000 (Tier III to Tier VI centres), in tune previous one year, from agriculture and allied activities. All other HHs are classified as Non‐Ag HH. 
with NABARD’s mandated jurisdiction. Hence, rural centres (up to IIFL comment: Less than half of rural HHs are categorised as agricultural HHs. 
population of 9,999) and some semi-urban centres (up to 49,999
population) come within the purview of the sample. The sample size is
comparable with that of SAS by NSSO (i.e., 36,000). Both agricultural
and non-agricultural households are included in the sample. Information
on all members of the household is collected through a detailed,
structured questionnaire. The reference year is 2016-17.

abh ijit . akella@iif lcap.com 2


551
Institutional Equities India - Agriculture

Asset ownership Figure 7: Proportion of households reporting ownership of livestock assets (in %) 


Type of Household  Milch Animals Draught Animals Small Ruminants  Poultry Birds 
Agricultural HH  50.7 10.8 13.6  8.8 
Figure 6: Average land owned by households (state‐wise, in ha) 
States  Agricultural HH  Non‐Agricultural HH All HHs Non‐Agricultural HH 5.7 1.9 4.1  3.1 
Andhra Pradesh  1.06  0.17 0.47 All HHs  27.1 6.1 8.6  5.8 
Arunachal Pradesh  1.46  0.37 1.11 Source: NABARD, IIFL Research 
Assam  0.98  0.27 0.61 IIFL comment: Milch animals = cows/buffaloes; draught animals = bullocks/animals used to pull a 
Bihar  0.40  0.08 0.23 load; small ruminants = goats/sheep 
Chhattisgarh  1.23  0.16 0.75
Goa  1.32  0.10 0.13
Gujarat  1.05  0.09 0.65 Figure 8:Proportion of HHs reporting ownership of various consumer durables (in %) 
Haryana  1.57  0.11 0.60 Type of HH  TV Radio Computer AC Car Scooter/  Landline  Mobile 
Himachal Pradesh  0.47  0.15 0.37 Motorcycle
Jammu  0.44  0.23 0.39 Agricultural           55.7 3.9 1.8 1.9 2.9 37.9 0.5  89.1 
Jharkhand  0.67  0.14 0.41
Non‐Agricultural  59.4 5.4 2.9 2.2 2.3 31.3 0.9  85.3 
Karnataka  1.19  0.28 0.81
Kerala  0.74  0.06 0.15 All   57.6 4.7 2.4 2.1 2.6 34.4 0.7  87.0 
Madhya Pradesh  1.72  0.10 1.03 Source: NABARD, IIFL Research 
Maharashtra  1.67  0.13 0.69 IIFL comment: Penetration of TVs/two‐wheelers is way higher than penetration of drip irrigation 
Manipur  1.02  0.34 0.73 systems 
Meghalaya  0.79  0.07 0.64
Mizoram  1.36  0.57 1.18
Nagaland  2.06  0.46 1.16
Odisha  0.52  0.12 0.35
Punjab  1.04  0.16 0.53
Rajasthan  1.90  0.30 1.32
Sikkim  0.43  0.21 0.34
Tamil Nadu  1.05  0.08 0.20
Telangana  1.01  0.20 0.58
Tripura  0.42  0.13 0.25
Uttar Pradesh  0.69  0.12 0.47
Uttarakhand  0.63  0.10 0.32
West Bengal  0.37  0.07 0.17
All India  1.00  0.13 0.54
Source: NABARD, IIFL Research 
IIFL comment: Low land holdings are a common theme across India 

abh ijit . akella@iif lcap.com 3


552
Institutional Equities India - Agriculture

Sources of income Figure 10: Average monthly income of agriculture households, state‐wise (Rs/month) 


Rs/month
Figure 9: Percentiles (Rs) of average household monthly income  West Bengal 7,756
Uttarakhand 10,855
Uttar Pradesh 6,668
Tripura 7,592
48,833 Telangana 8,951
Tamil Nadu 9,775
Sikkim 8,603
Rajasthan 9,013
Punjab 23,133
Odisha 7,731
17,000 Nagaland 9,950
8,333 11,000 Mizoram 9,931
6,667 Meghalaya 10,039
2,500 3,558 4,500 5,500
1,000 Manipur 9,861
0 Maharashtra 10,268
0 10 20 30 40 50 60 70 80 90 100 Madhya Pradesh 7,919
Kerala 16,927
Source: NABARD, IIFL Research  Karnataka 10,603
IIFL comment: Sharp disparity in income between the top 5% of rural HHs and the remaining 95%.  Jharkhand 6,991
Fig 9  indicates that 90% of rural HHs earn < Rs17,000 per month. The top 5%, on the other hand,  Jammu 9,355
earn between Rs23,000 and Rs49,000  Himachal Pradesh 11,828
Haryana 18,496
Gujarat 11,899
Goa 10,687
Chhattisgarh 8,580
Bihar 7,175
Assam 9,878
Arunachal Pradesh 9,072
Andhra Pradesh 6,920
INDIA 8,931
0 5000 10000 15000 20000 25000

Source: NABARD, IIFL Research 
IIFL comment: Punjab, Haryana, Kerala rank at the top 

abh ijit . akella@iif lcap.com 4


553
Institutional Equities India - Agriculture

Figure 11: Average monthly income of agricultural households from various sources, by size of land possessed (Rs per month per household)


Size of land holding‐>  <0.01 ha  0.01‐0.4 ha  0.41‐1 ha  1.01‐2 ha  >2 ha 
Sources of Income  Amount  (Share %)  Amount (Share %) Amount  (Share %) Amount (Share %) Amount (Share %) 
Cultivation  566  7 1,488 22.4 2,501  30.6 4,485 44.9 7,572 51.6 
Livestock Rearing  1,345  16.5 517 7.8 624  7.6 763 7.6 978 6.7 
Other Enterprises  251  3.1 384 5.8 455  5.6 416 4.2 1,030 7 
Wage Labour  3,508  43.1 2,932 44.1 3,044  37.3 2,777 27.8 3,340 22.7 
Govt/ Pvt Service  2,192  26.9 1,281 19.3 1,398  17.1 1,419 14.2 1,612 11 
Other Sources  274  3.4 48 0.7 148  1.8 130 1.3 150 1 
Total Income  8,136  100 6,650 100 8,171  100 9,990 100 14,682 100 
Source: NABARD, IIFL Research 
IIFL comment: Even for households that cultivate >2 ha of land, income from cultivation contributes only around half of total income. 

abh ijit . akella@iif lcap.com 5


554
Institutional Equities India - Agriculture

Figure 12: Distribution of households by number of sources of income (%)  Figure 15: Non‐agricultural occupations: people engaged and income earned therefrom 


Single  Two  Three  Four or More  Estimated  Estimated  Average 
Average no. of 
Category  Source  Sources Sources Sources Total Number of  Number of  Monthly 
members 
Agricultural Households  12.7  49.7 28.7 8.9 100 Occupations  Households  Persons  Income per 
Engaged per 
Non‐Agricultural Households 79.4  17.4 3.2 0 100 Engaged  Engaged  Household 
household
(million) (million)  (Rupees) 
All Households  46.6  33.3 15.7 4.4 100
Source: NABARD, IIFL Research 
Trading, Shopkeeping, etc.    20.4 1.2 24.94  4,988 
IIFL comment: Agricultural HHs typically rely on two or more sources of income  Selling NTFP/ Forest 
0.77 1.3 1.04  2,933 
Produce                              
Figure 13:  Monthly income of HHs with single/more sources of income (Rs)  Self Employed Profession 
3.42 1.3 4.31  5,372 
Single  Two  Three  Four or More  (doctor, lawyer, etc.) 
Category  Source  Sources Sources Sources Overall Running a Service 
Agricultural Households  5,324  7,850 11,385 14,958 8,931 Microenterprise (up to  0.23 1.7 0.4  11,715 
Non‐Agricultural Households 7,375  10,287 8,339 11,915 7,269 Rs1million) 
All Households  7,102  8,501 11,071 14,942 8,059 Running a Manufacturing 
Source: NABARD, IIFL Research  Microenterprise (up to  0.17 1.0 0.17  11,752 
IIFL comment: The variation in income between agricultural HHs is much wider than the variation  Rs2.5million) 
between non‐agricultural HHs  Running a Service 
Microenterprise (above  1.64 1.4 2.26  6,270 
Figure 14:Exposure to distress (in the last 10 years) and % of HHs that borrowed to cope  Rs1million) 
% HHs that faced  % HHs that  Running a Manufacturing 
Distress Events 
event borrowed Microenterprise (above  2.18 1.5 3.25  2,927 
Crop Failure due to excessive, very low or  Rs2.5million) 
53.8 63.4%
untimely rainfall  MNREGA Works  35.22 1.5 52.83  1,236 
Sudden decline in productivity of crops due to 
27.6 62.6% Agricultural Labour Works  66.51 1.5 98.15  3,526 
pest infestation, etc. 
Non‐Agricultural Skilled 
Sudden fall in market prices of crops  18.2 65.2% 36.22 1.3 46.03  5,082 
Labour Works 
Loss of livestock due to flood, diseases, etc.  9.8 65.4%
Non‐Agricultural Unskilled 
Source: NABARD, IIFL Research  56.83 1.4 80  4,921 
Labour Works 
IIFL comment: Weather affected more than half of surveyed HHs in the past decade. Two‐third of 
the HHs borrowed money to cope with financial distress  Govt. Private Jobs  38.99 1.2 48.59  10,347 
Source: NABARD, IIFL Research 
IIFL comment: Labour jobs dominate 

abh ijit . akella@iif lcap.com 6


555
Institutional Equities India - Agriculture

Consumption Figure 18: Average monthly income and consumption expenditure (Rs/month) 
Category  Income Consumption Expenditure 
Agricultural Households  8,931 7,152 
Figure 16: Monthly Per Capita Consumption Expenditure, percentiles (Rs)  
Non‐Agricultural Households  7,269 6,187 
5615 All Households  8,059 6,646 
Source: NABARD, IIFL Research 
IIFL comment: Agricultural HHs fare a little better than non‐agricultural HHs 

Figure 19: Average monthly income and consumption expenditure per HH, by decile (Rs) 
2945
Decile Class of  Non‐Agricultural 
Agricultural Households All Households 
2238 MPCE  Households 
1856
1587 Consumption  Consumption  Consumption 
1185 1375 Income Income Income 
997   Expenditure Expenditure Expenditure 
765
517 Overall  8,931 7,152 7,269 6,187 8,059  6,646 
1  1,293 2,465 793 1,899 1,019  2,156 
0 10 20 30 40 50 60 70 80 90 100 2  3,033 3,591 2,498 3,008 2,753  3,286 
Source: NABARD, IIFL Research  3  4,963 4,793 3,800 4,173 4,330  4,456 
IIFL comment: Sharp jump in monthly consumption expenditure for the top decile  4  5,970 5,711 4,728 4,841 5,342  5,271 
5  7,475 6,596 6,231 5,558 6,881  6,101 
Figure 17:Expenditure split between food/non‐food items, by size of land holding 6  9,856 7,118 7,011 6,246 8,484  6,697 
Expenditure on food items Expenditure on non‐food items 7  9,781 7,584 7,836 6,500 8,817  7,047 
100% 8  12,012 8,847 9,169 7,305 10,449  7,999 
9  13,702 10,333 10,633 8,716 11,981  9,426 
80% 49% 46% 47% 49% 49% 52% 10  22,269 15,134 19,175 13,149 20,548  14,030 
60% Source: NABARD, IIFL Research; Note: MPCE = Monthly Per Capita Consumption Expenditure 
IIFL comment: Agricultural HHs fare a little better than non‐agricultural HHs across income deciles 
40%
51% 54% 53% 51% 51% 48%
20%
0%
combined

0.01‐0.40

0.41‐1.00

1.01‐2.00
<0.01 ha

>2.00 ha
All sizes

ha

ha

ha

Source: NABARD, IIFL Research 
IIFL comment: Higher income HHs spend a smaller % of income on food items 

abh ijit . akella@iif lcap.com 7


556
Institutional Equities India - Agriculture

Savings and investment Figure 23: Proportion of HHs reporting any investment in the last one year (%) 


Agricultural  Non‐Agricultural  All 
Decile (of MPCE) 
Households Households Households 
Figure 20: Proportion of households reporting savings in the last one year (%) 
Agricultural  Non‐Agricultural  All  1  3.1 2.6 2.8 
Category 
Households  Households Households 2  5.9 2.3 4.0 
Reporting savings  55.2  46.3 50.6 3  6.3 2.5 4.2 
Of whom, saving in institutions  48.5  52.8 44.6 4  7.7 2.1 4.9 
Source: NABARD, IIFL Research  5  7.7 2.9 5.4 
IIFL comment: Agricultural HHs save a tad more often versus non‐agricultural HHs.  Around half of 
the savings are in institutions  6  9.3 5.5 7.5 
7  9.7 9.6 9.6 
Figure 21: Distribution of saver households according to place of savings (%)  8  12.4 10.8 11.6 
Agricultural  Non‐Agricultural  All  9  16.1 17.9 17.1 
Place of Saving 
Households  Households Households 10  28.0 28.6 28.3 
Bank  79.8  77.0 78.4
All Households  10.4 8.7 9.5 
Self Help Group  30.4  28.4 29.4
Source: NABARD, IIFL Research 
Post Office  0.8  0.8 0.8
IIFL comment: As expected, investment increases with rise in standard of living 
Home Saving  5.9  4.8 5.4
Chit Fund / Committee  0.4  0.4 0.4 Figure 24:% of HHs reporting any investment in last one year, breakdown by land size 
Source: NABARD, IIFL Research 
IIFL comment: Savings are mostly with banks  >2.00 ha

Figure 22: Average savings per agricultural HH in the last 1 year  1.01‐2.00 ha
Base  Saver 
Size Class of 
Agricultural  Base  All Agricultural Households  0.41‐1.00 ha
Land Possessed 
Households 
All  Institutional  All  Institutional  % Share of  0.01‐0.40 ha
Agencies  Agencies  Agencies  Agencies Institutional Savings in 
  <0.01 ha
(Rs) (Rs)  (Rs) (Rs) Total Amount Saved
<0.01 ha  14,547 14,447  7,893 7,840 99
All size classes
0.01‐0.40 ha  12,941 12,349  7,658 7,307 95
0.41‐1.00 ha  14,121 13,219  7,795 7,297 94 0% 5% 10% 15% 20%
1.01‐2.00 ha  22,430 21,150  11,836 11,160 94
Source: NABARD, IIFL Research 
>2.00 ha  31,831 30,188  15,984 15,159 95  
All Size Classes  17,488 16,576  9,657 9,153 95
Source: NABARD, IIFL Research 

abh ijit . akella@iif lcap.com 8


557
Institutional Equities India - Agriculture

Figure 25: Proportion of HHs investing in various kinds of assets (%)  Figure 28: % of investor households by source of funds for investments >Rs10,000  
Agricultural  Non‐Agricultural  All  Agricultural  Non‐Agricultural  All 
Indicator  Indicator 
Households Households Households Households Households Households 
HHs that made any investment  10.4 8.7 9.5 Own Funds  40 47 43 
HHs that invested in any Financial  From institutional sources  38 36 37 
3.6 1.5 2.5
Assets  From non‐institutional sources  22 17 20 
HHs that invested in any Physical  TOTAL  100 100 100 
8.7 7.5 8.1
Assets  Source: NABARD, IIFL Research 
HHs that invested in both Financial &  IIFL comment: More than half of investments are financed via external sources 
1.9 0.3 1.0
Physical Assets 
Source: NABARD, IIFL Research  Figure 29: % of agri HHs by source of funds for Investments <Rs10,000, by land size (ha) 
IIFL comment: Physical assets are more commonly purchased than financial assets  Indicator  <0.01 0.01‐0.4 0.41‐1 1.01‐2  >2 
Own Funds  43 31 40 45  37 
Figure 26: Average investment reported in last one year by type of asset (Rs) 
From institutional sources  30 37 34 34  45 
Agricultural  Non‐Agricultural  All 
Indicator  From non‐institutional sources 27 32 26 21  18 
Households  Households Households
Source: NABARD, IIFL Research 
All Assets   62,734 (100%)  58,131 (100%) 60,529 (100%) IIFL comment: Even at higher income levels, reliance on external financing remains 
Financial Assets                             15,731 (25%)  17,595 (30%) 16,624 (27%)
Physical Assets                              47,004 (75%)  40,535 (70%) 43,905 (73%)
Source: NABARD, IIFL Research 

Figure 27: Average investment reported in last one year by size of land possessed (ha) 
All Size 
Indicator  <0.01 0.01‐0.40  0.41‐1.00 1.01‐2.00 >2.00
Classes
All Assets   41,068 32,054  42,647 77,511 115,448 62,734
Financial Assets  19,923 6,035  11,178 31,764 13,478 15,731
Physical Assets  21,145 26,020  31,469 45,747 101,969 47,004
Source: NABARD, IIFL Research 
IIFL comment: Investment in financial assets does not increase with rise in income, whereas 
investment in physical assets does 

abh ijit . akella@iif lcap.com 9


558
Institutional Equities India - Agriculture

Indebtedness Figure 32: Average outstanding debt by MPCE decile (Rs per HH) 
Non‐Agricultural 
Agricultural Households All Households 
Decile  Households 
Figure 30: Incidence of indebtedness1 by MPCE decile (%) 
Class of  Per  Per  Per 
By Decile Class of  Agricultural  Non‐Agricultural  All  Per  Per  Per 
MPCE  Indebted  Indebted  Indebted 
MPCE  Households  Households Households Household Household Household 
Household Household Household 
1  39.5  33.8 36.4
1  41,622 99,410 23,952 64,864 32,081  81,839 
2  48.0  41.7 44.7 2  44,218 85,836 29,230 64,671 36,414  75,508 
3  49.7  37.0 42.8 3  37,023 69,867 25,823 62,249 31,069  66,283 
4  49.5  41.1 45.2
4  38,739 72,245 26,116 56,708 32,464  65,111 
5  52.9  42.0 47.7
5  49,042 84,495 29,419 64,323 39,648  76,026 
6  49.9  44.5 47.3
6  44,408 79,770 28,614 60,441 36,594  70,988 
7  51.5  44.6 48.1 7  69,634 124,788 35,489 75,703 52,445  102,211 
8  57.9  46.1 51.4 8  64,308 104,661 41,319 85,047 51,635  94,997 
9  59.5  50.9 54.7
9  73,304 116,421 42,895 80,769 56,141  97,804 
10  68.0  46.4 56.0
10  132,966 186,457 64,488 134,394 94,653  162,466 
All Households  52.5  42.8 47.4 Overall  59,053 104,602 35,302 76,731 46,574  91,407 
Source: NABARD, IIFL Research 
Source: NABARD, IIFL Research 
IIFL comment: Borrowings increase as income levels rise, indicating higher investment and better 
 
access to credit 
Figure 33: Breakdown of HHs by number of loans taken from Jul‐15 to Jun‐16 (%) 
Figure 31: Incidence of indebtedness among agricultural households by size class of land  Category  No. of Loans Taken  Total 
possessed (%)  One Loan Two Loans 3‐5 Loans 
All size classes  53 Agricultural Households      83.2 13.4 3.4  100 
<0.01 ha  49 Non‐Agricultural House‐      85.3 13.2 1.5  100 
0.01‐0.4 ha  48 All Households                      84.2 13.3 2.5  100 
0.41‐1 ha  52 Source: NABARD, IIFL Research 
1.01‐2 ha  56 IIFL comment: >80% of HHs took only one loan 

>2 ha  60
Source: NABARD, IIFL Research 
IIFL comment: Same conclusion as in figure 30 

1
 Defined as % of HHs with any outstanding loan on the date of survey

abh ijit . akella@iif lcap.com 10


559
Institutional Equities India - Agriculture

Figure 34: Distribution of loans by source (% of borrowing HHs)  Figure 36: Purpose of taking loans by borrowing households  
Agricultural  Non‐Agricultural  All  Purpose  All HH 
Agency 
Households  Households Households Sundry domestic needs  25% 
Institutional Sources  Housing  16% 
Commercial Bank / RRB  46.2  26.4 36.6 Medical expenses  15% 
SHG‐Bank Linked  10.6  14.4 12.4 Capex for agriculture  13% 
SHG‐NBFC/MFI  9.2  13.5 11.3 Running expenses for non‐agri enterprises  11% 
Co‐op. Society / Bank  6  5.3 5.7 Running expenses for agriculture  10% 
Financial Company  1  1.7 1.3 Capex for non‐agriculture  9% 
Finance Corporation  0.7  2.1 1.3 Education  5% 
Provident Fund  0.5  0.2 0.3 Source: NABARD, IIFL Research 
Insurance  0.3  0.2 0.2
Figure 37: Penetration of Kisan Credit Cards (KCC) 
Non‐Institutional Sources 
Land Size (ha)  Proportion of Households having Valid KCC (%) 
Relatives & Friends  22.7  26.8 24.7
Overall  10.5 
Moneylenders  10.8  12.3 11.5
< 0.01  1.2 
Landlord  6.1  4.3 5.2
0.01 ‐ 0.4  5.9 
Doctors, Lawyers, etc.  0.1  0.1 0.1
0.41 ‐ 1  10.8 
Input Supplier  0.1  0.1 0.1
Source: NABARD, IIFL Research  1.01 ‐ 2  14.1 
IIFL comment: Agricultural HHs use banks for borrowing more often than non‐agricultural HHs  > 2  23.8 
Source: NABARD, IIFL Research 
Figure 35: Average loan taken (Rs)  IIFL comment: Higher‐income HHs have better access to credit, and hence naturally use KCCs more 
frequently 
Agricultural  Non‐Agricultural  All 
Source of Loan 
Households  Households Households Figure 38: Usage of Kisan Credit Card (KCC) (Rs) 
From all sources                      107,083 (100%)  75,688 (100%) 91,852 (100%) Per Household 
From institutional                   77,473 (72%)  48,970 (65%) 63,645 (69%) Type of Household  Average Sanctioned  Average Amount  % Limit Utilised 
From non‐institutional           29,611 (28%)  26,718 (35%) 28,207 (31%) Limit  Drawn 
Source: NABARD, IIFL Research 
All Agricultural Households         139,208 91,202  65.5 
IIFL comment: Agricultural HHs use institutional sources more often 
Agricultural households 
owning more than 0.4 ha land  164,841 136,970  83.1 
and who took loan                       
Source: NABARD, IIFL Research 
 

abh ijit . akella@iif lcap.com 11


560
Institutional Equities India - Agriculture

Insurance Microfinance
Figure 39: Proportion of HHs with at least one member with insurance   Figure 42: Proportion of HHs associated with Microfinance  
Type of insurance  All HH  Agri HH Non‐agri HH HHs with any  HHs with any 
HHs with  HHs with any 
Any insurance  25%  26% 25% member  member 
membership in  member 
Life insurance  15%  17% 13% Categories  associated with  associated with 
any Microfinance  associated with 
Joint Liability  Livelihood 
Accident insurance  2%  2% 2% Group Self Help Groups
Groups Groups 
Health insurance  6%  5% 7%
All HH  22.7% 20.3% 1.6% 1.2% 
Vehicle insurance  5%  5% 6%
Agricultural HH  23.6% 21.6% 1.3% 1.2% 
Source: NABARD, IIFL Research 
Non‐ 
21.9% 19.2% 1.9% 1.2% 
Figure 40: Agricultural HHs having crop insurance and livestock insurance (%)  Agricultural HH 
Source: NABARD, IIFL Research 
Size Class of Land  Agricultural Households  Agricultural Households Having
Possessed (Ha)  Having Crop Insurance Livestock Insurance
Figure 43: Services availed from microfinance institutions (% of HHs) 
< 0.01 ha  0.1 0.7
All  Agricultural  Non‐ agricultural 
0.01 ‐ 0.4 ha  1.5 0.8 Service availed 
Households Households households 
0.41 ‐ 1 ha  5.1 1.0
Technical support/training for 
1.01 ‐ 2 ha  10.8 1.2 20.1 18.7 21.5 
any enterprise 
> 2 ha  8.0 5.4 Physical inputs for pursuing 
All Size Classes  6.9 1.7 14.6 15.5 13.7 
any enterprise 
Source: NABARD, IIFL Research  Cash loans for promoting any 
IIFL comment: Penetration of crop insurance is extremely low  26.5 26.6 26.5 
enterprise 
Cash loans for meeting 
Figure 41: Reasons for not taking insurance  64.4 62.5 66.2 
personal needs 
Reason  All HH Agri HH Non‐agri HH
Assistance in marketing of the 
Lack of adequate funds  59.0% 66.8% 62.7% 3.3 3.9 2.6 
products 
Did not feel the need for any insurance  37.8% 31.5% 34.8% Any other type of support  0.3 0.3 0.2 
No regular income  28.5% 32.3% 30.3% Source: NABARD, IIFL Research 
Want to take, but do not know where to get it  2.5% 2.7% 2.6%
Lack of trust due to bad experience of some family 
1.1% 1.8% 1.4%
in village 
Other reasons  3.3% 2.4% 2.9%
Source: NABARD, IIFL Research 
IIFL comment: The above responses are for HHs that did not have insurance, but are aware about its 
availability 

abh ijit . akella@iif lcap.com 12


561
Institutional Equities India - Agriculture

Financial knowledge, attitude and behaviour Figure 47: Sources of loans  


Source  Total Rural Urban 
Co‐operative society/bank 29.5% 28.8% 33.6% 
Figure 44: Modes of saving in past 12 months  Relatives & Friends 25.6% 27.2% 17.0% 
% Respondents who affirmed to be  Self Help Groups 21.4% 21.6% 20.3% 
Responses 
saving in the given ways Landlord/moneylender 17.1% 17.5% 15.2% 
Keeping cash at home or in your wallet  52.1 Commercial bank/RRB 10.2% 10.1% 10.3% 
Saving in bank account  38.3 Financial institution 8.8% 8.2% 12.5% 
Giving money to family to save on your behalf  21.9 Government  8.1% 7.5% 11.4% 
Has not been actively saving  17.2 Source: NABARD, IIFL Research 
Saving in informal chit funds or saving clubs/ SHG  9.9
Saving by buying assets like gold, property or  Figure 48: Reasons for seeking loans from non‐institutional sources (%) 
2
livestock  Rural Semi‐Urban  Overall 
Buying financial investment products like shares,  Easy Availability 76.2 71.3  75.7 
1.7 The reasons 
stocks, bonds, etc  No strict time for repayment 38.3 32.5  37.6 
cited for 
Do not know/Cannot say/Refused to answer  2.6 Loan available for all purposes 25.1 26.8  25.3 
taking Loans 
Source: NABARD, IIFL Research  Low or no rate of interest 26.3 18.7  25.4 
from Non‐ 
IIFL comment: Cash remains a highly popular way of saving  Faith on family or friends 32.1 24.6  31.2 
Institutional 
No paper work needed 24.5 20.5  24.1 
Sources 
Figure 45: Access to credit   No fear of Court legal implications 4.1 6  4.3 
Sought from  High interest rates 38.5 29.8  37.5 
Sought from non‐ Sought Loan  Did not 
Respondent  Institutional  Did not  Short loan term (maturity) 30 30.3  30.1 
institutional  but did not  Need any 
Characteristics  Sources and got  Seek Excessive collateral requirements 34.3 40.3  34.9 
Sources & got it get it Loan
it  Lengthy application process 49.4 36.1  47.9 
All Households  29%  14% 2% 3% 52% High costs associated with borrowing 17.7 9.7  16.8 
The reasons 
Source: NABARD, IIFL Research  No lending financial institution in 
cited for NOT 
IIFL comment: % of HHs rejected is low, at only 2%  convenient proximity to my business/  5.8 3.9  5.5 
taking Loans 
residence 
from 
Figure 46: Reasons for not getting loan  High risks – uncertain of own ability to 
Institutional  7.1 4.5  6.8 
pay interest and repay principal 
Reason  Sources 
Did not know could receive credit from 
Incomplete paperwork  43.0% 4.5 2.1  4.2 
a financial institution 
Previous debt not repaid  28.8% Didn’t apply because was denied credit 
1.4 1.2  1.4 
No collateral  24.3% earlier 
Poor economic situation  18.3% Didn’t need a loan 0.6 0.2  0.6 
Assessed as not creditworthy  8.5% Source: NABARD, IIFL Research 
Had loans from other places  6.9%
Source: NABARD, IIFL Research 

abh ijit . akella@iif lcap.com 13


562
Institutional Equities India - Agriculture

Figure 49: Use of various banking facilities in the last 3 months (% of respondents) 
Service type 
ATM services  23.6%
Mobile banking services  1.6%
Internet banking services  0.8%
Source: NABARD, IIFL Research 

Figure 50: Comfort with various banking services (% of respondents) 
Can use it 
Type of  Can use it with the  Don’t know/ 
independently  Afraid of/   not very 
Banking  help of any family  refused to 
without  comfortable using it
Services  member/ friend answer
anyone’s help
ATM/ Micro 
73.4 22.3 1.8 2.5
ATM 
Mobile Banking  39.1 55.5 1.7 3.7
Internet 
51.8 35 2.3 10.9
Banking 
Source: NABARD, IIFL Research 

Figure 51: Use of various payment mechanisms in the last 3 months  (% of respondents) 
Mechanism  %
Cheque  7.5%
Debit/credit card  7.4%
Money orders  0.6%
Source: NABARD, IIFL Research 

abh ijit . akella@iif lcap.com 14


563
Institutional Equities India - Agriculture

Disclosure : Published in 2018, © IIFL Securities Limited (Formerly ‘India Infoline Limited’) 2018

India Infoline Group (hereinafter referred as IIFL) is engaged in diversified financial services business including equity broking, DP services, merchant banking, portfolio management services, distribution of Mutual Fund,
insurance products and other investment products and also loans and finance business. India Infoline Ltd (“hereinafter referred as IIL”) is a part of the IIFL and is a member of the National Stock Exchange of India Limited
(“NSE”) and the BSE Limited (“BSE”). IIL is also a Depository Participant registered with NSDL & CDSL, a SEBI registered merchant banker and a SEBI registered portfolio manager. IIL is a large broking house catering to
retail, HNI and institutional clients. It operates through its branches and authorised persons and sub-brokers spread across the country and the clients are provided online trading through internet and offline trading
through branches and Customer Care.
a) This research report (“Report”) is for the personal information of the authorized recipient(s) and is not for public distribution and should not be reproduced or redistributed to any other person or in any form without
IIL’s prior permission. The information provided in the Report is from publicly available data, which we believe, are reliable. While reasonable endeavors have been made to present reliable data in the Report so far as
it relates to current and historical information, but IIL does not guarantee the accuracy or completeness of the data in the Report. Accordingly, IIL or any of its connected persons including its directors or subsidiaries
or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained, views and opinions expressed in this
publication.
b) Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and
estimates contained in this report reflect a judgment of its original date of publication by IIFL and are subject to change without notice. The price, value of and income from any of the securities or financial
instruments mentioned in this report can fall as well as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of
such securities or financial instruments.
c) The Report also includes analysis and views of our research team. The Report is purely for information purposes and does not construe to be investment recommendation/advice or an offer or solicitation of an offer to
buy/sell any securities. The opinions expressed in the Report are our current opinions as of the date of the Report and may be subject to change from time to time without notice. IIL or any persons connected with it
do not accept any liability arising from the use of this document.
d) Investors should not solely rely on the information contained in this Report and must make investment decisions based on their own investment objectives, judgment, risk profile and financial position. The recipients
of this Report may take professional advice before acting on this information.
e) IIL has other business segments / divisions with independent research teams separated by 'Chinese walls' catering to different sets of customers having varying objectives, risk profiles, investment horizon, etc and
therefore, may at times have, different and contrary views on stocks, sectors and markets.
f) This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication,
availability or use would be contrary to local law, regulation or which would subject IIL and its affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may
not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this Report may come are required to inform themselves of and to observe such restrictions.
g) As IIL along with its associates, are engaged in various financial services business and so might have financial, business or other interests in other entities including the subject company(ies) mentioned in this Report.
However, IIL encourages independence in preparation of research report and strives to minimize conflict in preparation of research report. IIL and its associates did not receive any compensation or other benefits
from the subject company(ies) mentioned in the Report or from a third party in connection with preparation of the Report. Accordingly, IIL and its associates do not have any material conflict of interest at the time of
publication of this Report.
h) As IIL and its associates are engaged in various financial services business, it might have:-
(a) received any compensation (except in connection with the preparation of this Report) from the subject company in the past twelve months; (b) managed or co-managed public offering of securities for the subject
company in the past twelve months; (c) received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) received any
compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) engaged in market making activity for the
subject company.
i) IIL and its associates collectively do not own (in their proprietary position) 1% or more of the equity securities of the subject company mentioned in the report as of the last day of the month preceding the publication
of the research report.
j) The Research Analyst engaged in preparation of this Report or his/her relative:-
(a) does not have any financial interests in the subject company (ies) mentioned in this report; (b) does not own 1% or more of the equity securities of the subject company mentioned in the report as of the last day
of the month preceding the publication of the research report; (c) does not have any other material conflict of interest at the time of publication of the research report.
k) The Research Analyst engaged in preparation of this Report:-
(a) has not received any compensation from the subject company in the past twelve months; (b) has not managed or co-managed public offering of securities for the subject company in the past twelve months; (c)
has not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) has not received any compensation for products or
services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) has not received any compensation or other benefits from the subject
company or third party in connection with the research report; (f) has not served as an officer, director or employee of the subject company; (g) is not engaged in market making activity for the subject company.
L) IIFLCAP accepts responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is delivered to a U.S. person other than a major U.S. institutional investor. The analyst
whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority (“FINRA”) and may not be an associated person of IIFLCAP and,
therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject NABARD, public appearances and trading securities held by a research analyst account.
We submit that no material disciplinary action has been taken on IIL by any regulatory authority impacting Equity Research Analysis.

abh ijit . akella@iif lcap.com 15


564
Institutional Equities India - Agriculture

A graph of daily closing prices of securities is available at http://www.nseindia.com/ChartApp/install/charts/mainpage.jsp, www.bseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes.
(Choose a company from the list on the browser and select the “three years” period in the price chart).

Name, Qualification and Certification of Research Analyst: Abhijit R. Akella, CFA (PGDM), Mohit Surana (PGDM)

IIFL Securities Limited (Formerly ‘India Infoline Limited’), CIN No.: U99999MH1996PLC132983, Corporate Office – IIFL Centre, Kamala City, Senapati Bapat Marg, Lower Parel, Mumbai – 400013 Tel: (91-22)
4249 9000 .Fax: (91-22) 40609049, Regd. Office – IIFL House, Sun Infotech Park, Road No. 16V, Plot No. B-23, MIDC, Thane Industrial Area, Wagle Estate, Thane – 400604 Tel: (91-22) 25806650. Fax: (91-22)
25806654 E-mail: mail@indiainfoline.com Website: www.indiainfoline.com, Refer www.indiainfoline.com for detail of Associates.
Stock Broker SEBI Regn.: INZ000164132, PMS SEBI Regn. No. INP000002213, IA SEBI Regn. No. INA000000623, SEBI RA Regn.:- INH000000248

Key to our recommendation structure

BUY - Stock expected to give a return 10%+ more than average return on a debt instrument over a 1-year horizon.

SELL - Stock expected to give a return 10%+ below the average return on a debt instrument over a 1-year horizon.

Add - Stock expected to give a return 0-10% over the average return on a debt instrument over a 1-year horizon.

Reduce - Stock expected to give a return 0-10% below the average return on a debt instrument over a 1-year horizon.

Distribution of Ratings: Out of 217 stocks rated in the IIFL coverage universe, 112 have BUY ratings, 7 have SELL ratings, 72 have ADD ratings and 25 have REDUCE ratings

Price Target: Unless otherwise stated in the text of this report, target prices in this report are based on either a discounted cash flow valuation or comparison of valuation ratios with companies seen by the analyst as
comparable or a combination of the two methods. The result of this fundamental valuation is adjusted to reflect the analyst’s views on the likely course of investor sentiment. Whichever valuation method is used there is a
significant risk that the target price will not be achieved within the expected timeframe. Risk factors include unforeseen changes in competitive pressures or in the level of demand for the company’s products. Such demand
variations may result from changes in technology, in the overall level of economic activity or, in some cases, in fashion. Valuations may also be affected by changes in taxation, in exchange rates and, in certain industries,
in regulations. Investment in overseas markets and instruments such as ADRs can result in increased risk from factors such as exchange rates, exchange controls, taxation, and political and social conditions. This
discussion of valuation methods and risk factors is not comprehensive – further information is available upon request.

abh ijit . akella@iif lcap.com 16


565
National Insurance Company Ltd

__________________________________________________________________________________________

Key Employees
National Insurance Company Ltd
Name Job Title

A K Acharya General Manager


Fast Facts
Headquarters Address , Kolkata, 700071 , India Arun Kaul Director
Director, Deputy Director-
Bhumika Verma
Department
Telephone + 91 22 831705
Bibhuti Bhusan Mishra Director
Fax + 91 22 831740
Dilbagh Singh General Manager
Website www.nationalinsuranceindia.com

Ticker Symbol, Stock Exchange N/A


Company Overview
Number of Employees N/A
National Insurance Company Ltd (NIC), a
Fiscal Year End December
subsidiary of India based General Insurance
Corp of India, is a general insurance company.
The company’s products portfolio includes motor
Revenue (in US$ million) N/A
insurance, health insurance, rural insurance,
commercial insurance, and industrial insurance.
Its personal insurance products include
individual personal accident insurance,
householder’s insurance, and Janata personal
accident insurance. NIC’s rural insurance
products comprise livestock insurance, sheep
and goat insurance, elephant insurance, dog
insurance, brackish water prawn insurance,
silkworm insurance, plantation insurance, and
Kisan agriculture pumpset insurance. The
company also offers industrial risk insurance,
machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability
insurance, and public liability insurance. It has
operations in Guwahati, Hyderabad, Bangalore,
Dharwad, Kolar, Gurgaon, Delhi, and Naraina,
India. NIC is headquartered in Kolkata, West
Bengal, India.

Key Competitors

AEGON Religare Life Insurance Company Limited

Bajaj Allianz General Insurance Company Limited


Cholamandalam MS General Insurance Company
Limited
PNB MetLife India Insurance Co Ltd

The New India Assurance Co Ltd

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 1

566
National Insurance Company Ltd

__________________________________________________________________________________________

TABLE OF CONTENTS
1 National Insurance Company Ltd - Business Analysis ................................................................................. 4
1.1 National Insurance Company Ltd - Company Overview ........................................................................................4
1.2 National Insurance Company Ltd - Major Products and Services .........................................................................5
2 National Insurance Company Ltd - Mergers & Acquisitions and Partnerships ............................................. 7
2.1 National Insurance Company Ltd - M&A and Partnerships Strategy .....................................................................7
3 National Insurance Company Ltd - Key Events ............................................................................................ 9
4 National Insurance Company Ltd - Key Employees ................................................................................... 10
5 National Insurance Company Ltd - Locations and Subsidiaries ................................................................. 11
5.1 National Insurance Company Ltd - Head Office ..................................................................................................11
5.2 National Insurance Company Ltd - Other Locations and Subsidiaries ................................................................11
6 Appendix .................................................................................................................................................... 13
6.1 Methodology .........................................................................................................................................................13
6.2 Disclaimer.............................................................................................................................................................13

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 2

567
National Insurance Company Ltd

__________________________________________________________________________________________

LIST OF TABLES
Table 1: National Insurance Company Ltd - Major Products and Services ......................................................... 5
Table 2: National Insurance Company Ltd - Key Events .................................................................................... 9
Table 3: National Insurance Company Ltd - Key Employees ............................................................................ 10
Table 4: National Insurance Company Ltd - Locations ..................................................................................... 11

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 3

568
National Insurance Company Ltd

__________________________________________________________________________________________

1 National Insurance Company Ltd - Business Analysis

1.1 National Insurance Company Ltd - Company Overview

National Insurance Company Ltd (NIC), a subsidiary of India based General Insurance Corp of India, is a general
insurance company. The company’s products portfolio includes motor insurance, health insurance, rural insurance,
commercial insurance, and industrial insurance. Its personal insurance products include individual personal accident
insurance, householder’s insurance, and Janata personal accident insurance. NIC’s rural insurance products comprise
livestock insurance, sheep and goat insurance, elephant insurance, dog insurance, brackish water prawn insurance,
silkworm insurance, plantation insurance, and Kisan agriculture pumpset insurance. The company also offers industrial
risk insurance, machinery insurance, electronic equipment insurance, commercial risk insurance, workmen compensation
insurance, product liability insurance, and public liability insurance. It has operations in Guwahati, Hyderabad, Bangalore,
Dharwad, Kolar, Gurgaon, Delhi, and Naraina, India. NIC is headquartered in Kolkata, West Bengal, India.

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 4

569
National Insurance Company Ltd

__________________________________________________________________________________________

1.2 National Insurance Company Ltd - Major Products and Services

NIC is an insurance company. Key products offered by the company include the following:

Table 1: National Insurance Company Ltd - Major Products and Services


Products:

Personal Line Insurance:

Individual Personal Accident Insurance

Householders Insurance

Janata Personal Accident Insurance

Rural Insurance:

Livestock Insurance

Sheep and Goat Insurance

Elephant Insurance

Dog Insurance

Brackish Water Prawn Insurance

Silkworm Insurance

Plantation Insurance

Kisan Agriculture Pumpset Insurance

Industrial Insurance:

Erection All Risks Insurance

Contractors All Risks Insurance

Machinery Insurance

Electronic Equipment Insurance

Consequential Loss Policy

Standard Fire and Special Perils Policy

Workmen Compensation Insurance

Product Liability Insurance

Public Liability Insurance

Commercial Insurance:

Burglary Policy

Shopkeepers Policy

Bankers Indemnity Policy

Office Package Policy

Glass Insurance

Money Insurance

Jewellers Block Policy

Extended Warranty Policy

Directors and Officers Liability Policy

Fidelity Guarantee Policy

Marine Cargo Insurance

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 5

570
National Insurance Company Ltd

__________________________________________________________________________________________

Table 1: National Insurance Company Ltd - Major Products and Services


Source: Timetric

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 6

571
National Insurance Company Ltd

__________________________________________________________________________________________

2 National Insurance Company Ltd - Mergers & Acquisitions


and Partnerships

2.1 National Insurance Company Ltd - M&A and Partnerships Strategy

Oriental Insurance Company and National Insurance to Merge with United India Insurance
Deal Type Merger Deal Sub Type
Deal Status Announced Announced Date 2018-02-01
Deal in Brief
Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance Company Limited., a
provider of general insurance for urban and rural customers, to merge with United India Insurance Co. Ltd., a provider of
non-life insurance products and services. All the companies are based in India.

Upon completion, the merged entity will be listed in stock exchange.


Participant Company Information
Company Name The United India Insurance Co Ltd Involvement Type Target
Company Overview
United India Insurance Company Limited (UIIC) is a general insurance provider. It offers a range of personal and
commercial general insurance products. The company offers personal insurance products for motor, fire, health, liability,
micro, credit, marine, home, personal accident, and travel. Its commercial insurance products include fire insurance,
marine insurance, motor insurance and industry equipment insurance. It also offers accident and hospitalization policies,
social policies, rural policies, travel policies, package policies, and business policies. In addition, the company provides
advisory and brokerage services. It has presence across various cities in India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of INR160,628.1 million during fiscal year ended March 2017(FY2017), an
increase of 31.1% over FY2016. The net earned premium of the company was INR120,323.1 million in FY2017, an
increase of 20% over FY2016.
Company Name The Oriental Insurance Company Ltd. Involvement Type Target
Company Overview
The Oriental Insurance Company Ltd. (Oriental Insurance), a wholly owned subsidiary of Oriental Government Security
Life Assurance Company Ltd, provides various general insurance services in the urban and rural sectors in India. The
company designs insurance coverage for projects, including power plants, petrochemical, steel and chemical plants
among otehrs. Oriental Insurance offers motor insurance policies, personal accident policy, Janata personal accident
policy, shopkeeper policy, householder policy, Nagarik suraksha policy and health insaurance policies among others. It
operates in across India and also has overseas operations in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 7

572
National Insurance Company Ltd

__________________________________________________________________________________________

State Bank of Hyderabad Signs Memorandum of Understanding with National Insurance


Deal Type Partnership Deal Sub Type Affinity Marketing
Deal Status Completed Announced Date 2015-05-05
Deal in Brief
State Bank of Hyderabad, a provider of commercial banking services, has signed a memorandum of understanding with
National Insurance Company Limited for extending Pradhan Mantri Surakhsa Bima Yojana to its account holders. Both
companies involved in the transaction are based in India.

National Insurance Company is a provider of general insurance products and services.

The Pradhan Mantri Surakhsa Bima Yojana is available across all its 1,821 branches at a cost of INR12 (USD0.18) per
policy per year. All the savings bank account holders in the age group of 18-70 years are eligible to join the Pradhan
Mantri Surakhsa Bima Yojana to avail of a risk cover of INR0.2 million (USD0.003 million).

Participant Company Information


Company Name State Bank of Hyderabad Involvement Type Target
Company Overview
State Bank of Hyderabad (SBH), a subsidiary of State Bank of India, provides banking and financial services. The bank
operates through four segments: Treasury Operations, Corporate, Retail Banking and Other Banking Operations. SBH
offers a variety of personal banking services, agriculture banking services, NRI (non-resident Indian) banking services,
and micro, small and medium enterprise (MSME) banking services. The bank primarily operates in India, where it is
headquartered in Hyderabad.

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 8

573
National Insurance Company Ltd

__________________________________________________________________________________________

3 National Insurance Company Ltd - Key Events

Table 2: National Insurance Company Ltd - Key Events


Year Event type Description

2017 Divestiture In January, Government of India sold 25% stake in National Insurance.

The company signed a memorandum of understanding with State Bank of


2015 Contracts/Agreements Hyderabad to implement Pradhan Mantri Suraksha Bima Yojana insurance
scheme.

1906 Incorporation/Establishment The company was incorporated.

Source: Timetric

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 9

574
National Insurance Company Ltd

__________________________________________________________________________________________

4 National Insurance Company Ltd - Key Employees

Table 3: National Insurance Company Ltd - Key Employees

Name Job Title Board Level

A K Acharya General Manager Senior Management

Arun Kaul Director Non Executive Board

Bhumika Verma Director, Deputy Director-Department Executive Board

Bibhuti Bhusan Mishra Director Non Executive Board

Dilbagh Singh General Manager Senior Management

Gope Panikkar General Manager Senior Management

Indu Sharma General Manager Senior Management

J. Sengupta Deputy General Manager Senior Management

John Pulinthanam Director, General Manager Executive Board

K Narayanan Deputy General Manager Senior Management

K Sanath Kumar Managing Director, Chairman Executive Board

K.B. Vijay Srinivas General Manager Senior Management

M Vasantha Krishna Director, General Manager Executive Board

P. Vijaya Kumar Deputy General Manager Senior Management

P.C.Subudhi Deputy General Manager Senior Management

Ravi Krishan Takkar Director, Managing Director Executive Board

Sashikala Muralidharan General Manager Senior Management

Sivaraman Mahadevan Director Non Executive Board

Sudhakar Pahi Director Non Executive Board

Vijay Walia General Manager, Chief Visionary Officer Senior Management

Source: Timetric

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 10

575
National Insurance Company Ltd

__________________________________________________________________________________________

5 National Insurance Company Ltd - Locations and


Subsidiaries

5.1 National Insurance Company Ltd - Head Office

National Insurance Company Ltd


Kolkata
Zip: 700071
India
Tel: + 91 22 831705
Fax: + 91 22 831740

5.2 National Insurance Company Ltd - Other Locations and Subsidiaries

Table 4: National Insurance Company Ltd - Locations

Second and Third Floor


First Floor
Lohia Mansio, G. S. Road, Bhangagarh
Jubilee Building, Nampally Station Road
Guwahati
Hyderabad
Zip: 781005
Zip: 500001
India
India
Tel: + 91 8942 222564
Fax: + 91 8942 252906

2nd Floor
Second Floor
Shubharam Complex, 144 M G Road-908
Arihant Plaza, Kusugal Road
Bangalore
Dharwad
Zip: 90880
Zip: 58002
India
India
Tel: + 91 80 25584081
Fax: + 91 80 25584506

1092-2, New Extension, Near Dome Light Circle SCO 41-43, Sector, 31/32 A, Gurgaon
Kolar Gurgaon
Zip: 563101 Zip: 122001
India India

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 11

576
National Insurance Company Ltd

__________________________________________________________________________________________

Table 4: National Insurance Company Ltd - Locations

32, Community Centre 21 Dariya Ganj


Naraina Delhi
Zip: 110028 Zip: 110002
India India
Fax: + 91 23 281650

302, N N Mall, Sector 3, Rohini


New Delhi
Zip: 110085
India

Source: Annual Report, Company Website, Primary and Secondary Research

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 12

577
National Insurance Company Ltd

__________________________________________________________________________________________

6 Appendix

6.1 Methodology

Timetric company reports are based on a core set of research techniques which ensure the best possible level of quality
and accuracy of data. The key sources used include:
• Company Websites
• Company Annual Reports
• SEC Filings
• Press Releases
• Proprietary Databases

Notes
• Financial information of the company is taken from the most recently published annual reports or SEC filings
• The financial and operational data reported for the company is as per the industry defined standards
• Revenue converted to US$ at average annual conversion rate as of fiscal year end

6.2 Disclaimer

All Rights Reserved

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, Timetric.

The data and analysis within this report is driven by Timetric from its own primary and secondary research of public and
proprietary sources and does not necessarily represent the views of the company profiled.

The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the
findings, conclusions and recommendations that Timetric delivers will be based on information gathered in good faith from
both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such Timetric can
accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect.

___________________________________________________________________________________________

National Insurance Company Ltd - Company Capsule Page 13

578
The United India Insurance Co Ltd

__________________________________________________________________________________________

Key Employees
The United India Insurance Co Ltd
Name Job Title

Anitha Rajaram Deputy General Manager


Fast Facts
Headquarters Address , Chennai, 600014, India B Balachandra Director, General Manager

B Rajaram Deputy General Manager


Telephone + 91 4428520161
General Manager, Chief
B. B. Dash
Financial Officer
Fax N/A
C.R.Vijayan General Manager
Website www.uiic.co.in

Ticker Symbol, Stock Exchange N/A


Company Overview
Number of Employees 16,167
United India Insurance Company Limited (UIIC)
Fiscal Year End March
is a general insurance provider. It offers a range
of personal and commercial general insurance
products. The company offers personal
Revenue (in US$ million) 3,364
insurance products for motor, fire, health,
liability, micro, credit, marine, home, personal
accident, and travel. Its commercial insurance
products include fire insurance, marine
insurance, motor insurance and industry
equipment insurance. It also offers accident and
SWOT Analysis hospitalization policies, social policies, rural
policies, travel policies, package policies, and
Strengths Weaknesses business policies. In addition, the company
provides advisory and brokerage services. It has
Distribution Network Combined Ratio presence across various cities in India. UIIC is
headquartered at Chennai, India.
Premium Earnings Profitability
The company reported gross premium income of
Solvency Margin INR160,628.1 million during fiscal year ended
March 2017(FY2017), an increase of 31.1%
over FY2016. The net earned premium of the
Opportunities Threats company was INR120,323.1 million in FY2017,
an increase of 20% over FY2016.
Economy in India Changing Regulations

Non-Life Insurance segment Outlook Key Competitors


Competition
in India
Bajaj Allianz General Insurance Company Limited
Interest Rates
HDFC ERGO General Insurance Company Limited

ICICI Lombard General Insurance Company Limited

Royal Sundaram General Insurance Co. Limited

The Oriental Insurance Company Ltd.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 1

579
The United India Insurance Co Ltd

__________________________________________________________________________________________

TABLE OF CONTENTS
1 The United India Insurance Co Ltd - Business Analysis .............................................................................. 4
1.1 The United India Insurance Co Ltd - Company Overview .....................................................................................4
1.2 The United India Insurance Co Ltd - Business Description ...................................................................................4
1.2.1 Fire Insurance ....................................................................................................................................................4
1.2.2 Marine Insurance ...............................................................................................................................................4
1.2.3 Miscellaneous Insurance ...................................................................................................................................4
1.3 The United India Insurance Co Ltd - Major Products and Services .......................................................................5
2 The United India Insurance Co Ltd - Mergers & Acquisitions and Partnerships .......................................... 6
2.1 The United India Insurance Co Ltd - M&A and Partnerships Strategy ..................................................................6
3 The United India Insurance Co Ltd - Recent Developments ...................................................................... 10
4 The United India Insurance Co Ltd - SWOT Analysis ................................................................................ 12
4.1 The United India Insurance Co Ltd - SWOT Analysis - Overview .......................................................................12
4.2 The United India Insurance Co Ltd - Strengths....................................................................................................12
4.3 The United India Insurance Co Ltd - Weaknesses ..............................................................................................12
4.4 The United India Insurance Co Ltd - Opportunities..............................................................................................12
4.5 The United India Insurance Co Ltd - Threats .......................................................................................................13
5 The United India Insurance Co Ltd - Company Statement......................................................................... 14
6 The United India Insurance Co Ltd - History .............................................................................................. 15
7 The United India Insurance Co Ltd - Key Employees ................................................................................ 17
8 The United India Insurance Co Ltd - Locations and Subsidiaries .............................................................. 19
8.1 The United India Insurance Co Ltd - Head Office ................................................................................................19
8.2 The United India Insurance Co Ltd - Other Locations and Subsidiaries ..............................................................19
9 Appendix .................................................................................................................................................... 21
9.1 Methodology .........................................................................................................................................................21
9.2 Disclaimer.............................................................................................................................................................21

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 2

580
The United India Insurance Co Ltd

__________________________________________________________________________________________

LIST OF TABLES
Table 1: The United India Insurance Co Ltd - Major Products and Services ...................................................... 5
Table 2: The United India Insurance Co Ltd - History ....................................................................................... 15
Table 3: The United India Insurance Co Ltd - Key Employees ......................................................................... 17
Table 4: The United India Insurance Co Ltd - Subsidiaries............................................................................... 19
Table 5: The United India Insurance Co Ltd - Locations ................................................................................... 19

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 3

581
The United India Insurance Co Ltd

__________________________________________________________________________________________

1 The United India Insurance Co Ltd - Business Analysis

1.1 The United India Insurance Co Ltd - Company Overview

United India Insurance Company Limited (UIIC) is a general insurance provider. It offers a range of personal and
commercial general insurance products. The company offers personal insurance products for motor, fire, health, liability,
micro, credit, marine, home, personal accident, and travel. Its commercial insurance products include fire insurance,
marine insurance, motor insurance and industry equipment insurance. It also offers accident and hospitalization policies,
social policies, rural policies, travel policies, package policies, and business policies. In addition, the company provides
advisory and brokerage services. It has presence across various cities in India. UIIC is headquartered at Chennai, India.

The company reported gross premium income of INR160,628.1 million during fiscal year ended March 2017(FY2017), an
increase of 31.1% over FY2016. The net earned premium of the company was INR120,323.1 million in FY2017, an
increase of 20% over FY2016.

1.2 The United India Insurance Co Ltd - Business Description

United India Insurance Company Limited (UIIC) offers a range of personal and commercial general insurance products.
The company markets and sells its products through a network of offices, agents, brokers, corporate agencies, and
bancassurance and online channel. As on March 31, 2017, the company operated through 2,129 offices across India.

The company classifies its operations into three segments: Marine Insurance, Fire Insurance, and Miscellaneous
operations.

1.2.1 Fire Insurance

Overview

Offers standard fire and special perils policies and fire loss of profit policies.

1.2.2 Marine Insurance

Overview

Offers marine cargo and marine hull insurance.

1.2.3 Miscellaneous Insurance

Overview

Offers motor insurance, health insurance, and public and product liability policies.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 4

582
The United India Insurance Co Ltd

__________________________________________________________________________________________

1.3 The United India Insurance Co Ltd - Major Products and Services

UIIC is a general insurance company that provides personal and commercial insurance products. The company's key
products include:

Table 1: The United India Insurance Co Ltd - Major Products and Services

Products:

Motor Insurance

Fire Insurance

Health Insurance

Marine Insurance

Industrial Insurance

Liability Insurance

Micro Insurance

Credit Insurance

Home Insurance

Personal Accident Insurance

Travel Insurance
Source: Timetric

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 5

583
The United India Insurance Co Ltd

__________________________________________________________________________________________

2 The United India Insurance Co Ltd - Mergers & Acquisitions


and Partnerships

2.1 The United India Insurance Co Ltd - M&A and Partnerships Strategy

Oriental Insurance Company and National Insurance to Merge with United India Insurance
Deal Type Merger Deal Sub Type
Deal Status Announced Announced Date 2018-02-01
Deal in Brief
Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance Company Limited., a
provider of general insurance for urban and rural customers, to merge with United India Insurance Co. Ltd., a provider of
non-life insurance products and services. All the companies are based in India.

Upon completion, the merged entity will be listed in stock exchange.


Participant Company Information
Company Name National Insurance Company Ltd Involvement Type Target
Company Overview
National Insurance Company Ltd (NIC), a subsidiary of India based General Insurance Corp of India, is a general
insurance company. The company’s products portfolio includes motor insurance, health insurance, rural insurance,
commercial insurance, and industrial insurance. Its personal insurance products include individual personal accident
insurance, householder’s insurance, and Janata personal accident insurance. NIC’s rural insurance products comprise
livestock insurance, sheep and goat insurance, elephant insurance, dog insurance, brackish water prawn insurance,
silkworm insurance, plantation insurance, and Kisan agriculture pumpset insurance. The company also offers industrial
risk insurance, machinery insurance, electronic equipment insurance, commercial risk insurance, workmen compensation
insurance, product liability insurance, and public liability insurance. It has operations in Guwahati, Hyderabad, Bangalore,
Dharwad, Kolar, Gurgaon, Delhi, and Naraina, India. NIC is headquartered in Kolkata, West Bengal, India.
Company Name The Oriental Insurance Company Ltd. Involvement Type Target
Company Overview
The Oriental Insurance Company Ltd. (Oriental Insurance), a wholly owned subsidiary of Oriental Government Security
Life Assurance Company Ltd, provides various general insurance services in the urban and rural sectors in India. The
company designs insurance coverage for projects, including power plants, petrochemical, steel and chemical plants
among otehrs. Oriental Insurance offers motor insurance policies, personal accident policy, Janata personal accident
policy, shopkeeper policy, householder policy, Nagarik suraksha policy and health insaurance policies among others. It
operates in across India and also has overseas operations in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 6

584
The United India Insurance Co Ltd

__________________________________________________________________________________________

Kerala Gramin Bank Signs MoU with United India Insurance Company
Deal Type Partnership Deal Sub Type Affinity Marketing
Deal Status Completed Announced Date 2015-04-30
Deal in Brief
Kerala Gramin Bank, a regional rural bank that provides deposits and loans, has signed a memorandum of understanding
(MoU) with United India Insurance Company Limited (UIIC), a general insurance company, to provide life and accidental
insurance cover to all its Savings account holders under Prime Minister Jeevan Jyoti Bima Yojana (PMJJBY) and
Pradhan Mantri Suraksha Bima Yojana (PMSBY). Both companies involved in the transaction are based in India.

PMJBY is a life insurance scheme provides insurance cover for death due to any reason, while PMSBY is the personal
accident insurance scheme provides insurance cover for death or disability due to accident.

PMJBY offers life insurance cover of INR0.2 million (USD0.0032 million) to the bank account holders in the age group of
18-50 years at an annual premium of INR330 (USD5.27) plus service tax, whereas PMSBY cover of INR0.2 million
(USD0.00314 million) to the bank account holders in the age group of 18-70 years at an annual premium of INR12
(USD0.18).

Participant Company Information


Company Name Kerala Gramin Bank Involvement Type Target
Company Overview
Kerala Gramin Bank is a regional rural bank. The main focus of the bank is to initiate appropriate intervention for overall
economic upliftment of the people of Kerala by giving financial assistance to the sectors like Agriculture, Micro, Small and
Medium Enterprises, education, housing, micro-credit, weaker sections, SC/ST communities etc.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 7

585
The United India Insurance Co Ltd

__________________________________________________________________________________________

Dena Bank Signs MoU with United India Insurance Company


Deal Type Partnership Deal Sub Type Affinity Marketing
Deal Status Completed Announced Date 2015-04-21
Deal in Brief
Dena Bank, a provider of corporate banking products and services, has signed a memorandum of understanding (MoU)
with United India Insurance Company Limited (UIIC) to provide accidental insurance cover to all its Savings account
holders under Pradhan Mantri Suraksha Bima Yojana (PMSBY). Both companies involved in the transaction are based in
India.

UIIC is a general insurance company, while PMSBY is the personal accident insurance scheme provides insurance cover
for death or disability due to accident.

PMSBY offers insurance cover of INR0.2 million (USD0.00314 million) to the bank account holders in the age group of 18-
70 years at an annual premium of INR12 (USD0.18).

Participant Company Information


Company Name Dena Bank Involvement Type Target
Company Overview
Dena Bank (the bank) is an Indian public sector bank engaged in providing banking and related financial services. It offers
deposit accounts, loans, debit cards, and public provident fund (ppf) accounts. The bank provides services such as loan
syndication, channel financing, corporate finance, dividend / interest warrant payments, insurance products, retail/deposit
products, forex transactions, acceptance of taxes and cash management services. The bank also provides specific
schemes for educational institutions, builders, hospitals, hotels and restaurants, and entertainment sectors. Additionally it
offers export services, import services, correspondent banking, authorised dealer branches and remittances. The bank is
headquartered in Mumbai, Maharastra, India.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 8

586
The United India Insurance Co Ltd

__________________________________________________________________________________________

Vijaya Bank partners with United India Insurance to sell non-life insurance products
Deal Type Partnership Deal Sub Type Co-Marketing
Deal Status Completed Announced Date 2010-03-06
Deal in Brief
Vijaya Bank, a provider of wholesale, corporate, and retail banking products and services, has entered into a
memorandum of understanding (MoU) with The United India Insurance Company Limited (UIIC), a general insurance
provider, for distribution of non-life insurance products. Both companies involved in the transaction are based in India.

Undfer the terms of the transaction, Vijaya Bank will distribute general insurance policies through its over 1,200 branches.

Vijaya Bank provides a wide range of banking products and services for individual and corporate customers. Its portfolio
of products and services includes credit cards, debit cards, NRI services, savings bank accounts, current accounts,
recurring deposits, capital gains schemes, tax savings schemes, home loans, vehicle loans, loan against property,
personal loans, education loans, online retail loans, NRE and NRO accounts, loan for traders and jewel loans.

United India offers a range of personal and commercial general insurance products.
Participant Company Information
Company Name Vijaya Bank Involvement Type Target
Company Overview
Vijaya Bank (VB) is a provider of retail and commercial banking, and treasury solutions. Its deposits and cards portfolio
includes savings bank accounts, current accounts, recurring deposits, fixed deposits, term deposits, non-resident rupee
accounts, resident ordinary rupee accounts, credit cards, gift cards, and debit cards. IThe bank provides lending solutions
for home, personal needs, education, online retail, jewelry, corporate, vehicle, property, securities, and trading,. It also
offers government sponsored schemes such as Prime Minister’s Employment Generation Programme, Deen Dayal
Antyodaya National Urban Livelihood, and Self Employment scheme for Rehabilitation of Manual Scavengers. The bank
also provides services such as NRI services, international banking, treasury, foreign exchange, mobile banking, and
remittance. VB is headquartered in Bangalore, India.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 9

587
The United India Insurance Co Ltd

__________________________________________________________________________________________

3 The United India Insurance Co Ltd - Recent Developments

Indian Extension For Aqualis Offshore

Date : 25 May 2016

United India Insurance Company has reappointed Aqualis Offshore to provide marine warranty services to the Oil and
Natural Gas Corporation Limited’s (ONGC) assets offshore India.This is the third one-year contract Aqualis Offshore has
received after the company first started working for United India Insurance Company and ONGC in 2014.Under the
agreement, Aqualis Offshore will continue to provide marine warranty services to ONGC's fleet of jack-up rigs and mobile
offshore production units (MOPU) in Indian waters."A contract extension such as this is the best possible confirmation that
a client is satisfied with the services we provide. We look forward to continue supporting ONGC and its many assets
operating offshore India," says Rodger Dickson, group marine director in Aqualis Offshore.Aqualis Offshore will support
ONGC with marine warranty surveyors from Aqualis Offshore's office in Dubai. The operations include review of rig move
documentation, issue of certification and on-board attendance.

Aqualis Offshore Signs Contract With ONGC

Date : 12 Jun 2015

Aqualis Offshore, part of Aqualis ASA, has been reappointed by United India Insurance Company to provide marine
warranty services to the Oil and Natural Gas Corporation Limited (ONGC) offshore India.Under the agreement,
international offshore marine and engineering consultancy Aqualis Offshore will provide marine warranty services to
ONGC's fleet of six jack-up rigs and three mobile offshore production units (MOPU) in Indian waters."We are proud to
announce this agreement with ONGC, the leading Indian energy company. We started working with ONCG last year, so
we believe this agreement confirms our capability and ability to deliver world-class services to a major offshore oil
company," says Reuben Segal, Director - Middle East, Aqualis Offshore.Aqualis Offshore will support ONGC with marine
warranty surveyors from Aqualis Offshore's office in Dubai. The operations include review of rig move documentation,
issue of certification and on-board attendance.Aqualis Offshore is a specialized marine and offshore engineering
consultancy focusing on the shallow and deep-water segments of the offshore oil, gas and wind industries.Aqualis
Offshore's contract party is Aqualis Offshore Marine Services LLC.

UBI, Dena Bank partner with insurers

Date : 22 Apr 2015

Union Bank of India (UBI) has joined forces with Star Union Dai-ichi Life Insurance and New India Assurance for offering
life and accidental death insurance policies respectively to its account-holders.The yearly premium for the life cover will be
INR330, and the annual premium for the accidental death cover will be INR12.The premium amount will be debited
directly from savings accounts of customers after they opt for it.Both the policies will offer assured sum of INR2 lakh each
to accountholders between the age-group 18 to 50 years.The policies will be offered under the Pradhan Mantri Jeevan
Jyoti Bima Yojana (PMJJBY) and Pradhan Mantri Suraksha Bima Yojana (PMJJBY) schemes. Customers will be allowed
to voluntarily opt for these schemes after paying the applicable premium.Moreover, Dena Bank has tied up with United
India Insurance to offer accidental insurance cover under the Prime Minister's Pradhan Mantri Suraksha Bima Yojana
(PMSBY).The cover, effective from 1 June 2015, will cover risk of INR2 lakh for accidental death and full disability and
INR1 lakh for partial disability.It will have a yearly premium of INR12, which will be auto-debited from the policy holder's
account. The cover will be available to all savings account holders of the bank between 18 to 70 years.

United India Insurance posts Rs.229 crores net profit for first quarter 2014-15

Date : 08 Aug 2014

United India Insurance Company, wholly owned by Government of India, has reported a healthy premium of ` 2,729 Crs.
for the first quarter ended 30th June, 2014, posting a growth rate of over 11%.The company has also reported an
impressive first Quarter (Q1) Profit After Tax (PAT) of ` 228.76 Crs., as against a PAT of ` 210.76 Crs. last year.The
Investment income of the company for the first Quarter stood at over ` 531 Crs. as against ` 447 Crs. for the
corresponding period in the previous year. The company, through efficient claims management, was able to reduce the
claims ratio from 83.27% to 81.95% during Q1. The Combined ratio (a measure of the profitability of insurance operations)
was reduced to 111.65% from 116.10% for 2013-14. The Market value of the company's total investment portfolio at the
end of the first quarter was ` 24,155 Crores, up by 12% over the end of last year. The networth of the company stood at a
robust ` 5,589 Crores as on 30.06.2014.The company continues to enjoy strong fundamentals with a solvency ratio of
2.60 as against the regulatory requirement of 1.50. ICRA has accorded iAAA rating for the 12th successive year to the
company, indicating its highest claim paying credentials. The company has also a rating of B++ (positive) from AM Best,
an International Rating Agency. The Q1 results show that the company's strategies are yielding the desired results and
the company is optimistic to comfortably complete a premium of ` 11,000 Crores in the current fiscal.The company would

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 10

588
The United India Insurance Co Ltd

__________________________________________________________________________________________

continue its thrust on the retail, MSME and rural insurance segments. The company is efficiently managing the mammoth
TN Chief Minister's Health Insurance Scheme for BPL families. The company also secured the mandate to implement the
TN Government Pensioners' Health Insurance Scheme in the current year.The company will continue to launch initiatives
to further the insurance inclusion in the Country by opening 200 Micro Offices in tier 4 towns and below, taking the total of
such offices to 1,314. The company has 66,500 agents and plans to take it to 80,000 by the year end. Of this, there are
193 micro insurance agents who take general insurance to the door step of common man in the rural areas. The company
has 51 Bancassurance tie-ups which includes many major nationalized banks. The company has tied up with 100 BCs
and 2,624 BCAs as on date. The company will leverage the Common Service Centres (CSCs) to deliver simple, retail
general insurance products in rural areas.The company continues to innovate on product offerings by recently launching a
revised and improved Family Medicare product with an unique "remote medical opinion" benefit. The company has on-line
customer portals in respect of 8 retail insurance products (Motor, Health, PA, OMP, House holders, Shopkeeper, Crop
insurance and Marine Insurance Open cover). On-line portal facilities have also been extended to our business
intermediaries like agents, motor dealers, bancassurance partners etc. The company has successfully deployed mobile
insurance applications and insurance kiosks to facilitate easy access to buy insurance for the customers.The company
plans to recruit 300 Officers and 630 Assistants during the current year to meet the growing customer service
requirements.The company maintains a robust solvency margin, which displays its strong and inherent fundamentals, and
continues to be in a premier position in rural and social insurance sector and thereby contributing to the insurance
inclusion in the Country.

United India Insurance clocks RS 9709 crores premium and posts RS 528 crores net profit

Date : 28 Apr 2014

United India Insurance Company continued to report improved performance, for the year ending 2013-14 by reporting an
impressive Profit Before Tax (PBT) of `633 Crores and a Profit After Tax (PAT) of over`528 Crores.The Company could
reduce the claims ratio to 82.56% for the year against 84.61% in 2012-13 thanks to better underwriting practices and
claims control measures deployed, this was despite the Uttarakhand flood losses. The Market Value of the Company's
total investment portfolio at the end of the year was 21545 Crores as against 19950 Crores last year, the investment
income stood at 1857 Crores. The networth of the Company grew to a robust 5361 crores from 4952.63 Crores last
year.The Company continues to enjoy strong fundamentals with a Solvency Ratio of 2.54 as against the Regulatory
requirement of 1.50. ICRA has accorded iAAA rating for the 11th successive year to the Company, indicating its highest
claim paying credentials. The Company has also secured a rating of B++(Positive) from AM Best, an International Rating
Agency. The results show that the Company's strategies are yielding the desired results. The Company is optimistic to
cross `11,000 Crores premium in the current fiscal.The Company has a network of 2242offices including 1114 micro
offices in remote locations, with a staff strength of 16907. The Company has 66500 agents and plans to take it to 80000
this year. In addition to this there are 193 micro insurance agents who take general insurance to the doorstep of common
man in the rural areas. The Company has the largest bancassurance tie-up with major nationalized and other banks. The
Company has also tied up with 16 BCs and 2624 BCAs as on date. Similarly, tie-up has been made with Common Service
Centres (CSCs) to deliver General Insurance Products in rural areas.The Company continues its thrust on the retail,
MSME and rural insurance segments. The Company is active in the roll-out of the Government of India's flagship health
Insurance programme for the BPL population (RSBY) and efficiently managing the mammoth Tamil Nadu Chief Minister's
Comprehensive Health Insurance Scheme for BPL families.The Company has developed online portals for 8 retail
insurance products (Motor, Health, PA, OMP, House holders, Shopkeeper, Crop Insurance and Marine Insurance Open
cover). Online portal facilities have also been extended to business intermediaries like agents, motor dealers,
bancassurance partners, brokers, etc. The Company has a wide spectrum of general insurance products offerings totaling
235, to meet the various requirements of the insuring public.

Source: Timetric

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 11

589
The United India Insurance Co Ltd

__________________________________________________________________________________________

4 The United India Insurance Co Ltd - SWOT Analysis

4.1 The United India Insurance Co Ltd - SWOT Analysis - Overview

The United India Insurance Co Ltd (UIIC) is a general insurance company, which provides personal and commercial
general insurance products. The company’s premium earnings, portfolio of products, and solvency margin are its key
strengths, even as its combined ratio and cash position remain areas of concern. In future, interest rates, natural
calamities, and regulation may affect the company’s business operations. However, economy in India, business
expansion, and non-life insurance segment in India may provide growth opportunities for the company.

4.2 The United India Insurance Co Ltd - Strengths

Strengths - Solvency Margin

The company maintains a strong solvency margin and ratio reflecting its ability to meet all its long term obligations. During
FY2017, the company was required to maintain solvency margin of INR39,980.1 million in FY2017. the company reported
solvency margin of INR46,080.2 million, which was well above the minimum requirement. UIIC’s solvency margin was
1.15 times higher than the requirement in FY2017.

Strengths - Premium Earnings

Increase in premium earnings reflects growth in demand for the company’s offerings. The company reported strong
growth in premiums during FY2017. Its gross direct premium increased by 31.1% to INR160,628.1 million in FY2017 from
INR122,503.6 million in FY2016. Growth was primarily due to strong performance of Fire and Miscellaneous segments,
which reported 4.1% and 36.2% increase in gross direct premium in FY2017, respectively. It had a market share of 13.4%
in general insurance industry based on gross direct premium in FY2017. It recorded net earned premiums of
INR120,323.1 million in FY2017, an increase of 20% over FY2016.

Strengths - Distribution Network

The company’s strong distribution network helps in generating strong sales. UIIC markets and sells its products through a
network of offices, agents, brokers, corporate agencies, and bancassurance and online channel. As on March 31, 2017,
the company operated through 2,129 offices across India. In FY2017, the company had strengthened its bancassurance
channel through tie ups with one private bank, seven major banks, 20 Non Banking Finance Companies, 31 Gramin and
Cooperative Banks. Furthermore, the company plans to enter into agreements to sell insurance policies online.

4.3 The United India Insurance Co Ltd - Weaknesses

Weaknesses - Profitability

The company reported decline in profitably during FY2017, which is an area of concern. The company reported operating
loss of INR22,406.8 in FY2017 compared to INR5,126.1 million in FY2016. Its net loss was INR19,135.3 million in FY2017
compared to net income of INR2,205.9 million in FY2016. The reported losses was primarily due to increase in net claims
incurred, commission expenses, and operating expenses related to insurance business by 47.6%, 21.6%, and 5.3% in
FY2017, respectively. Its operating profit ratio and net earnings ratio declined from -4.6% and 2.1% in FY2016,
respectively, to -19.4% and -14.3% in FY2017, respectively.

Weaknesses - Combined Ratio

The company’s combined ratio in FY2017 reached above the level of 100%, which is a concern area. At the end of
FY2017, the combined ratio of the company stood at 134%, compared to 119.9% in FY2016. The combined ratio above
100% indicates that the company is making underwriting losses. The company reported underwriting loss of INR44,445.8
million in FY2017.

4.4 The United India Insurance Co Ltd - Opportunities

Opportunities - Economy in India

The company may benefit from the growing Indian economy. According to the International Monetary Fund (IMF), GDP
growth rate of India stood is expected to reach 7.4% in 2018 and 8.2% in 2022. Such economic growth is likely to enable

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 12

590
The United India Insurance Co Ltd

__________________________________________________________________________________________

favorable market conditions and encourage spending on housing finance products in the country. The growth is expected
to be driven by robust consumer demand from a general increase in wages that offsets a slowdown in investment.

Opportunities - Non-Life Insurance segment Outlook in India

Growth in the Indian non-life insurance segment will allow the company to capitalize on growing opportunities and cater to
diverse requirements of its customers. According to in- house research, the gross written premium of Indian non-life
insurance segment is expected to value INR1.3 trillion (US$18.1 billion) in 2020. The growth in non-life insurance segment
is expected to be driven by increasing automobile sales, growth in the real estate and construction industries, and
favorable regulatory changes.

4.5 The United India Insurance Co Ltd - Threats


Threats - Competition

UIIC operates in an intensely competitive Indian insurance market, which may adversely affect its market share and
profits. The company competes with various insurance companies based on the factors such as premiums charged and
other terms and conditions offered, products and services provided, financial ratings assigned by independent rating
agencies, speed of claims payment, reputation, selling effort, perceived financial strength and the experience of the
insurer or reinsurer in the line of insurance or reinsurance to be written. Some of the major competitors of the company
include Bajaj Allianz General Insurance Company Limited, ICICI Lombard General Insurance Company Limited, Royal
Sundaram General Insurance Co. Limited, The Oriental Insurance Company Ltd, and HDFC ERGO General Insurance
Company Limited.

Threats - Changing Regulations

The company’s businesses are regulated by various governmental and regulatory authorities. Changes in government
policy, legislation or regulatory interpretation may adversely affect the company’s product range, distribution channels,
capital requirements and, consequently, reported results and financing requirements. These changes include possible
changes in statutory pension arrangements and policies, the regulation of selling practices and solvency requirements.
The Indian insurance industry is supervised and regulated by the Insurance Regulatory and Development Authority of
India (IRDAI). The recent changes made in insurance regulatory framework in March 2017 include issuance of guidelines
on claim processing for group life insurance policies for new categories of master policyholders, and introduction of two
panels of actuaries for life insurers and non-life insurers. In January 2017, IRDAI established a committee to review
regulations governing life insurance products. Thus, the changes in government policies and regulations may have a
negative impact on the company’s growth and expansion strategies.

Threats - Interest Rates

Fluctuations in interest rates may have an adverse effect on the company’s profitability. The company’s investment
portfolio contains interest rate-sensitive investments, such as municipal and corporate bonds. Interest rates are highly
sensitive to monetary policies of government, domestic and international economic and political conditions, and other
factors beyond the company’s control. Such volatile interest rates may impact the company’s operating performance, as
its income and investment returns depend on the level of interest rates.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 13

591
The United India Insurance Co Ltd

__________________________________________________________________________________________

5 The United India Insurance Co Ltd - Company Statement


A statement by Mr. M.N. Sarma, the Chairman and Managing Director of the company is given below. The following
statement has been taken from the company’s 2017 annual report.

During 2016-17, we retained our position in the Industry on premium terms, collecting a record premium of 16,062 Crores
with a growth rate of 31%. The year saw our foray into new segments like Crop Insurance. There was growth in Gross
Direct Premium across all segments. However, the financials were a cause for concern. The Top Management of the
Company is confident about restoring past glory of the Company within the next 12 months. The Company has its
strength in its 16500 + human resources, 60000 + Agency force and a lot of other business partners and associates
spread across the Country, selling non-life insurance in the hinterlands of this great Country. The strategy laid down by
the Management together with disciplined execution by all our employees, particularly the marketing force, is bound to
achieve growth of business in profitable lines of business. This, together with faster and better claims management and
proactive and goal oriented management of our Investment Resources, would certainly help us achieve 'Growth with
Profit', the need of the hour.

We are also working on development of new products to meet our customer needs better and on the Government of
India's financial inclusion objectives. Leveraging all the new distribution channels is certainly the way forward.

I place my sincere appreciation and gratitude to the Board of Directors and the Regulatory Authority for the guidance and
support received from them. I also wish to place on record my gratitude to our customers, employees, business
intermediaries and vendors for their continued support. All these facilitated our Company to deliver credible operational
performance, under challenging circumstances, as also deliver excellence in customer service. With our resolve to adhere
to prudent underwriting and efficient claims management, I look forward to the next financial year with great optimism.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 14

592
The United India Insurance Co Ltd

__________________________________________________________________________________________

6 The United India Insurance Co Ltd - History

Table 2: The United India Insurance Co Ltd - History


Year Event type Description

The company received approval for the point of sale distribution of ten new
2017 New Product Approvals
products.

In March, the company was honored with Vigilance Excellence Award 2016-17
2017 Corporate Awards
by the Institute of Public Enterprises, Hyderabad.

2016 New Products/Services In September, the company launched its online portal for individuals.

The company implemented a crop insurance scheme in Bihar, Rajasthan,


2016 New Products/Services
Odisha, West Bengal, Karnataka, Kerala, Gujarat, and Puducherry.

In May, the company reappointed Aqualis to offer marine warranty services to


2016 Contracts/Agreements
the Oil and Natural Gas Corporation Limited’s assets offshore India.

The company launched four new policies, UNI MSME Protect Insurance Policy,
2015 New Products/Services UNI EXECUTIVE PROTECT-Directors and Officers, Uni Product Liability –
Insurance and Shopkeepers Insurance Policy.

The company and Life Insurance Corporation of India entered into a


memorandums of understanding with Kerala Gramin Bank to provide life and
2015 Contracts/Agreements
accident insurance covers for all the savings account holders under the‘Pradhan
Mantri Jeevan Jyoti Bima Yojana’ and Pradhan Mantri Suraksha Bima Yojana.

The company and Star Union Dai-Ichi Life New India Insurance entered into an
2015 Contracts/Agreements agreement with Dena Bank and Union Bank of India to provide accidental
insurance cover under the social schemes.

2014 Corporate Changes/Expansions The company opened two new regional offices in Raipur and Puducherry.

2014 Corporate Changes/Expansions The company opened 162 micro offices in the country.

The company established 15 micro insurance cells in the country to promote


2014 Corporate Changes/Expansions
Micro insurance business.

United India Insurance received two Finnoviti Awards in recognition of its two
2012 Corporate Awards innovations in financial services sector in the Finnoviti 2012 Awards Ceremony
by banking frontiers, Glocalinfomart Pvt. Ltd.

The company was awarded ‘General Insurer of the Year–Public Sector’ for the
2012 Corporate Awards
second consecutive year by Bloomberg UTV.

The company won the General Insurer of the year Award – Public Sector by
2011 Corporate Awards
Bloomberg UTV at the Financial Leadership Awards 2011.

The company entered into an agreement with Dena Bank for marketing the
2011 Contracts/Agreements
general insurance policies through their branches.

The company signed a memorandum of understanding (MoU) with Vijaya Bank


2011 Contracts/Agreements
for the distribution of general insurance products.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 15

593
The United India Insurance Co Ltd

__________________________________________________________________________________________

Table 2: The United India Insurance Co Ltd - History


Year Event type Description

The company was named as the 'Best Insurer-Non-Life' at the 3rd Dalal Street
2011 Corporate Awards
Investment Journal PSU Awards 2011.

2011 Corporate Awards The company received the 'SKOCH Financial Inclusion Award 2011'.

The company was awarded the Best Non-Life Insurer by NDTV Profit - Business
2010 Corporate Awards
Leadership Awards 2010.

The company signed agreement with LICHFL Financial Services ltd, to distribute
2010 Contracts/Agreements
the non life products of UIIC.

The company was selected as one of the top three general insurance companies
2010 Corporate Awards
at the 14th Asia Insurance Industry Awards 2010.

The company opened four large corporate cells in Pune, Kolkata, Hyderabad
2009 Corporate Changes/Expansions
and Bengaluru to continue its foray into large corporate business.

The company and The Export Credit Guarantee Corporation of India Ltd. signed
2008 Contracts/Agreements
an agreement to provide marine insurance cover for its customers.

The company launched three new health insurance policies under the name of
2007 New Products/Services
Platinum, Gold and Senior Citizens.

2007 Corporate Awards UIIC received best implemented IT projects award from PCQuest.

The company signed a seven-year agreement with Hewlett Packard to


2007 Contracts/Agreements
implement a complete turnkey solution for core insurance.

UIIC along with the National Insurance Company, and New India Insurance
2000 Others
Company operated as a subsidiary of General Insurance Company.

1972 Commercial Operation The company's General Insurance Business was nationalized.

The general insurance operations of Life Insurance Corporation of India southern


1972 Acquisitions/Mergers/Takeovers
region were merged with United India Insurance.

Twelve Indian Insurance Companies, four cooperative insurance societies and


1972 Acquisitions/Mergers/Takeovers Indian operations of five foreign insurers were merged with United India
Insurance Company Limited.

1938 Incorporation/Establishment The United India Insurance Company Limited was incorporated.

Source: Timetric

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 16

594
The United India Insurance Co Ltd

__________________________________________________________________________________________

7 The United India Insurance Co Ltd - Key Employees

Table 3: The United India Insurance Co Ltd - Key Employees

Name Job Title Board Level Since

Anitha Rajaram Deputy General Manager Senior Management

B Balachandra Director, General Manager Executive Board

B Rajaram Deputy General Manager Senior Management

B. B. Dash General Manager, Chief Financial Officer Senior Management 2016

C.R.Vijayan General Manager Senior Management

D Nagalakshmi Deputy General Manager Senior Management

D T V Sastri General Manager Senior Management 2017

Gauri Venkatesan Deputy General Manager Senior Management

K Nandakumar Deputy General Manager, Chief Risk Officer Senior Management

K. Govindarajan Chief Marketing Officer, General Manager Senior Management 2017

M Shahul Hameed Deputy General Manager Senior Management

M.N. Sarma Managing Director, Chairman Executive Board 2017

Madnesh Kumar Mishra Director, Joint Secretary Executive Board

P. Hemamalini Director, General Manager Executive Board

Parijat Dutta Director Non Executive Board

R A Sankara Narayanan Director Non Executive Board

R Balaji Deputy General Manager Senior Management

R C Agrawal Deputy General Manager Senior Management

R Hariharan Deputy General Manager Senior Management

Rajamohan Bhavaraju General Manager Senior Management

S Ramadoss Deputy General Manager Senior Management

S V Venkatesh Murthy Deputy General Manager Senior Management

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 17

595
The United India Insurance Co Ltd

__________________________________________________________________________________________

Table 3: The United India Insurance Co Ltd - Key Employees

Name Job Title Board Level Since

Sindhu Pillai Director Non Executive Board

Siva Prasad Petla Deputy General Manager Senior Management

Sukesini Ramaswamy Deputy General Manager Senior Management

V K Ramchander Deputy General Manager Senior Management

V Subbulakshmi Appointed Actuary Senior Management

V. Sundaresan Chief Vigilance Officer Senior Management 2017

Venkataraman S Secretary - Company Senior Management

Source: Timetric

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 18

596
The United India Insurance Co Ltd

__________________________________________________________________________________________

8 The United India Insurance Co Ltd - Locations and


Subsidiaries

8.1 The United India Insurance Co Ltd - Head Office

The United India Insurance Co Ltd


Chennai
Zip: 600014
India
Tel: + 91 4428520161

8.2 The United India Insurance Co Ltd - Other Locations and Subsidiaries

Table 4: The United India Insurance Co Ltd - Subsidiaries

Zenith Investments and Securities Limited


Mehta House
Samachar Marg
Mumbai
India

Source: Timetric

Table 5: The United India Insurance Co Ltd - Locations

Silingi Buildings SCO No.123-124


134, Greams Road Sector 17-B
Chennai Chandigarh
Zip: 600006 Zip: 160008
India India
Tel: + 91 44 28293933 Tel: + 91 172 2716339
Fax: + 91 44 28293639 Fax: + 91 172 2711483

No.3, Enkay Complex, I Floor Krishi Bhavan, 5th and 6th Floor
Keshwapur Nrupathunga Road
Hubli Banglore
Zip: 560023 Zip: 560001
India India
Tel: + 91 836 2264460 Tel: + 91 80 22534011
Fax: + 91 836 2366983 Fax: + 91 80 22534024

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 19

597
The United India Insurance Co Ltd

__________________________________________________________________________________________

Table 5: The United India Insurance Co Ltd - Locations

Arif Chambers,1 6th floor, United India Bhawan


Kaporthala Bagh Complex Nr. Income-Tax Circle, Ashram Road
Lucknow Ahmedabad
Zip: 226020 Zip: 380014
India India
Tel: + 91 522 2327043 Tel: + 91 79 27544711
Fax: + 91 522 2327061 Fax: + 91 79 27544718

136, Feroze Gandhi Market 3-5-817 & 818, P.B.No:1020


P.B.No:352 United India Towers, Basheerbag
Ludhiana Hyderabad
Zip: 141001 Zip: 500029
India India
Tel: + 91 161 5030736 Tel: + 91 40 23236367
Fax: + 91 161 2773084 Fax: + 91 40 23231847

Chibbar House, Floor No.1


364-367 Dr.Nanjappa Road
G.S.Road
Coimbatore
Guwahati
Zip: 641018
Zip: 781005
India
India
Tel: + 91 422 2239709
Tel: + 91 361 2341577
Fax: + 91 422 2230402
Fax: + 91 361 2340606

Source: Annual Report, Company Website, Primary and Secondary Research

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 20

598
The United India Insurance Co Ltd

__________________________________________________________________________________________

9 Appendix

9.1 Methodology

Timetric company reports are based on a core set of research techniques which ensure the best possible level of quality
and accuracy of data. The key sources used include:
• Company Websites
• Company Annual Reports
• SEC Filings
• Press Releases
• Proprietary Databases

Notes
• Financial information of the company is taken from the most recently published annual reports or SEC filings
• The financial and operational data reported for the company is as per the industry defined standards
• Revenue converted to US$ at average annual conversion rate as of fiscal year end

9.2 Disclaimer

All Rights Reserved

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, Timetric.

The data and analysis within this report is driven by Timetric from its own primary and secondary research of public and
proprietary sources and does not necessarily represent the views of the company profiled.

The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the
findings, conclusions and recommendations that Timetric delivers will be based on information gathered in good faith from
both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such Timetric can
accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect.

___________________________________________________________________________________________

The United India Insurance Co Ltd - SWOT Profile Page 21

599

You might also like